ma (cantab.), md (cantab.), frcp (lond.) - newa1 curriculum vitae july, 2018 professor c. b. bunker...

1

CURRICULUM VITAE July, 2018

Professor C. B. Bunker

MA (Cantab.), MD (Cantab.), FRCP (Lond.)

Consultant Physician, Dermatology

University College and Chelsea & Westminster Hospitals, London

Honorary Professor

University College and Imperial College, London

Honorary Consultant in Dermatology

Royal Hospital Chelsea and St Luke’s Hospital for the Clergy, London

ADDRESSES:

NHS

University College Hospital,

235 Euston Road, London

NW1 2BU

[email protected]

Academic [email protected]

Private Practice

King Edward VII Hospital

Beaumont Sreet, London W1G 6AA, UK

+44 (0)20 7794 5943

[email protected]

Home

3 Rudall Crescent, London

NW3 1RR, UK

+44 (0)20 7794 5943

[email protected]

FOR AN EXPEDITIOUS RESPONSE, PLEASE SELECT EMAIL ADDRESS JUDICIOUSLY

CIVIL STATUS: British. Married. 2 daughters. dob: 22nd November, 1956

PROFESSIONAL General Medical Council 2699954 Revalidated 2016

STATUS: Medical Defence Union 161597J

ORCID ID 0000-0002-6693-7483

mailto:[email protected]




2

NAME: Christopher Barry BUNKER

EDUCATION: Wycliffe College, Stonehouse, Glos. 1970-74

St. Catharine’s College, Cambridge 1975-78

Westminster Medical School, London 1978-81

QUALIFICATIONS: BA (Cantab.) 2(i) Nat. Sci. Tripos (Path. Part II) 1978

LRCP (Lond.), MRCS (Lond.), MB, BS (Lond.) 1981

MRCP (UK) 1985

Specialist accreditation in Dermatology 1991

MD (Cantab.) 1992

FRCP (Lond.) 1996

MAJOR HONOURS, First Scholarship to Wycliffe College 1970

AWARDS & Kitchener Scholarship (Lord Kitchener National Memorial Fund) 1975-81

POSITIONS: Sir Jules Thorn Research Fellowship 1988-90

Sir Walter Langdon Brown Prize (joint winner), MD, Cantab. 1992-93

John Thornton Ingram Lecture, Royal College of Physicians 2001 & 2015

Personal Chair, Imperial College, London 2005

Personal Chair, University College, London 2010

President, St John’s Hospital Dermatological Society 2006-07

President, West London Medico-Chirurgical Society 2007-08

American Dermatological Association (International Honorary Member) 2008

President, Chelsea Clinical Society 2010-11

Dowling Orator, The Dowling Club 2010

Neil Smith Lecturer, St John’s Hospital Dermatological Society 2011

European Dermatology Forum, Member 2013

Poulogy Prize (Inaugural winner - Archives of Dermatology, USA) 2010

Clinical Excellence Awards: National Silver 2006-2017

President, British Association of Dermatologists 2012-14

Council, Royal College of Physicians, London 2012-14

Who’s Who 2015-

Plenary Lecturer, European Academy of Dermatovenereology (EADV) 2016

President, Dermatology Section, Royal Society of Medicine 2015-16

Pierre Deville Memorial Lecturer, Royal Society of Medicine 2016

President, The Dowling Club 2016-17

IMPACT METRICS: h-index 37; i10-index 145; citations 5,95; Research Gate 45.93; top 97.5% 2018

CURRENT UK Board Member, European Academy of Dermatovenereology (EADV) 2014-2020

POSITIONS: Honorary Secretary and Trustee, British Skin Foundation (BSF) 2015-

Trustee, START & Dermatrust

Medical Adviser & Oversight Group, All Party Parliamentary Group on Skin 2002-

External Professional Assessor, Health Service Ombudsman 2010-2012; 2014-

Board Member, British Society for Skin Care in Immunosuppressed Individuals (BSSCII) 2011-

Board Member, British Society for Male Genital Dermatology (BSMGD) 2000-

Expert Resource Group; STDs and HIV, American Academy of Dermatology 2010- Chair, Data Monitoring Committee, SPOT trial 2014-

Editorial Board, Clinics in Dermatology 2015-

3

Editorial Board, Dermatology in Practice 2016-

4

MOST IMPORTANT PUBLICATIONS-PAPERS:

1. Bunker CB, Terenghi G, Springall DR, Polak JM & Dowd PM. Deficiency of calcitonin gene-

related peptide in Raynaud’s phenomenon. Lancet 1990;336:1530-33.

2. Bunker CB, Reavley C, O’Shaughnessey D & Dowd PM. Calcitonin gene-related peptide in

treatment of severe peripheral vascular insufficiency in Raynaud’s phenomenon. Lancet 1993;

342:80-82.

3. Bunker CB, Foreman JC & Dowd PM. Digital vascular responses to histamine, compound 48/80

and calcitonin gene-related peptide in patients with Raynaud’s phenomenon. J Invest Dermatol

1991;96:314-317.

4. Bull HA, Courtney PF, Bunker CB, Rustin MHA, Pearce FL & Dowd PM. Basophil mediator

release in atopic dermatitis. J Invest Dermatol 1993;100:305-309.

5. Rowe A, Mallon E, Rosenberger P, Barrett M, Walsh J & Bunker CB. Depletion of cutaneous

peptidergic innervation in HIV-associated xerosis. J Invest Dermatol 1999;112:284-9.

6. Mallon E, Newson R & Bunker CB. HLA-Cw6 and the genetic predisposition to psoriasis: a

meta analysis of serological studies. J Invest Dermatol 1999;113:693-5.

7. Bunker CB, Newton JA, Kilborn J, Patel A, Conway GS, Jacobs HS, Greaves MW & Dowd PM.

Most women with acne have polycystic ovaries. Br J Dermatol 1989;121:675-680.

8. Mallon E, Young D, Bunce M, Gotch FM, Easterbrook PJ, Newson R & Bunker CB

HLA-Cw*0602 and HIV associated psoriasis. Br J Dermatol 1998;139:527-533.

9. Mallon E, Bunce M, Savoie H, Rowe A, Newson R, Gotch F & Bunker CB. HLA-C and

guttate psoriasis. Br J Dermatol 2000;143:1177-1182.

10. Fearfield LA, Larkin JMG, Rowe A, A’Hern R, Fisher C, Francis N, MacKie R, McCann B, Gore

ME & Bunker CB. Expression of p16, CD95, CD95L and HPA in relapsing and non-relapsing

very thin melanoma. Br J Dermatol 2007;156:440-7.

11. Chapman A, Williams G, Soni N, Bunker CB. G-CSF in toxic epidermal necrolysis (TEN). Br J

Dermatol 2010;162:860-5.

12. Edmonds EVJ, Barton G, Buisson S, Francis N, Gotch F, Game L, Haddad H & Bunker CB. Gene

expression profiling in male genital lichen sclerosus (MGLSc). Int J Exp Pathol 2011;92:320-

325.

13. Edmonds E, Hunt S, Hawkins D, Dinneen M, Francis N & Bunker CB. Clinical parameters in

male genital lichen sclerosus: a case series of 329 patients. J Eur Acad Dermatol Venereol

2012;26:730-7.

14. Singh S, Kaye S, Francis N, Peston D, McClure & Bunker CB. Human endogenous retrovirus K

(HERV-K) rec mRNA is expressed in primary melanoma but not in benign naevi or normal skin.

Pig Cell & Mel Res 2013;26:426-8.

5

15. Bunker CB, Patel, N & Shim TN. Urinary voiding symptomatology (micro-incontinence) in male

genital lichen sclerosus (MGLSc). Acta Derm Venereol 2013;93:216–256.

16. Rashidghamat E, Bunker CB, Bower M & Banerjee P. Kaposi Sarcoma in HIV-negative men who

have sex with men. Br J Dermatol 2014;171:1267-8.

17. Kravvas G, Shim TN, Doiron PR, Freeman A, Jameson C, Minhas S, Muneer A, Bunker CB. The

diagnosis and management of male genital lichen sclerosus: a retrospective review of 301 patients.

JEADV 2018;32:91-95.

18. Shim TN, Doiron PR, Francis N, Minhas S, Muneer A, Hawkins D, Dinneen, M & Bunker CB

Penile lymphoedema: approach to investigation and management. Clin Exp Dermatol 2018 (in

press).

MOST IMPORTANT PUBLICATIONS-REVIEW ARTICLES:

1. Bunker CB. Acne: a review of therapy. Drugs of Today 1988;24 229-234.

2. Bunker CB. CGRP, ET-1 and Raynaud’s phenomenon. Current Medical Literature:

Rheumatology 1993;12: 87-89.

3. Bunker CB. Topics in penile dermatology. Clin Exp Dermatol 2001;26:469-79.

4. Porter WM & Bunker CB. The dysfunctional foreskin. Int J STD & AIDS 2001;12:216-20.

5. Singh S & Bunker CB. Male genital dermatoses in old age. Age Ageing 2008;37:500-504

6. Singh S, Kaye S, Gore ME, McClure MO, Bunker CB. The role of human endogenous

retroviruses in melanoma. Br J Dermatol 2009;161:1225-1231.

7. Meys R Gotch FM & Bunker CB. Human papillomavirus in the HAART era of HIV: an immune

reconstitution associated disease (IRAD)? Br J Dermatol 2010;162:6-11.

8. Morar N, Willis-Owen SA, Maurer T & Bunker CB. HIV associated psoriasis: pathogenesis,

clinical features and management. Lancet Inf Dis 2010;10:470-478.

9. Bunker CB & Shim TN. Male genital lichen sclerosus. Indian J Dermatol 2015;60:111-7.

10. Chan I, Hawkins, D & Bunker CB. Balanoposthitis. BMJ Point-of-Care 2009-

2015;http://www.pointofcare.bmj.com. Point of Care (US version) http://online.epocrates.com.

Best Practice (rest-of-world version) http://bestpractice.bmj.com/best-practice/welcome.html

11. Edwards S, Bunker C, Ziller F, van der Meijden WI. 2013 European guideline for the

management of balanoposthitis. Int J STD AIDS 2014;25:615-626.

http://www.pointofcare.bmj.com./

http://online.epocrates.com/

http://bestpractice.bmj.com/best-practice/welcome.html

http://www.ncbi.nlm.nih.gov/pubmed/24828553


6

MOST IMPORTANT PUBLICATIONS-GUIDELINES:

1. Abela C, Hartmann CE, De Leo A, de Sica Chapman A, Shah H, Jawad M, Bunker CB, Williams

GJ, Leon-Villapalos J. Toxic epidermal necrolysis (TEN): The Chelsea and Westminster Hospital

wound management algorithm. J Plast Reconstr Aesthet Surg 2014;67:1026-32.

2 Creamer D, Walsh SA, Dziewulski P, Exton LS, Lee HY, Dart JK, Setterfield J, Bunker CB,

Ardern-Jones MR, Watson KM, Wong GA, Philippidou M, Vercueil A, Martin RV, Williams G,

Shah M, Brown D, Williams P, Mohd Mustapa MF & Smith CH. UK guidelines for the

management of Stevens-Johnson syndrome/toxic epidermal necrolysis. Br J Dermatol 2016;174:

1194-227 & J Plast Reconstr Aesthet Surg 2016;69:736-41

3. Lewis FM, Tatnall FM, Velangi SS, Bunker CB, Kumar A, Brackenbury F, Mohd Mustapa MF,

& Exton LS. British Association of Dermatologists guidelines for the management of lichen

sclerosus 2018. Br J Dermatol 2018 Jan 4. doi: 10.1111/bjd.16241. [Epub ahead of print]

GUIDELINES DEVELOPED DURING BAD THERAPETICS AND AUDIT COMMITTEE MEMBERSHIP: 1. Roberts DT, Taylor WD & Boyle J. Guidelines for treatment of onychomycosis. Br J Dermatol 2003;148:402.

2. Sterling JC, Handfield-Jones, S & Hudson PM. Guidelines for the management of cutaneous warts. Br J Dermatol

2001;144:4-11.

3. Higgins EM, Fuller LC & Smith CH. Guidelines for the management of tinea capitis. Br J Dermatol. 2000:143:53-

58.

4. Cox N, Eedy D & Morton C. Guidelines for the management of Bowen’s disease. Br . Dermatol 1999;141: 633-641.

5. Roberts DLL, Anstey AV, Barlow RJ& Cox NH (BAD) and Newton-Bishop JA, Corrie PG, Evans J, Gore ME, Hall

PN & Kirkham N (MSG). UK guidelines for the management of cutaneous melanoma. Br J Dermatol 2002;146:7.

6. Motley R, Kersey P & Lawrence C. Multiprofessional guidelines for the management of the patient with primary

cutaneous squamous cell carcinoma. Br J Plas Surg 2003:56:85-91. 7. Grattan C, Powell S & Humphreys F. Management and diagnostic guidelines for urticaria and angio-oedema. Br J

Dermatol 2001;144: 708-714.

8. Wojnarowska F, Kirtschig G, Highet AS, Venning VA & Khumalo W. Guidelines for the management of bullous

pemphigoid. Br J Dermatol 2002;147:214.

9. Bourke J, Coulson I, & English J. Guidelines for care of contact dermatitis. Br J Dermatol 2001;145:877-885.

10. Neill SM, Tatnall FM & Cox NH. Guidelines for the management of lichen sclerosus. Br J Dermatol.2002;147:640.

MOST IMPORTANT PUBLICATIONS-LETTERS:

1. Bunker CB & Dowd PM. Topical minoxidil, scalp hair, and vasodilatation. Lancet 1987; i:1266.

2. Bunker CB, Foreman JC, & Dowd PM. Calcitonin gene-related peptide and Raynaud’s

phenomenon. Lancet 1990;335:239.

3. Bunker CB, Whittaker S, Luzatto L, Gore ME, Rustin MHA, Smith NP & Levene GM. Indolent

cutaneous prodrome of fatal HTLV-1 infection. Lancet 1990;335:426.

4. Rowe A, Farrell A, Kazmi SH, & Bunker CB. Expression of inducible nitric oxide synthase in

dermal microvasculature in psoriasis. Lancet 1994;344:1371.



7

5. Dowd PM, Bunker CB, Bull HA, Foreman JC, Terenghi G, Springall DR, & Polak JM.

Raynaud’s phenomenon, calcitonin gene-related peptide, endothelin and cutaneous vasculature.

Lancet 1990;336:1014.

6. Mallon E, Newson R & Bunker CB. HLA-Cw6 and the genetic predisposition to psoriasis: a

meta-analysis of published serologic studies. J Invest Dermatol 1999;113:693-5.

7. Burge S, Bunker C & Eedy D. Modernising Medical Careers. Young Doctors. The Times 2007

(Mar 21).

8. Singh S, Kaye S, Francis ND, Peston D, Gore ME, McClure MO & Bunker CB. Revisiting the

past: utilising archival tissue for the detection and quantification of gene expression. Br J

Dermatol 2009;160:885-6.

9. Bunker CB, Edmonds E, Hawkins D, Francis N & Dinneen M. Re: Pugliese et al. Lichen

sclerosus: review of the literature and current recommendations for management. J Urol

2009;181:1802-3.

10. Bunker CB. Urine in the causation of male genital lichen sclerosus. Re: Kulkarni S et al. Lichen

sclerosus of the male genitalia and urethra: surgical options and results in a multicenter

international experience with 215 patients. Eur Urol 2009;55:945–956.

11. Bunker CB. Comments on the BAD guidelines for the management of lichen sclerosus Br J

Dermatol 2011;164:894-5.

12. Doiron P & Bunker CB. Response to "Expanding the benefits of HPV vaccination to boys and

men”. Lancet 2016;388:659.

MOST IMPORTANT PUBLICATIONS-BOOKS:

1. Bunker CB & Dowd PM. Skin Disease. In: Medicine. Edited by Axford J. Blackwell Scientific

Publications, Oxford, 1996.

2. Bunker CB & Dowd PM. Raynaud’s phenomenon. In: Cutaneous Medicine and Surgery.

Edited by Arndt et al.. Saunders, New York, 1996.

3. Bunker CB. Dermatological Problems in HIV Infection and AIDS. In: Medical Management of

HIV and AIDS. Edited by Millar A. Springer-Verlag. Berlin, 1996; 162-189.

4. Bunker CB & Bridgett CK. Depression and the Skin. In: Depression and Physical Illness.

Edited by Robertson MM. & Katona CLE. John Wiley & Sons, London,1997.

5. Bunker CB & Staughton RCD. Dermatology. In: Chelsea & Westminster AIDS Care

Handbook. Edited by Gazzard B. Mediscript, London, 1999.

6. Bunker CB. Dermatology. In: Medicine at a Glance. Edited by Davey P. Blackwell Scientific

Publications, Oxford, 2002

8

7. Bunker CB & Staughton RCD. Dermatology. In: Chelsea & Westminster AIDS Care

Handbook. Edited by Gazzard B. Mediscript, London, 2002.

8. Fearfield L, Stephenson A, Bunker CB, Thomas M & Gore M. Skin cancer and melanoma. In:

Cancer in Primary Care. Eds Gore M. & Russell D. Martin Dunitz, London & New York,

2003.

9. Bunker CB. Male Genital Dermatology. Saunders, London, 2004.

10. Agnew K, Gilchrest B & Bunker CB. Fast Facts-Skin Cancer. Health Press, London UK, 2005

11. Bunker CB & Gotch F. HIV and AIDS. In: Textbook of Dermatology (Rook). 7th Edition.

Oxford, Blackwells. 2004.

12. Bunker CB & Neill SA. The Umbilicus, Perianal and Genital Regions. In: Textbook of

Dermatology (Rook). 7th Edition. Oxford, Blackwells. 2004.

13. Bunker CB. Skin Disease. In: Medicine 2e (Edited by Axford J, O’Callaghan J.) Blackwell

Scientific Publications. Oxford, 2004.

14. Bunker CB & Staughton RCD. Genital inflammatory papules and nodules. In: Genital

Dermatology. Edited by Edwards L. Saunders, Philadelphia, 2004.

15. Bunker CB. Dermatology. In: Medicine at a Glance 2e. Edited by Davey P. Blackwell

Scientific Publications, Oxford, 2005.

16. Bunker CB. Chapter 51. Non-venereal penile dermatoses. In: Kumar B, Gupta S Eds.

Sexually Transmitted Infections. Elsevier, New Delhi, 2005; pp 539-564.

17. Bunker CB. Male Genital Dermatology. Fitzpatrick’s Dermatology in General Medicine, 7th

edition. Wiley 2007.

18. Bunker CB & Gotch F. HIV and AIDS. In: T.Burns, S. Breathnach, N.Cox and C. Griffiths,

(eds.) Rook’s Textbook of Dermatology. 8th edition. Wiley-Blackwell, New York. 2010;35:1-

47.

19. Bunker CB & Neill S.A. The genital, perianal and umbilical regions. In: T.Burns, S. Breathnach,

N.Cox and C. Griffiths, (eds.) Rook’s Textbook of Dermatology. 8th edition. Wiley-Blackwell,

New York. 2010;71:1-102.

20. Bunker CB. Dermatology. In: Medicine at a Glance 3e. Edited by Davey P. Wiley-Blackwell,

Oxford, 2010.

21. Edwards S & Bunker CB. Other conditions affecting the male genitalia. In: ABC of Sexually

Transmitted Infections. Ed. Rogstad KE. Sixth Edition. Wiley-Blackwell 2011, pp 35-41.

22. Bunker CB. Non-venereal penile dermatoses. In: Gupta S. & Kumar B. Eds. Sexually

Transmitted Infections. 2nd edition. Elsevier, New Delhi, 2012; pp 703-727.

9

23. Calonje E, Neill S, Bunker C, Francis N, Chaux A & Cubilla AC. Diseases of the anogenital

skin. In: McKee’s Pathology of the Skin. Eds Calonje E, Brenn T, Lazar A& McKee P. 4th

Edition. Elsevier Saunders. London. 2012 Chapter 12. 438-519; pp 452-456.

24. Bunker CB. Diseases and disorders of the male genitalia. In: Goldsmith LA. Katz SI, Gilchrest

BA, Paller AS, Leffell DJ & Wolff K. Eds. Fitzpatrick’s Dermatology in General Medicine. 8th

edition. McGraw Hill 2012, pp 852-877.

GUEST EDITORSHIP Clinical Medicine CME Dermatology (Royal College of Physicians):

1. Fogo A, du Vivier A. The cutaneous manifestations of haematological malignancy. Clin Med

2009;9:366-70. Erratum in: Clin Med 2009;9:495.

2. Groves RW. Pemphigus. Clin Med. 2009;9:371-5.

3. Topham E. Cutaneous manifestations of cancer and chemotherapy. Clin Med 2009;9:375-9.

4. Dhoat S, Rustin M. The skin in general medicine. Clin Med 2009;9:379-84.

5. Roberts N. Infantile haemangioma: harmless 'strawberry' or life-threatening vascular anomaly?

Clin Med 2009;9:385-9.

MAJOR GRANTS:

1. Dr CB Bunker: Sir Jules Thorn Research Fellowship. Salary and costs. 1988-1990

2. Dr Eleanor Mallon: Research Fellowship. Salary and costs. 1998-1989

Joint Research Committee (Chelsea & Westminster Hospital).

3. Dr Louise Fearfield: Research Fellowship. Salary and costs. 1998-2000

Joint Research Committee (Chelsea & Westminster Hospital.)

4. Medical Research Council Grant No: G0000328 Grant ID: ID56834. 2001-2003

“Does venous surgery improve healing and minimise recurrence of venous ulcers?”

USABLE Trial (ICRCTN 97621126).

Investigators: Davies A, Greenhalgh R, Powell J, Russell I, Cullen N,

Thompson S, Bradbury A, Buxton M, Bunker CB, Stansby G, Torgerson D.

MRC alpha B rated from the Health Service Public Health Research Board.

5. Dr Emma Edmonds: Clinical Research Fellowship. Salary and costs. 2004-2006

START* and Joint Research Committee (Chelsea & Westminster Hospital).

6. Dr Sarita Singh: Clinical Research Fellowship. Salary and costs. 2006-2008

START* and Spyros Retsas Melanoma Research Fund.

7. Dr Rhonda Meys: Clinical Research Fellowship. Salary and costs 2007-2008

Joint Research Committee (Chelsea & Westminster Hospital) and START*.

8. Dr Sacha Goolamali: Clinical Research Fellowship, £70,000 salary 2009-2011

British Skin Foundation Grant



10

9. Dr Tang Shim: Sir John Fisher Trust. £75,000 salary and START costs 2011-2013

10. Dr Phil Doiron: Chelsea & Westminster Healthcare Charity. £150,000 salary and costs 2014-16

Clinical Research Fellowship

11. The Linbury Trust (Sainsbury family trust). £600,000. (in abeyance) 2014

Gerontodermatology

12. Dr Richard Watchorn: European Association of Dermatovenereology. €30,000 (costs) 2016

*START: Skin Treatment and Research Trust.

OTHER AWARDS and HONOURS:

French Scholarship (Royal College of Physicians/French Government), Sevres, Paris 1989

Dowling Club Bioglan Travelling Fellowship 1989

Lederle Acne Fellowship 1988

Silver Award, American Academy of Dermatology (Historical Poster) 1990

Gold Award, American Academy of Dermatology (Historical Poster) 1991

Bronze Award, American Academy of Dermatology (Historical Poster) 1992

Overseas Scholarship, World Congress of Dermatology 1992

Bristol Cup, British Association of Dermatologists (Research Poster) 1998

Visiting Professor, New York University, NY, USA 2000

Visiting Professor, Post Graduate Medical Institute, Chandigarh, India 2004

Visiting Professor, Boston University, MA, USA 2007

‘Highly Commended’, Medicine at a Glance. BMA Book Awards 2007

NHS Champions Nomination, Kings Fund 2008

Visiting Professor, Maadi Military Hospital, Cairo, Egypt 2009-2010

Nominee, (1/23), London Deanery, Best Clinical Trainer 2011

Excellence in Education, Outstanding Clinical Educators

Royal College of Physicians Regional Lecturer (Taunton) 2010

Honorary Member, Baltic Association of Dermatovenereologists 2014

Discretionary Points: 2 (1996); 1 (1997); 2 (1998); 1 (2000); 1 (2001)

Merit Awards: “B” (2001, 2005)

Clinical Excellence Awards: Local Bronze (2004); National Silver 2006-20

MEDICOLEGAL REPORTS:

Reports prepared for solicitors and counsel especially in melanoma, 1992-

pyoderma gangrenosum and penis cancer, often as a single joint expert.

Several reports for the Healthcare Commission 2007-2009

(Associate Complaints Advisor)

Several reports for the Health Service Ombudsman 2007-

11

(External Professional Assessor)

MISCELLANEOUS REPORTS:

Independent Review Panel: multidisciplinary care of a patient at another hospital 1999

(details confidential)

For the Health Service Ombudsman: patient complaint about 2007

clinical research ethics and governance at another institution (details confidential)

For Deputy Registrar: patient complaint about clinical research ethics and governance 2008

at another institution (details confidential)

For a Primary Care Trust and Cancer Network: 2009

Independent Review of Skin Cancer Services (details confidential)

12

GENERAL MEDICAL TRAINING:

House Physician and House Surgeon Posts, Westminster Hospital, London 1981-1982

Senior House Officer Posts, Derby, Oxford and The Middlesex Hospitals, London 1982-1985

Registrar, Psychiatry, The Middlesex Hospital, London 1985

Lecturer, Medicine (locum: Hon. Registrar)

University College & Middlesex School of Medicine, London 1985-1986

DERMATOLOGY TRAINING:

Senior House Officer, The Middlesex Hospital, London 1985

Registrar, The Middlesex and University College Hospitals, London 1986-1988

Honorary Clinical Assistant, St. John’s Hospital for Diseases of the Skin, London 1986-1987

Research Fellow (Hon. Senior Registrar), University College, London 1988-1990

Senior Registrar, University College Hospitals, London 1989-1992

MANAGEMENT EXPERIENCE:

King’s Fund College residential course for Senior Registrars (E729) 1991

Lead Clinician/Speciality Director, Dermatology, Chelsea & Westminster Hospital 1992-2001

Riverside Health Authority and Chelsea & Westminster Hospital Healthcare Trust

Project Board (HR 2000, Accounts and Personnel Database) 1992-1993

Project Group (HISS implementation) 1993-1995

Secretary, Medical Committee, Chelsea & Westminster Hospital 1995-2000

Chairman, Medical Committee, Chelsea & Westminster Hospital 2003-2007

ACADEMIC EXPERIENCE-TEACHING:

Undergraduate teaching and admin., Westminster, Nottingham, Oxford, UCMSM 1981-1991

Undergraduate teaching and admin., CXWMS, ICSM 1992-

BSc (Immunology, Biochemistry), UCMSM 1986-1994

MSc (STDs), ICSM 1999

MRCP course Parts I and II, UCMSM (BPMF, 1988) invigilator 1985

teacher 1985-91

organiser 1986-90

AFOM (RCP) invigilator 1985-7

~190 Postgraduate lectures (listed separately: p. 72) 1986-2009

20 Undergraduate and Postgraduate textbooks and chapters written 1986-2009

Learning, Teaching and Assessment Course, Oxford 2007

ACADEMIC EXPERIENCE-EXAMINING

500 MCQs (UCMSM MRCP): Two books published 1986-1992

OSSE and OSCE, CXWMX and ICSM 1997-

External Examiner, Diploma in Dermatology, 1996-2002

13

St. John’s Institute of Dermatology, St. Thomas’ Hospital, London,

MD (London), Dr J. Ramsbotham, Genetics of Psoriasis 1997

Examiner, Diploma in HIV Medicine, Society of Apothecaries, London 2002-2012

Dermatology KBA Question Setting Group RCP (Jun) 2005

Dermatology KBA Question Setting Group RCP (Nov) 2005

MCQs for Medicine, 2nd Edition 2005

PhD (Manchester), Dr Helen Young (VEGF in Psoriasis) 2006

Dermatology SCE (Specialist Certificate Examination) Board (Jan) 2009

MD (London), Dr Emmanuela Campalani (Psoriasis Pharmacogenetics) 2009

MD (London), Dr Jane Setterfield (Mucous Membrane Pemphigoid) 2009

MD (London), Dr Catriona Maybury (Co-morbidities in Sever Psoriasis) 1st yr review 2013

PhD (Nottingham), Dr Ser Ling Chua (Pruritic Papular Ereuption in HIV) 2015

ACADEMIC EXPERIENCE-RESEARCH:

Part II Pathology ( Cantab.) supervised by Dr M. Mitchison) 1977 Tissue culture Biochemist (supraregional PRU, Westminster Hospital) supervised by Dr P. Riches 1978 Radioimmunoassay (IgE), polyacrylamide gel electrophoresis (CSF)

Clinical Research-Raynaud’s phenomenon, systemic sclerosis and acne 1985-1991 Laser Doppler velocimetry, video capillary microscopy, ovarian ultrasound, electron microscopy,

pulmonary function, psychometry, immunohistochemistry, biostatistics

Sir Jules Thorn Research Fellow-CGRP and Raynaud’s phenomenon 1988-1990 intradermal pharmacology, ELISA, DNA and RNA extraction, cloning and sub-cloning,

DNA restriction enzyme analysis, Sanger nucleic acid sequencing, Southern blotting,

polymerase chain reaction nucleic acid amplification, in situ hybridisation,

human endothelial cell culture, radioimmunoassay (CGRP, PG) immunohistochemistry, biostatistics

Clinical and Laboratory Research 1992-

vascular pharmacology, inflammation, psoriasis, lichen sclerosus, HIV, melanoma immunohistochemistry, molecular biology, electron microscopy, intradermal pharmacology,

nuclear magnetic reasonance spectroscopy, virology, immunogenetics

epidemiology, biostatistics

Research Supervision 1991-

BMS II (UCMSM) Psoriasis (mutageneticity of treatment) Mr M. Jefford 1991

BSc (Imperial College) Zoon’s balanitis Ms K. Bhate 2005

MD (Frieberg) Neuropeptides in HIV xerosis Dr P. Rosenberger 1997-1998

MD (Hamburg) HLA-C in psoriasis Dr J. Schilling 1998-2000

MD (London) Immunogenetics of psoriasis Dr E. Mallon 1997-1999

DM (Oxon) Prognosis of thin melanoma Dr L. Fearfield 1998-2004

MD (London) Male genital lichen sclerosus Dr E. Edmonds 2004-2007 (not submitted)

MD (Imperial College) Retroviruses in melanoma Dr S. Singh 2006-2009

MD (Imperial College) HPV in HIV IRD Dr R. Meys 2007-2010

MD (Imperial College) Non-melanoma skin cancer in HIV Dr S. Goolamali 2009-

MD (Imperial College) Male genital lichen sclerosus Dr T. Shim 2011-2016

MD (UCD) Male genital lichen sclerosus Dr R. Watchorn 2016-

14

Dr Mallon won the Norman Plummer Memorial Prize (Charing Cross Hospital, ICSM) 1999

Dr Singh was a runner-up for the Everett C. Fox prize 2011

(Residents and Fellows Symposium, American Academy of Dermatology, New Orleans)

Dr Singh and Dr Meys were joint runners up for the BAD Clive Archer THESI prize 2014

Dr Shim won a Scholarship to the World Congress on Cancers of the Skin (Edinburgh) 2014

One of his posters was selected for plenary presentation

Dr Shim was Runner Up in inaugural Royal Society of Medicine AbbVie 2015

Dermatology Trainee Research Prize awards

Dr Watchorn was a awarded and NIHR/BAD Travel Bursary to the IID, Orlando 2018

Dr Watchorn was Runner Up in Royal Society of Medicine AbbVie

Dermatology Trainee Research Prize awards

Seven sandwich students, University of East London (with Dr A. Rowe) 1994-2000

ACADEMIC EXPERIENCE-ADMINISTRATION

Medical Student Selection, UCSM 1989-91

Medical Student Selection, CXWMS, ICSM 1992-

Clinical Tutor, Imperial College 2005-2010

Research Director and Trustee, START (Skin Treatment and Research Trust) 1992-

Laboratories headed by headed by Dr A. Rowe PhD (molecular biochemist) until 2003

British Association of University Teachers of Dermatology (now defunct) 1993-2001

Westminster Medical School Research Trust – Trustee 1994-

Westminster Medical School Oncology Trust – Trustee (now defunct) 1999-2009

Research Committee /Way Forward Group, Chelsea & Westminster Hospital 1998-

Board Member/Executive Committee Member, Skin Pharmacology Society 1993-1995

School Council/Executive Board/Advisory Standing Sub-Committee/Academic Board

Charing Cross & Westminster Medical School 1995-1997

Vice-Principal’s Advisory Group, Imperial College School of Medicine 1997-1999

Convenor, Dermatology Curriculum Review, CXWSM and ICSM 1995-1997

College Tutor, Royal College of Physicians, Chelsea & Westminster Hospital 1995-2000

Good Clinical Practice and the EU Directive, ICH, (2001/20/EC), London 2005

I coordinated the successful RCP Visit and Review of ~50 Training Posts in Medicine and

Paediatrics at the CWH in April 1995.

GRANT REVIEWS:

Trustees of the Welcome Foundation. (Grant Review) 1993

Joint Research Committee, Chelsea and Westminster Hospital 1995-2010

Royal College of Surgeons of England, Research Fellowship Scheme Assessor 1999-2003

Reviewed application for BUPA Foundation Grant 2002


Royal College of Surgeons of England, Referee, Professors and Lecturers 2004

15


Royal College of Surgeons/Healing Foundation Research Fellowship Interviews 2005

Royal College of Surgeons, Hunterian Professorship Selection 2006

Royal College of Surgeons, Election of Professors & Lectureships 2007

British Skin Foundation, Grants Advisory Committee 2008-2010

Royal College of Surgeons Research Fellowship Scheme 2009


Rosetrees Trust, Small Grant Application 2010



Royal College of Surgeons, Hunterian Lectureship Selection 2014

Lupus, UK 2016

Abertawe Bro Morgannwg University Health Board 2016

UCLH Pleomorphic Dermal Sarcoma, Single peer review of research protocol 2017

16

EDITORIAL ACTIVITIES:

Associate/Co-Editor, Clinical & Experimental Dermatology 2003-2005

Editorial Board, British Journal of Dermatology 2012-2010

Editorial Board, Clinics in Dermatology 2015-

Editorial Advisory Board, Indian Journal of Dermatology Venereology and Leprosy 2009-2010

Editorial Advisory Board, International Journal of STD and AIDS 2010-

Advisory Editorial Board, Clinical & Experimental Dermatology 1995-2005

Helper, Lancet 1994, 1997, 2016

Reviewer,

American Journal of Clinical Dermatology, Archives of Dermatology; JAMA

Dermatology, British Journal of Dermatology, Skin Pharmacology, Clinical and

Experimental Dermatology, Journal of Experimental Pathology, Journal of Rheumatology,

Acta Dermato-Venereologica, Journal of Dermatological Treatment, Journal of

Immunopharmacology, Genitourinary Medicine and now Sexually Transmitted Infection,

Journal of Affective Disorders, Prescriber, Care of the Critically Ill, Journal of the

European Association of Dermatovenereology, Bone Marrow Transplantation, Journal of

Medical Case Reports, HIV Medicine, British Journal of Medical and Surgical Urology,

Histopathology, European Journal of Dermatology, Practical Neurology, Nature Urology

Reviews

Reviewer, Sexually Transmitted Infections CD ROM for Wellcome Trust 2003

Reviewer, Society of Authors and Royal Society of Medicine 2002, 2006, 2007

Medical Book Awards

Reviewer, NHS Clinical Knowledge Series-HIV Infection and AIDS www.cks.nhs.uk 2010

Executive Committee, Society of Authors Medical Writers Group 2005 –2007

ACADEMIC AMBITIONS;

I was successful in creating a University Chair in Dermatology at ICSM on the CWH campus (2001) but

this lapsed with the resignation of the appointee. The establishment of a University Department is still a

major ambition and that was one of the reasons for my move to UCLH and UCL in 2010. In 2014 I

secured ~£K650 from the Linbury Trust (Sainsbury Family Trusts) to establish and academic

department of Gerontodermatology at UCL; unfortunately a suitable appointment was not achieved.

I was awarded a Personal Chair at Imperial College in 2005 and at University College in 2010.

I continue to press for academic developments in Dermatology at UCL and ICL and in the UK.

(i) to provide research opportunities for Dermatology trainees,

http://www.cks.nhs.uk/

17

ii) to augment British dermatological research output, currently disproportionate to populace

morbidity and

iii) to improve the curricular prominence of Dermatology, currently disproportionate to populace

morbidity.

My personal research ambitions are to develop my interests in:

i) Genital dermatology (lichen sclerosus, penile intraepithelial neoplasia, penis cancer)

ii) Aetiopathogenesis, management and prognosis of thin melanoma

iii) HIV related skin disease, including skin and genital cancer

iv) Gerontodermatology

v) Toxic epidermal necrolysysis

18

OTHER CONTRIBUTIONS TO TEACHING, TRAINING, CME/CPD:

College Tutor, Royal College of Physicians 1995-2000

North Thames Specialist Training Committee, Dermatology (Vice-chair) 1996-2005

Proposal for 5 year curriculum HIV (for British Association of Dermatologists) 1998

SAC/JCHMT (Derm), British Association of Dermatologists Representative 2000-

Chairman (2005-2007)

SAC/JCHMT (GUM), British Association of Dermatologists Representative 2002-

British Association of Dermatologists (Therapeutics & Audit Subcommittee) 1997-2002

British Association of University Teachers of Dermatology (now defunct) 1994-2004

Royal Society of Medicine-Member of Council (Dermatology) 1977-2000

THESIS (The Skin Investigation Society) 1993-

Examiner, Diploma in HIV Medicine, Worshipful Society of Apothecaries, 2002-

In person, 2006, 2008, 2009

Imperial College London Examining

OSCE’s 2006

MBBS Finals Medicine 2006

MBBS PACES 2008

OSCE’s 2008

Kuwait Board of Dermatology Visiting Examiner, Part I Examinations 2008

International Investigative Dermatology, Edinburgh 2013

Local Organising Committee

XV World Congress on Cancers of the Skin, Edinburgh 2012-14

Local Organising Committee Member

Reviewer: International Classification of Diseases (ICD) 11th Revision/Review (beta version) 2014

Disorders of Male Genitalia

19

PREVIOUS POSTS:

Biochemist, Protein Reference Unit, Westminster Medical School, London 1978

Prof. J. Hobbs and Dr (later Prof.) P. Riches

House Physician, Westminster Hospital, London 1982

Drs F. Gibberd, R. Guiloff, R. Zeegen, A. Keat and Prof. D. Brewerton

House Surgeon, Westminster Hospital, London 1982

Messrs. D. Evans, B. Andrews, P. Aichroth, and K. Robinson

Senior House Officer, General and Renal Medicine, Derby City Hospital 1982-1983

Dr G. Cohen

Senior House Officer, Neurology, Derbyshire Royal Infirmary 1983

Drs R. Godwin-Austin, D. Jefferson and A. Whitely

Senior House Officer, Oncology, Churchill Hospital, Oxford 1983

Drs C. Paine, G. Wiernik, A. Laing and K. Durrant

Senior House Officer, Osler Chest Unit, Churchill Hospital, Oxford 1983-1984

Dr D. Lane

Senior House Officer, Endocrinology and Clinical Pharmacology, 1984

Radcliffe Infirmary, Oxford

Drs T. Hockaday, R. Turner, C. Burke, J. Mann and Prof. Grahame-Smith

Senior House Officer, Department of Dermatology, 1984-1985

The Middlesex Hospital, London

Drs G. Levene and Dr (later Prof.) P. Dowd

Registrar, Department of Psychiatry, 1985

The Middlesex, University College and St. Lukes Woodside Hospitals, London

Drs A. Beard and E. Chesser

Lecturer in Medicine, Honorary Registrar (locum) 1985-1986

Department of Medicine, University College and Middlesex School of Medicine

Dr N. Mcl. Johnson and Prof. S. Semple

Registrar (locum), Department of Dermatology, 1986

University College and Middlesex School of Medicine,

Drs T. Robinson, G. Levene, J. Gilkes and Dr (later Prof.) P. Dowd

Registrar, Department of Dermatology, 1986-1988

University College and Middlesex School of Medicine


Senior Registrar (locum), Department of Dermatology, 1986-1987


20


Honorary Clinical Assistant, St. John’s Hospital for Diseases of the Skin 1986-1987

Dr (later Prof.) P. Dowd and Prof. M. Greaves

Sir Jules Thorn Research Fellow, Honorary Senior Registrar 1988-1990

Departments of Dermatology, Pharmacology and Molecular Biology,


Dr (later Prof.) P. Dowd, Dr (later Prof.) J. Foreman, Prof J. Polak,

Prof R. Craig, Dr (later Prof.) P. Brickell

Senior Registrar, Department of Dermatology, 1989-1992



Consultant Physician, Department of Dermatology, Westminster Hospital 1992-1993

Consultant Physician, Department of Dermatology, Charing Cross Hospital 1992-2003

Consultant Physician, Department of Dermatology, Royal Marsden Hospital 1997-2010

PREVIOUS POSITIONS:

At School and University

Head of School House, Wycliffe College 1974

St. Catharine’s College May Ball Committee 1978

Summer Festival Committee, Westminster Medical School 1979

Publicity, Flowers Action Committee, Westminster Medical School 1980

Treasurer, Westminster Hospital Doctors Mess 1981-1982

As a Trainee

Secretary, UCMSM Wine Club 1988-1990

Local Organiser, Skin Pharmacology Society Meeting, Pitlochry, Scotland 1991

As a Consultant

Chairman, Westminster Wake Committee 1993

Lead Clinician, Department of Dermatology, Riverside HA 1992-2002

Project Board (Computerised Accounts and Personnel), RHA 1992-1993

Consultant, Procter & Gamble 1992-2005

(product development and post-marketing surveillance)

Project Group (HISS implementation), Chelsea & Westminster Hospital 1993-1995

Chelsea & Westminster Hospital Postgraduate Education Committeee 1993-1999

Board Member/Executive Committee Member, Skin Pharmacology Society 1993-1995

Trustee, Westminster Medical School Research Trust 1994-2010

Secretary, Medical Committee, Chelsea & Westminster Hospital 1994-2000

21

Editorial Advisory Board, Clinical & Experimental Dermatology 1995-2003

School Council/Executive Board/Advisory Standing Sub-Committee/

Academic Board-Charing Cross & Westminster Medical School 1995-1997

College Tutor, Royal College of Physicians, Chelsea & Westminster Hospital 1995-1999

Joint Research Committee, Chelsea & Westminster Hospital 1995-2010

North Thames Specialty Training Committee, Dermatology (Vice-Chair 2000-2004) 1996-2004

Royal Society of Medicine-Member of Council (Dermatology Section) 1997-2000

Therapeutics & Audit Subcommittee, British Association of Dermatologists 1997-2002

Archives Committee, Chelsea & Westminster Hospital, 1997-2005

Vice-Principal’s Advisory Group, Imperial College School of Medicine 1997-1999

Charing Cross and Westminster Medical School/Imperial College School of Medicine

“Past, Present and into the Future”, Cobham Event Committee Member 1998

Charing Cross and Westminster Medical School Alumnus Committee 1999-2007

Member, Specialty Advisory Committee (Dermatology), RCP 2000-2009

Consultant, British Advertising Clearance Centre 2001-2006

Adviser, London Regional Specialised Commisioning Group, Dermatology 2000-2001

Adviser, National Specialised Services Definition Set-Phase 2, Dermatology 2001-2002

Medical Committee, St. Luke’s Hospital for the Clergy (Clinical Lead, Dermatology) 2001-2008

Medical Advisory Panel, Independent Television Commission 2001-2005

Private Practice Committee, British Association of Dermatologists 2001-2004

Hon. Secretary, Westminster Hospital School and Staff Dining Club 2002-2010

Chairman, Skin Cancer Multidisciplinary Team, Charing Cross Hospital 2002-2003

Chairman, Skin Cancer Multidisciplinary Team, Chelsea &Westminster Hospital 2002-2010

Member, Skin Care Campaign Future Dermatology Services Working Party 2003-2004

Co-Editor, Clinical & Experimental Dermatology 2003-2004

Chairman, Medical Staff Committee, Chelsea & Westminster Hospital 2003-2007

Clinical Tutor, Imperial College (Medical Student Supervisor) 2005-2010

Scientific Committee, European Academy of Dermatovenereology, London 2005

Chairman, Specialty Advisory Committee (Dermatology), RCP 2005-2007

Member Joint Specialty Committee (Dermatology), Royal College of Physicians 2005-2007

Executive Committee, The Medical Writers Group, The Society of Authors 2005-2007

Member Specialty Advisory Committee, (GUM), JRCPTB, RCP 2005-2009

Chairman, Medical Advisory Board, The Mole Clinic/Scansol UK 2006-2007

West London Skin Tumour Working Group 2006-2010

Council Member, St John’s Hospital Dermatological Society 2006-2011

President, St John’s Hospital Dermatological Society 2006-2007

Organiser, inaugural Lucy Bull Memorial Melanoma Lecture 2007

Dermatology Adviser, England & Wales Cricket Baord 2007

European Union of Medical Specialists, Dermatology Representative 2007-2009

Associate Complaints Advisor, Healthcare Commission 2007-2009

Chairman, Specialist Skin Cancer Multi Disciplinary Team, CWH 2008-2010

Advisory Committee for Clinical Excellence Awards, North West Thames 2008-2010

Advisory Committee for Clinical Excellence Awards, North East Thames 2010-

Grants Committee, British Skin Foundation 2008-2010

Royal Society of Medicine-Member of Council (Library Rep.Dermatology Section) 2009-2011

Clinical Resource Group, Dermatology, National Commissioning Board 2011-2013

Chair, Steering Committee, LIMIT-1 (Lentigo maligna & imiquimod treatment) 2010-2013

Advisory Group, Tackling HIV Testing, MedFASH 2008-

Council, Dermatology Section, Royal Society of Medicine 2008-

22

Advisory Committee for Clinical Excellence Awards (NE & NW Thames) 2007-15

POSTGRADUATE COURSES:

Dowling Club Educational Weekend, Hull 1986

Entomology and Dermatology, RAMC, London 1986

Dowling Club Educational Weekend, Norwich 1986

Practical Procedures in Dermatology, Oxford 1986

Communications in Medicine, Windsor 1986

Biology of the Skin, Cambridge 1986

New Drug Treatments for Skin Diseases, Institute of Dermatology, London 1987

Histopathology of the Skin, Glasgow 1988

Dowling Club Educational Weekend, Oxford 1988

Dowling Club Educational Weekend, Liverpool 1988

Recent Advances in the Biological Sciences Applied to Dermatology, Cambridge 1988

Datastar On-line Literature Searching, London 1988

American Academy of Dermatology, Washington 1988 (Advanced Immunology, Dermatopharmacology, Directions in Dermatology, Ageing Skin,

Dermatitis Herpetiformis and Linear IgA Disease, Resident’s Symposium (Faculty Member)

Cell Membrane Receptors in Skin Diseases, Internal Medicine and Dermatology, Pharmacology of Drugs

Around the Corner, Update on Genodermatoses, Clinical Immunology, Contact Dermatitis and Contact Urticaria)

French for the Medical Profession, Royal College of Physicians./Institut Francais 1988-1989

French for The Medical Profession, Centre Internationale Etudes Pedagogique, Paris 1989 (sponsored place awarded by the French government and the Royal College of Physicians)

American Academy of Dermatology, San Francisco 1989 (Advanced Immunology, Life Threatening Dermatoses, Residents Symposium (Faculty Member)

Gross and Microscopic Dermatology (Faculty Member)

Dowling Club Educational Weekend, Sheffield 1990

In Situ Hybridisation, Royal Postgraduate Medical School, London 1990

Society for Investigative Dermatology, Washington 1990 (Special Methods Workshop: DNA Probes; the Polymerase Chain Reaction)

Dowling Club Educational Weekend, Leicester 1990

American Academy of Dermatology, Atlanta 1990 (Photobiology, Skin Disease in Black Races, Lasers in Dermatology)

Dowling Club Educational Weekend, London 1991

Management Training for Senior Registrars, King’s Fund College, London 1991

Dowling Club Educational Weekend, Durham 1991

American Academy of Dermatology, Dallas 1991 (Langerhans Cells, Dermatopharmacology (Faculty Member), Malignant Melanoma,

Contact Dermatitis, Psoriasis)

American Academy of Dermatology, San Francisco 1992 (Dermatopharmacology (Faculty Member)

American Academy of Dermatology, Washington 1993 (Dermatopharmacology (Faculty Member)

American Academy of Dermatology, New Orleans 1995 (Dermatopharmacology (Faculty Member), Advanced Immunology, Lasers, Atopic Dermatitis)

British Postgraduate Medical Federation, Appraisal and Assessment, London 1995

13th Annual Course in Advances in Dermatology, London 1996

College Tutor’s Seminar, Royal College of Physicians, London 1997

College Tutor’s Seminar, Royal College of Physicians, London 1998

Examining for: Objective Structured Skills Examination - OSSE 1998

23

Imperial College School of Medicine, Chelsea & Westminster Hospital, London

British Society for Dermatological Surgery Intermediate Workshop, Manchester 1998

Special Conference for College Tutors - Clinical Governance, 1999 Royal College of Physicians, London

Appraisal and Assessment, 1999 Chelsea & Westminster Hospital, Training Resource Centre, London Equal Opportunities/Non-discriminatory selecting and interviewing 1999 Chelsea & Westminster Hospital, Training Resource Centre, London American Academy of Dermatology, New Orleans 1999

Clinical Governance (Prof A. Newman Taylor, Dr N. Beresford) 1999 Chelsea & Westminster Hospital, London Television Teaching Course, ICSM, Chelsea & Westminster Hospital, London 2000

Postgraduate Course/ESDR/Stockholm

2001 Molecular tools in medical research, Gene therapy, UV and apoptosis, HPV and skin cancer,

Proteoglycan biology

Appraisal for Senior Medical Staff: Seminar. MiAD.uk 2002 Chelsea & Westminster Hospital OSCE Training Course for Examiners ICSM 2002

SAC/RSA/JCHMT Induction Day, Royal College of Physicians, London 2003

Direct Entry in the Specialist Register/JCHMT, Royal College of Physicians, London 2003

London Deanery Equal Opportunities Training, Beechcroft Wansboroughs, London 2004

Assessment Methods for SpR Training, Royal College of Physicians, London 2004

Competency Based Assessment Methods, Royal College of Physicians, London 2004

Dermatology Scientific Day, Update in Genetic Skin Diseases: the UK story, London 2005

Bringing Biotechnology to Dermatology, Royal College of Physicians 2005

Good Clinical Practice (Clinical Research) and the EU Directive (2001/20/EC) 2005

Research & Development office, Chelsea & Westminster Hospital

Article 14 Evaluators Training, JCHMT, Royal College of Physicians, London 2006

Adult & Paediatric Basic Life Support Update, Chelsea & Westminster Hospital 2006

Competency Assessments Feedback, Delegate and Speaker, BAD 2006

Creating a Robust Assessment Strategy for Undergraduate Medicine, Prof Val Wass 2006

Learning, Teaching and Assessment Course (Dermatology), Oxford 2007

Effective Supervision of Research Students, Institute of Cancer Research 2007

Interviewers’ Discussion Forum, Imperial College School of Medicine. 2007

American Academy of Dermatology, San Antonio 2008 (Hot Topics in Dermatology, Skin disease in the Oncology patient, Modern dermatological therapy,

Resident’s & Fellows Symposium, Drug Actions, Issues impacting your practice, Cutaneous cancer syndromes,

Consultative Dermatology for the hospitalised patient, Managing melanoma in the modern millennium)

Adult Basic Life Support & Advanced Life Support, Chelsea & Westminster Hospital 2008

UK Guidelines for HIV Testing (BASHH/BHIVA/BIS), Royal College of Physicians 2008

American Academy of Dermatology, San Antonio 2008 Medical Dermatology

Information Governance: Online Training Course E-learning Application 2008

Chelsea & Westminster Hospital

Specialty Certificate Examination Dermatology Examining Board 2009 Royal College of Physicians (two days)

Mandatory Training for Consultants, Royal Marsden Hospital 2009 Infection control, Medicine Management, Fire, Manual handling, Risk Management (Learning from SUIs), Safeguarding children, Consent, MCA, Safeguarding Adults, Communication Skills

Clinical Supervision for Experienced Supervisors 2009 Chelsea and Westminster Hospital

24

Advanced Communication Skills 2009 Royal Marsden Hospital Mandatory Training for Consultants 2010 Royal Marsden Hospital Infection Control, CPR

UCLH Induction Programme 2010 Corporate communications, Occupational Health and Safety, Clinical effectiveness,

Information governance, Safeguarding children and vulnerable adults, Infection control,

Fraud awareness, Equality and Diversity, Fire safety, Pneumatic tube system, Care of the back,

Medical Devices, Pharmacy and Medicines management, Anticoagulation,

Aseptic non-touch technique, Safe Transfusion practice, Malnutrition Universal Screening Tool,

Adult Resuscitation (Basic Life Support)

American Academy of Dermatology, New Orleans 2011 Residents and Fellows Symposium

Examiner Training (Assessment, OSCEs, BO5), Society of Apothecaries 2011

American Academy of Dermatology, San Diego 2012 Dermatology Diagnosis and the Visual Arts, Dermatology Speaker Development,

Tropical Dermatology, Telomeres, Leadership, Botox, Cosmetics, AIDS and STDs,

Strategies for Care for Uninsured and Underinsured, Clinical Issues in Medical Dermatology

Educational Supervision Course, UCLH/London Deanery 2013

Central London Research Network Dermatology Specialty Group Open Meeting 2013 Chelsea & Westminster Hospital

American Academy of Dermatology, Miami Beach 2013 TENS/SJS, Late-Breaking Research, World Congress 2015 Preview, Photodermatology,

Advaced Medical Dermatology

Non-melanoma Skin Cancer Update, BAD/RCP, London 2014

American Academy of Dermatology, Denver 2014 Warts, GVHD, Anger Management: ‘Hot Buttons’, Statistics, Skin of Color,

Hyroxychloroquine, Medical Dermatology Australasian College of Dermatologists, Melbourne 2014 Registrar Training Day, Genital Dermatology Symposium, Sentinel Node Biopsy

Dealing with Difficult People, ACM Training, London 2015

Good Clinical Practice, NIHR Research Governance, CWH, London 2015

An Introduction to Research Student Supervision, UCL, London 2017

Advanced Dermoscopy Course, St. John’s Academy, London 2017

CLINICAL AND SCIENTIFIC MEETINGS:

British Association of Dermatologists, Sheffield 1986

British Society for Investigative Dermatology, York 1986

Psoriasis, Cambridge 1986

A Biological Approach to the Wound Healing Process, RCP, London 1987

Laser Doppler User’s Group, Kings College Hospital, London 1987

Dermatopharmacology, RSM, London 1987

British Association of Dermatologists, London 1988

Centre Internationale Recherche Dermatologique Symposium, Cannes 1988

British Society for Investigative Dermatology, Manchester 1988

American Academy of Dermatology, Washington D. C. 1988

Laser Doppler User’s Group, St. Bartholomew’s Hospital, London 1989

Society for Investigative Dermatology, Japanese Society of Investigative Dermatology

& European Society for Dermatological Research, Washington D. C. 1989

25

European Society for Histamine Research, Breda, Holland 1989

British Association of Dermatologists, Cambridge 1989

Skin Pharmacology Society, New York 1989

Forum on Computers in Medicine, RSM, London 1989

Bayliss and Starling Society, Nottingham 1989

European Academy of Dermatology and Venereology, Florence 1989

American Academy of Dermatology, San Francisco 1989

British Microcirculation Society, London 1990

Society for Investigative Dermatology, Washington 1990

European Society for Histamine Research, Kuopio, Finland 1990

British Association of Dermatologists, Warwick 1990

British Society for Investigative Dermatology, Newcastle 1990

British Society for Rheumatology, London 1990

Skin Pharmacology Society, Hiroshima 1990

American Academy of Dermatology, Atlanta 1990

European Society for Dermatological Research, Copenhagen 1991


Skin Pharmacology Society (Local Secretary and Treasurer), Pitlochry, Scotland 1991

British Society for Investigative Dermatology, Leicester 1991

American Academy of Dermatology, Dallas 1991

Society for Investigative Dermatology, Baltimore 1992

World Congress of Dermatology (Overseas Scholarship), New York 1992

European Conference on the Microcirculation, London 1992

British Association of Dermatologists, Bournemouth 1992

British Society for Investigative Dermatology, Sheffield 1992

Skin Pharmacology Society, Cleveland, Ohio 1992


Society for Investigative Dermatology, Washington D.C. 1993

Skin Pharmacology Society (Session Moderator), Hong Kong 1993

American Academy of Dermatology, Atlanta 1993

Society for Investigative Dermatology, Baltimore 1994


British Society for Investigative Dermatology, Bath 1994

Skin Pharmacology Society, London 1994

American Academy of Dermatology, New Orleans 1995

British Society for Investigative Dermatology, Oxford 1995

Society for Investigative Dermatology, Chicago 1995

Skin Pharmacology Society, Vienna 1995

British Society for Investigative Dermatology, Glasgow 1996

Society for Investigative Dermatology, Washington D. C. 1996

Psoriasis-From Gene to Clinic, London 1996

British Society for Investigative Dermatology, Bristol 1997

Inflammatory & Thrombotic problems in Vascular Surgery. 1997 19th International Charing Cross Symposium, London Society for Investigative Dermatology, Washington D. C. 1997

European Academy of Dermatology and Venereology, Dublin 1997

British Society for Investigative Dermatology, Liverpool 1998

British Association of Dermatologists, Brighton 1998

Current Issues in Skin Therapeutics, London 1998 Society of Pharmaceutical Medicine and British Association of Dermatologists

26

UK Melanoma Study Group Meeting, Royal Marsden Hospital, London 1999

Joint Meeting, Sections of Coloproctology and Dermatology, RSM, London 1999


Society for Investigative Dermatology, Chicago 1999

Joint Meeting of Sections of Rheumatology and Dermatology, RSM, London 1999

UK Melanoma Study Group Meeting, Cambridge 2000



European Society for Dermatological Research, Berlin 2000

The Effective Management of Malignant Melanoma, RCP, London 2000

5th International Conference on Melanoma, Venice 2001

Society for Investigative Dermatology, Washington D. C. 2001

European Society for Dermatological Research, Stockholm 2001

European Academy of Dermatology & Venereology, Munich 2001

UK Melanoma Study Group, Royal Marsden Hospital, London 2002

Topical Immunomodulators (treatment of Atopic Dermatitis meeting), London 2002

UK Melanoma Study Group, Royal Marsden Hospital, London 2003

European Academy of Dermatology & Venereology, Barcelona 2003

Indian Association of Dermatology, Venereology and Leprosy, Mumbai 2004

British Association of Dermatologists, Belfast 2004

European Academy of Dermatology & Venereology, Florence 2004

Society for Investigative Dermatology, St Louis 2005

British Association of Dermatologists, Glasgow 2005

European Academy of Dermatology & Venereology, London 2005


British Association of Dermatologists, Manchester 2006

Melanoma Study Group Meeting, Southampton 2006

European Academy of Dermatology & Venereology, Rhodes 2006

Indian Association of Dermatology, Venereology and Leprosy, Dermacon, Chennai 2007

American Academy of Dermatology, Washington, D.C. 2007

Society for Investigative Dermatology, Los Angeles 2007

European Academy of Dermatology & Venereology, Vienna 2007

Scottish Dermatology Association, Dunfermline 2007

British Association of Dermatologists, Birmingham 2007

European Society for Dermatological Research, Zurich 2007

Indian Association of Dermatology, Venereology and Leprosy, Dermacon, Chandigarh 2008

American Academy of Dermatology, San Antonio 2008

International Investigative Dermatology Meeting, Kyoto 2008

Key Advances in the Effective Management of Malignant Melanoma, London 2008

Masterclass in Advanced Cancer Medicine-Skin Cancers, London 2008

Psoriasis – From Gene to Clinic, 5th International Congress, London 2008


World Congress on Cancer of the Skin, Tel Aviv 2009

Society for Investigative Dermatology, Montreal 2009

International Society of Dermatology, Prague 2009

Key Advances in the Effective Management of Malignant Melanoma, London 2009

Masterclass in Advanced Cancer Medicine-Malignant Melanoma, London 2010

American Academy of Dermatology, Miami Beach 2010

Society for Investigative Dermatology, Atlanta 2010

27

Dowling Club, Lincoln 2010

European Academy of Dermatology & Venereology, Gothenburg 2010

Sharm Derma 2010, Sharm El Sheikh 2010

European Society for Sexual Medicine, Malaga 2010

Royal College of Physicians (SW) Regional Meeting, Taunton 2010

American Dermatological Association, New York 2010

British Association of Dermatologists Annual UK Consultants Course, London 2010


Primary Care Dermatology Society of Ireland, Galway 2011

UCLH Penile Cancer Day 2011

VII All-Russian Congress “Men’s Health”, Rostov-on-Don 2011


Dowling Club, Oxford 2011

European Academy of Dermatology & Venereology, Lisbon 2011

Eastern Mediterranean Seminar on General Medicine, Limassol 2011

Asicon, National Conference of AIDS Society of India, Lucknow 2011

Medical Dermatology Meeting, BSMD/Endocrinology, RCP, London 2012

Indian Association of Dermatology, Venereology and Leprosy, DERMACON, Jaipur 2012

Dowling Club, India 2012

Ulster Dermatological Society, Craigavon 2012

European Association of Urology, Paris 2012

British Association of Dermatologists Strategy Day, London 2011

American Academy of Dermatology, San Diego 2012

Dowling Club, Stratford-upon-Avon 2012

Society for Investigative Dermatology, Raleigh 2012

International League of Dermatological Societies, 1st Summit. Berlin 2012

European Academy of Dermatology & Venereology, Verona 2012

International Medical Meeting, Riga 2012

Clinical Dermatology Update Meeting, SAS Doctors, Manchester 2012

American Dermatological Association, Washington 2012


Medical Dermatology Meeting, BSMD/Neurology, RCP, London 2013

European Dermatology Forum, Lucerne 2013

Dowling Club International Visit, Addis Ababa 2013

American Academy of Dermatology, San Diego 2013

Midlands Dermatological Society, Leicester 2013

International Investigative Dermatology, Edinburgh 2013

British Association of Dermatologists, Liverpool 2013

Dowling Club, Brecon, Wales 2013

European Academy of Dermatology & Venereology, Istanbul 2013

Clinical Dermatology Update Meeting, SAS Doctors, Manchester 2013

Baltic Association of Dermatovenereologists, Kaunas 2013

Primary Care Dermatology Society, Edinburgh 2013

XI International Congress of Dermatology and 42nd Dermacon, New Delhi 2013


European Dermatology Forum, Bern 2014

Primary Care Dermatology Society, Kenilworth 2014

American Academy of Dermatology, Denver 2014

British Society for the Study of Vulval Disease, Glasgow 2014

28

Australasian College of Dermatologists, Melbourne 2014

Australasian Society for Dermatological Research, Melbourne 2014

Baltic Association of Dermatovenereologists, Riga 2014

Dowling Club, Moscow 2014

British Association of Dematologists, Glasgow 2014

World Congress on Cancer of the Skin, Edinburgh 2014

European Academy of Dermatology & Venereology, Amsterdam 2014

Melanoma Focus, London 2014

UK TREND, London 2014

Medical Dermatology Meeting, (RCP, BAD, BSMD, BSSCII), London 2015

European Dermatology Forum, Bern 2015

Dermatology and Oral Medicine, UCL, London 2015

European Academy of Dermatology & Venereology, Valencia 2015

History of Dermatology Society, San Francisco 2015


European Association of Urology, Madrid 2015

Dubai Derma, Dubai World Dermatology & Laser Conference & Exhibition, Dubai 2015

Teach In. Dermatology for the General Physician, RCP 2015

Male Genital Disease, Anogenital & Oral Genital Dermatology Course, London 2015

Dowling Club & British Hair and Nail Society, Brighton 2015

British Association of Dermatologists, Manchester 2015

European Academy of Dermatology and Venereology, Copenhagen 2015

Euroderm Excellence, Nice 2015

Medical Dermatology Meeting (BAD, BSMD, RCP), London

Dansk Dermatologisk Selskab, Munkebjerg, Veijle 2016

Primary Care Dermatology Society of Ireland, Killarney 2016

European Academy of Dermatology and Venereology, Athens 2016

British Association of Dermatologists, Birmingham 2016

European Academy of Dermatology and Venereology, Vienna 2016

International Conference of Dermatology 2016

& Society of Dermatologists, Venereologists & Leprologists of Nepal,

SODVELON, Kathmandu

Euroderm Excellence, Nice 2016

Medical Dermatology Meeting (BAD, BSMD, RCP), London 2017

European Dermatology Forum, Montreux 2017

British Association of Dermatologists, Liverpool 2017

South West of England & Wales Dermatological Society & Dowling Club, Bristol 2017

Dowling Club Business Skills, Interview Training and Clinical Meeting, Derby 2017

Sri Lanka College of Dermatologists /Dowling Club Meeting, Colombo, Galle & Kandy 2017

European Academy of Dermatology & Venereology, Geneva 2017

European Academy of Dermatology & Venereology, Budva, Montenegro 2018

Dowling Club, Valletta, Malta 2018

British Association of Dermatologists, Edinburgh 2018

Not listed are attendances at weekly St John’s Hospital Saturday clinical meetings (1984-88), the

monthly Westminster Hospital/Chelsea & Westminster Hospital Combined Clinics (1992-), the

monthly St Johns’ Hospital Dermatological Society Thursday meetings (1984-), the monthly

29

Dermatology Section of the Royal Society of Medicine meetings (1984-) and the quarterly North

London clinical meetings (2010-)

POST GRADUATE TRAINING MEETINGS

College Tutors’ Seminar 1995

Royal College of Physicians, London

College Tutors/Regional Advisors Meeting: NW Thames 1995








NW Thames Meeting of College and Associate College Tutors 1998


SAC/RSA Induction Day RCP 2003

Launch, PMETB, London 2005

SAC Chairs Meeting, PMETB, London 2005

SAC Chairs Meeting, Royal College of Physicians, London (Jun) 2005

Meetings of SAC Chairs and Directors of Training, PMETB, London (Nov) 2005

SAC Chairs Meeting, Royal College of Physicians, London (Dec) 2005

JCHMT SAC Chairs Meeting, Royal College of Physicians, London (Mar) 2006

SAC Chairs Meeting, Royal College of Physicians, London (April) 2006

SAC Chairs Meeting, Royal College of Physicians, London (Sept) 2006

Dermatology Curriculum, PMETB, London 2006

JRCPTB Inaugural Meeting, Royal College of Physicians, London 2007

Dermatology Assessment Programme, PMETB, London 2007

ROLES AT MEETINGS:

Local Secretary and Treasurer, Skin Pharmacology Society 1991 Pitlochry, Scotland

European Melanoma Day 2000 The Lister Hospital, London

Chair, Immuno-Dermatology & Immune Response Modifiers 2001

3M, Chelsea & Westminster Hospital

Instigator, Organiser, Chair and Lecturer, Dermatology for Plastic Surgeons 2001 Chelsea and Westminster Hospital, London

Chair, Plenary Scientific Session 2005 British Association of Dermatologists, Glasgow

30

Scientific Committee Member, London EADV 2005 2003-2005

European Academy of Dermatology & Venereology, London

Chair, Symposium S16 – Penile Dermatoses 2005 European Academy of Dermatology & Venereology, London

Co-Chair, FCO5 - Cosmetic Dermatology and Related Topics (15 papers) 2005 European Academy of Dermatology & Venereology, London

Chair, Symposium S44 – Genital Dermatoses 2006 European Academy of Dermatology & Venereology, Rhodes

Chair, Optimising Treatment Outcomes in Psoriasis 2006 RCP Live, Royal College of Physicians, London

Co-Chair Symposium S45 – Sexual Health, ‘Male dyspareunia’. 2007 European Academy of Dermatology & Venereology, Vienna

Chair and Organiser, ‘Festschrift’ for Professor Pauline M Dowd 2007

Royal Society of Medicine

Chair and Organiser, ‘Festschrift’ for Dr Richard Staughton 2007

Chelsea and Westminster Hospital

Symposium Planning Committee; Chair, Clinical Services and Evaluation Session 2008

Key Advances in the Effective Management of Malignant Melanoma UK Key Advances in Clinical Practice Series, 2nd National Update, London

Organiser and Chair, Genital Dermatology 2008 HIV/GUM Course, Chelsea and Westminster Hospital, London

Expert Panel Member, Masterclass in Advanced Cancer Medicine-Skin Cancers 2008 Association of Cancer Physicians and British Oncological Association, London

Sessional Chair, Key Advances in the Effective Management of Malignant Melanoma 2009

London

Expert Panel Member, Masterclass in Advanced Cancer Medicine-Skin Cancers 2009 Association of Cancer Physicians and British Oncological Association, London

Orator, Dowling Club, 2010

Lincoln

Co-Chair, SO5 Sexually Transmitted Infections 2010 European Academy of Dermatology & Venereology, Gothenburg

Co-Chair, Session XVIII (Medical Dermatology) 2010 Sharm Derma, Sharm El Sheikh, Egypt

College Lecturer, Royal College of Physicians (SW) Regional Meeting, Taunton 2010

31

Co-Chair, Session 12. Sexual Disorders as a Social Problem of Gender Relations 2011

VII All-Russian Congress “Men’s Health”, Rostov-on-Don

Co- Chair, Session TY07, Genital and Oral Lesions-Whats your Diagnosis? 2011

(with Drs Setterfield, Lewis and Pelisse)

Chair, SessionXXIV HIV & Malignancies 2011

ASICON 2011: 4th National Conference of AIDS Society of India

SGPG, Lucknow

Chair, Ask the Expert session II 2012

DERMACON 2012, Jaipur

Expert Panellist, Strategies for the Care for Uninsured and Underinsured 2012

FO75 American Academy of Dermatology, San Diego

Co-Chair, WS01 Diseases of the Anogenital Mucosa 2012

European Academy of Dermatology & Venereology, Verona

Chair, Male Genital Dermatoses 2012

Ano-Genital and Mucosal Dermatology Course, St Thomas’ Hospital

Expert Panel, Interactive Case Discussion 2102

British Society for Skin Care in Immunocompromised Individuals,

British Association of Dermatologists, Birmingham

Co-Chair, Professors & Registrars Forum 2012


Co-Chair, Plenary Session 2012

International Medical Meeting, Riga

Chair, BAD Strategy Day 2013

British Association of Dermatologists, London

Welcome Address, Medical Dermatology Meeting 2013

British Society for Medical Dermatology/Neurology, RCP, London 2013

Local Organising Committee 2013

International Investigative Dermatology, Edinburgh

Chair, Public Lecture, Dr Michael Mosley, The Pleasures of Self-Experimenting 2013


President and Organising Committee Member 2013

British Association of Dermatologists, Liverpool

Chair, Scientific Session 2013


32

Chair, Understanding Pharma 2013


Chair, Professors & Registrars Forum 2013


Co-Chair, Symposium SY29, Penile Dermatoses in Later Life 2013

European Academy of Dermatology & Venereology, Istanbul

Co-Chair, Rare Case Reports 2013

Baltic Association of Dermatovenereologists, Kaunas

Chair, Workshop 8, Genital Dermatology 2013

International Congress of Dermatology and Dermacon, New Delhi

Co-Chair, Plenary 7, Sexually Transmitted Diseases 2013


Non-melanoma Skin Cancer Update, BAD/RCP, London 2014

Introduction (Crisis in Dermatology)

Co-Chair, Plenary Invited Lecturers Session 2014

Baltic Association of Dermatovenereologists, Riga

Chair, Clinical and Research Agenda, British Association of Dermatologists 2014

UK TREND Launch, London

President and Organising Committee Member 2014

British Association of Dermatologists, Glasgow

Chair, Plenary Session 2014


Local Organising Committee Member 2012-14

XV World Congress on Cancers of the Skin, Edinburgh

Chair, WS38 Anogenital diseases: Digging deep for answers 2014

European Academy of Dermatology & Venereology, Amsterdam

Programme planning and Abstract Reviewer 2015

Medicine 2015: Delivering the Future Hospital

Royal College of Physicians, Harrogate

Abstract Reviewer 2015

European Academy of Dermatology & Venereology, Valencia

Chair, Review and Update: STIs and HIV: RU28


33

Faculty, FO35, Hot Topics in AIDS and STIs 2015

American Academy of Dermatology, San Francisco

Faculty, Inaugural European School of Urology Course: Penile Diseases 2015

European Association of Urology, Madrid

Chair and Organiser 2015

Teach In, Dermatology for the General Physician


Chair and Co-Organiser 2015

Male Genital Disease

5th Annual Anogenital and Oral Genital Dermatology Course

St John's Institute of Dermatology, Royal College of Physicians, London


AM113, Best of British

World Congress of Dermatology, Vancouver


SY70, Men's Issues


Co-Chair 2015

British Society for Skin Care in Immunocompromised Individuals

British Association of Dermatologists, Manchester

Co-Chair 2015

D1T05.4, Review and Updates: HIV

European Academy of Dermatology & Venereology, Copenhagen

Chair and Organiser,

Gerontodermatology symposium 2015



Male (GUM, Andrology, Urology, HIV) symposium





Co-Chair 2016

International Dermatology, British Association of Dermatologists, Birmingham

Judging Committee 2016


34

Abstract Selection Committee 2016

British Society for Skin Care in Immunocompromised Individuals


Co-Chair

Plenary Session A, European Academy of Dermatology and Venereology, Athens 2016

Organising Committee (Secretary of the BSF) 2016

British Skin Foundation ‘Skin Deep’ – 20th Anniversary Symposium


Co-Chair 2016

STI & HIV Session

2nd International Conference of Dermatology &

XIIIth Society of Dermatologists, Venereologists & Leprologists of Nepal

SODVELON, Kathmandu

Co-Chair 2016

GUM & STI session

Euroderm Excellence, Nice

Co-Organiser (President of the Dowling Club)

South West of England & Wales Dermatological Society & Dowling Club, Bristol 2017

Co-Organiser (President of the Dowling Club) 2017

Business Skills, Interview Training and Clinical Meeting, Derby

Co-Organiser (President of the Dowling Club) 2017

Sri Lanka College of Dermatologists and Dowling Club Meeting, Colombo

Chief Guest (President of the Dowling Club) 2017


Chair 2017

Acne and Coesmtic Symposium











35




Co-Chair 2017

Dermatology of the mucosae (D3T07.3)

European Academy of Dermatology & Venereology, Geneva

Panel 2018

Business Skills Interview Training, Dowling Club, London

36

MEMBERSHIP OF LEARNED SOCIETIES AND OTHER ORGANISATIONS:

British Medical Association 1980-

Royal College of Physicians of London 1985-

College Tutor 1995-2000

SAC/JCHMT (Derm), BAD Rep., UEMS Rep., (Chairman) 2000-2009

SAC/JCHMT (GUM) 2002-2009

Council 2012-2014

Royal College of Physicians of Edinburgh 2008-2009

Royal Society of Medicine 1986-

Member of Council-Dermatology (1997-2001; 2008-)

Library Representative

President 2015-2016

British Association of Dermatologists 1986-

Therapeutics & Audit Subcommittee 1997-2002

Private Practice Subcommittee 2001-2004

Executive (ex officio: SAC Chair; UEMS Rep) 2005-2009

President Elect 2011-2012

President 2012-2014

Skin Care Campaign Future Dermatology Services Working Party 2003-2004

American Academy of Dermatology (Non-resident Fellow) 1999-

American Dermatological Association (International Honorary Member) 2008-

European Dermatology Forum 2013-

British Association of University Teachers of Dermatology (defunct) 1994-2004

Society for Investigative Dermatology 1986-

Skin Pharmacology Society (defunct)-Committee and Executive Board (1993-6) 1988-1996

British Society for Investigative Dermatology 1987-

European Society for Dermatological Research 1990-

European Academy of Dermatovenereology 1998-

European Society for Histamine Research 1987-1992

British Society for the Skin Care of Immunocompromised Individuals 2011-

St. John’s Hospital Dermatological Society 1996-

President 2006-2007

Primary Care Dermatology Society (Honorary Member) 2005-

THESIS (The Skin Investigation Society) 1993-

UK Melanoma Study Group 1999-2010

Melanoma Focus 2014-

Baltic Association of Dermatovenereologists (Honorary Member) 2014-

Associate Parliamentary Group on Skin (Medical Adviser) 2002-

British Skin Foundation Top 100 Club 2012

Laser Doppler Users Group 1988-1994

National Health Service Consultants Association 2003-

Worshipful Society of Apothecaries of London (Livery, 1998) 1994-

Member, Chelsea & Westminster Hospital NHS Foundation Trust 2006-2010

Chelsea Clinical Society 1998-

Council 2006-2009

President 2010-2011

Medical Society of London 1995-

37

West London Medico-chirurgical Society 1994-

President 2006-2007

Dowling Club 1986-

Orator 2010

Society of Authors including the Medical Writers Group 2002-2010

Authors’ Licensing & Collecting Society 2006-

Kitchener Scholars Association 1981-

Committee 1992-2002

Garrick Club 2002-

United Oxford and Cambridge University Club 1982-2004

Crabtree Foundation (University College London) 1990-

Cambridge Society 1981-2008

Cambridge Union Society 1975-

Cambridge University Medical Graduates Club 1980-

Alibert Society 1989-

National Geographic Society 1998-2000

Marylebone Cricket Club (Associate Member 2002-2010) 2011-

Middlesex County Cricket Club 1995-2011

Hampstead Parochial Church Council 2000-2002

Hampstead Medical Society 2011-

38

PUBLICATIONS-ORIGINAL PAPERS, LETTERS, ARTICLES, BOOKS and CHAPTERS:

1. Bunker CB. Medical Education in London. The Times 1980 (Mar 1).

2. Bunker CB & Gilkes JJH. Geriatrics: Dermatology. Br J Hosp Med 1987;37:122-134. 3. Bunker CB & Dowd P. M. Alterations in scalp blood flow after the epicutaneous application of 3%

minoxidil and 0.1% hexyl nicotinate in androgenetic alopecia. Br J Dermatol 1987;117:668-669.

4. Bunker CB & Dowd PM. Topical minoxidil, scalp hair, and vasodilatation. Lancet 1987;i:1266.

5. Sumners D & Bunker CB. Affective disorder and neoplasia: can malignancy present with hypomania?

Br J Clin Soc Psychiatry 1987;4:99-103

6. Bunker CB. Angiostrongyliasis. Sunday Telegraph 1987 (Jun 8).

7. Bunker CB. Acne: a review of therapy. Drugs of Today 1988;24 229-234.

8. Johnson NMcI & Bunker CB. More MRCP Part 1. Springer-Verlag. London 1988.

9. Bunker CB & Maurice P. Sweet’s syndrome associated with IgG paraproteinaemia. Clin Exp Dermatol

1988;13:135.

10. Bunker CB & Dowd PM. Giant cell arteritis and systemic lupus erythematosus. Br J Dermatol

1988;119:115-120.

11. Bunker CB, Lanigan SW, Rustin MHA & Dowd PM. The effects of topically applied hexyl

nicotinate on the cutaneous blood flow in patients with Raynaud’s phenomenon. Br J Dermatol 1988;119:

771-776.

12. Maurice PDL, Bunker CB, Giles F, Goldstone A & Holton J. Mycobacterium avium-intracellulare

infection associated with hairy cell leukaemia. Arch Dermatol 1988;124:1545-549.

13. Rustin MHA, Bunker CB & Dowd PM. Chronic leg ulceration with livedoid vasculitis and response

to oral ketanserin. Br J Dermatol 1989;120:101-105.

14. Bunker CB, Smith NP, Russell RCG & Dowd PM. Cock’s peculiar tumour. Clin Exp Dermatol

1989;14:237-239.

15. Rustin MHA, Bunker CB, Dowd PM & Robinson TWE. Erythema multiforme due to griseofulvin.

Br J Dermatol 1989;120:455-458.

16. Bunker CB. Topical erythromycin. Drugs of Today 1989;25:427-430.

17. Bunker CB, Sheron N, Maurice PDL, Kocjan G et al. Isotretinoin and eosinophilic pleural effusion.

Lancet 1989:1;435-436.

18. Rustin MHA, Bunker CB & Levene GM. Follicular mucinosis presenting as acute dermatitis and

response to dapsone. Clin Exp Dermatol 1989;14:382-384.

19. English JSC, Bunker CB, Ruthven K Dowd PM & Greaves MW. A double-blind comparison of the efficacy of

betamethasone dipropionate cream twice daily versus once daily in the treatment of steroid responsive dermatoses.

Clin Exp Dermatol 1989;14:32-34.

20. Maurice PDL, Bunker CB & Dowd PM. Isotretinoin in the treatment of systemic sclerosis.

Br J Dermatol 1989;121:367-374.

21. Bunker CB, Newton JA, Kilborn J, Patel A, Conway GS, Jacobs HS, Greaves MW & Dowd PM. Most women with

acne have polycystic ovaries. Br J Dermatol 1989;121:675-680.

22. Rustin MHA, Bunker CB, Gilkes JJH, Robinson TW & Dowd PM. Extensive linear epidermal naevi and polyostotic

fibrous dysplasia. Clin Exp Dermatol 1989;14:371-375.

23. Bunker CB, Maurice PDL & Dowd PM. Isotretinoin and curly hair. Clin Exp Dermatol 1990;15:

143-145.

24. Bunker CB, Rustin MHA & Dowd PM. Isotretinoin treatment of severe acne in post-transplant

patients taking cyclosporine. J Am Acad Dermatol 1990;22:693-694.

25. Bunker CB, Delhantey J & Dowd PM. Familial localised scleroderma and telangiectasia associated with

cytogenetic abnormalities. J Roy Soc Med 1990;83:531-532.

26. Bunker CB, Erskine K, Rustin MHA & Gilkes JJH. Severe polymorphic eruption of pregnancy

occurring in twin pregnancies. Clin Exp Dermatol 1990;15:228-231.

27. Bunker CB, Foreman JC & Dowd PM. Calcitonin gene-related peptide and Raynaud’s phenomenon.

Lancet 1990;335:239.

28. Bunker CB, Whittaker S, Luzatto L, Gore ME, Rustin MHA, Smith NP & Levene GM. Indolent

cutaneous prodrome of fatal HTLV-1 infection. Lancet 1990;335:426.

29. Dowd PM, Bunker CB, Bull HA, Foreman JC, Terenghi G, Springall DR & Polak JM.

Raynaud’s phenomenon, calcitonin gene-related peptide, endothelin and cutaneous vasculature.

Lancet 1990;336:1014.

39

30. Bunker CB, Terenghi G, Springall DR, Polak JM & Dowd PM. Deficiency of calcitonin

gene-related peptide in Raynaud’s phenomenon. Lancet 1990;336:1530-33.

31. Bunker CB, Cerio R, Bull HA, Evans J, Dowd P M & Foreman JC. The effect of capsaicin

application on mast cells in normal human skin. Agents and Actions 1991;33:195-196.

32. Bunker CB, Foreman JC & Dowd PM. Vascular responses to histamine at low temperatures in normal

digital skin and Raynaud’s phenomenon. Agents and Actions 1991;33:197-199.

33. Bunker CB, Foreman JC & Dowd PM. Digital vascular responses to histamine, compound 48/80 and

calcitonin gene-related peptide in patients with Raynaud’s phenomenon. J Invest Dermatol 1991;96:

314-317.

34. Bunker CB, Maurice PDL, Little S, Johnson NM & Dowd PM. Isotretinoin and lung function in systemic sclerosis.


35. Terenghi. G, Bunker CB, Liu Y, Springall DR, Cowen T, Dowd PM & Polak JM. Image

analysis quantification of peptide-immunoreactive nerves in skin of patients with Raynaud’s phenomenon and

systemic sclerosis. J Pathol 1991;164:245-252.

36. Bunker CB, Newton JA, Conway GS, Jacobs HS, Greaves MW, Dowd PM. The endocrinological differences

between women with acne who have polycystic ovaries and other presentations of polycystic ovaries. Clin Exp

Dermatol 1991;16:420-423

37. Bull HA, Bunker CB, Terenghi G, Springall DR, Zhao Y, Polak JM. & Dowd PM.

Endothelin-1 in human skin: immunolocalization, receptor binding and effects on cutaneous microvascular

endothelial cells. J Invest Dermatol 1991;97:618-623.

38. Heagerty AH & Bunker CB. Dermatological manifestations of HIV infection. Hospital Update 1992;

18:213-218.

39. Bunker CB & Dowd PM. Henry Radcliffe Crocker. Int J Dermatol 1992;31:446-450.

40. Markus HS, Bunker CB, Kouris K, Costa DC & Harrison MJ. rCBF abnormalities detected and

sequentially followed by SPECT in neuro-Behcet’s syndrome with normal CT and MRI imaging. J Neurol 1992;

239:363-6.

41. Hayes N, Bunker CB, Marshall I, Dowd PM & Foreman JC. The action of a calcitonin gene-related peptide

antagonist in human skin. Agents & Actions 1992;38:C212-214.

42. Bunker CB. (1992) The role of calcitonin gene-related peptide in the pathophysiology and treatment of

Raynaud’s phenomenon. MD Dissertation, University of Cambridge. 1992.

43. Bunker CB, Coulson ML, Hayes N, Dowd PM & Foreman JC. Further studies on the actions

of endothelin-1 on blood flow in human skin. Br J Dermatol 1992;127,85-90.

44. Bunker CB. SHO posts in Dermatology for vocational trainees. Horizons, June 1992:282-288.

45. Roberts N & Bunker CB. The gut and the skin. Br J Hosp Med 1993;50:31-39.

46. Bull HA, Courtney PF, Bunker CB, Rustin MHA, Pearce FL & Dowd PM. Basophil mediator release

in atopic dermatitis. J Invest Dermatol 1993;100:305-309.

47. Knock GA, Terenghi G, Bunker CB, Bull HA, Dowd PM & Polak JM. Characterization of

endothelin-binding sites in human skin and their regulation in primary Raynaud’s phenomenon and systemic

sclerosis. J Invest Dermatol 1993;101:73-78.

48. Schifter S, Johannsen L, Bunker C, Brickell P, Bork E, Lindberg L & Faber J. Calcitonin gene-related

peptide (CGRP) in small cell lung carcinomas. Clin Endocrinol 1993;39:59-65.

49. Carney O, Ross E, Bunker CB, Ikkos G & Mindel A. A prospective study of the psychological impact

on patients with a first episode of genital herpes. Genitourin Med 1993;70:40-45.

50. Bunker CB, Reavley C, O’Shaughnessey D & Dowd PM. Calcitonin gene-related peptide in treatment of

severe peripheral vascular insufficiency in Raynaud’s phenomenon. Lancet 1993;342:80-82.

51. Roberts N & Bunker CB. Adverse drug reactions: identifying adverse drug reactions: skin (part 1)

Prescriber: October 19, 1993;57-62.

52. Bunker CB. CGRP, ET-1 and Raynaud’s phenomenon. Current Medical Literature: Rheumatology 1993;12:

87-89.

53. Wilkinson LS, Bunker CB, Edwards JC, Scurr JH & Smith PD. Leukocytes: their role in the

aetiopathogenesis of skin damage in venous disease. J Vasc Surg 1993;17:669-675.

54. Bunker CB & Brown E. Unilateral bullous pemphigoid in a hemiplegic patient. Br J Dermatol 1993;129:

502.

55. Roberts N & Bunker CB. Adverse drug reactions: identifying severe skin reactions to drugs (Part 2).

Prescriber December 3, 1993;47-50.

56. Johnson N McI & Bunker CB. Further MRCP Part 1. Springer -Verlag, London 1994

57. Goldsmith PC, Molina FA, Bunker CB, Terenghi G, Leslie TA, Fowler CJ, Polak JM & Dowd

40

PM. Cutaneous nerve fibre depletion in vibration white finger. J R Soc Med 1994;87:377-381.

58. Review: Physical Signs in Dermatology; Colour Atlas and Text. Lawrence CM & Cox NH. Retinoids Today. July

1994;30.

59. Smith RA, Ross JS & Bunker CB. Localised trichorrhexis nodosa. Clin Exp Dermatol 1994;19:441-442.

60. Rowe A, Farrell A, Kazmi SH & Bunker CB. Expression of inducible nitric oxide synthase in dermal

microvasculature in psoriasis. Lancet 1994;344:1371.

61. Smith RA, Ross JS, Branfoot AC, Asboe ID, Gazzard BG & Bunker CB. Panniculitis with

pseudomonas septicaemia in AIDS. JEADV 1995;4:166-169.

62. Bunker CB. Sir Thomas Lewis. Dermatology in Practice 1994;57:2-3,

63. Bewley AP, Bracka A, Staughton RCD & Bunker CB. Extramammary Paget’s disease of the penis, Br J

Dermatol 1994;131: 445-46.

64. Bunker CB. Unusual penile dermatoses. Dermatology in Practice 1996;4: 18-19.

65. Bunker CB & Dowd PM. Raynaud’s phenomenon. In: Cutaneous Medicine and Surgery. Eds Arndt KA,

Robinson JK, LeBoit PE & Wintroub BU. WB Saunders. Philadelphia. ISBN 0-7216-4852-5:1996;537-542. 66. Bunker CB & Dowd PM. Skin Disease. In: Medicine. (Ed. Axford J.) Blackwell

Scientific Publications. Oxford; 1996.

67. Bunker CB. Dermatological Problems in HIV Infection and AIDS. In: Medical Management of HIV and AIDS.

Ed. Millar A. Springer-Verlag. Berlin Heidelberg New York ISBN 3-540-19958-6: 1996; 162-189.

68. Farrell A, Ross JS, Barton SE & Bunker CB. Multiple pilomatricomas and myotonic dystrophy in a patient with

AIDS. Clin Exp Dermatol 1995;20:423-424.

69. Goldsmith P, Bunker CB, Leslie T, Foreman JC & Dowd PM. The effect of topical steroid on the actions of

vasoconstrictor and vasodilator peptides in human skin. Skin Pharmacol 1996;9:289-297.

70. Farrell AM, Sabroe RA & Bunker CB. Urticarial vasculitis associated with polycythaemia rubra vera. Clin

Exp Dermatol 1996;21:302-304.

71. Farrell AM, Gooptu C, Woodrow D, Costello C, Bunker CB & Cream JJ. Cutaneous lymphocytic vasculitis in acute

myeloid leukaemia. Br J Dermatol 1996;135:471-474.

72. Bunker CB, Goldsmith PC, Leslie TA, Hayes N, Foreman JC & Dowd PM. Calcitonin gene-related peptide,

endothelin-1, the cutaneous microvasculature and Raynaud’s phenomenon. Br J Dermatol 1996;134:399-406. 73. Papadavid E, Yu RC, Bunker CB, Scoones D & Chu AC. Tumour progression in a patient with granulomatous

mycosis fungoides. Br J Dermatol 1996;134:740-43.

74. Sabroe RA, Staughton RCD & Bunker CB. Bronchospasm induced by isotretinoin. Br Med J. 1996;312:886

75. Bewley AP, Ross JS, Bunker CB & Staughton RCD. Successful treatment of a patient with octreotide-

resistant necrolytic migratory erythema. Br J Dermatol 1996;134:1101-104.

76. Farrell AM, Ross JS, Umasankar S & Bunker CB. Staphylococcal scalded skin syndrome in an HIV-1

seropositive man. Br J Dermatol 1996;134:962-65.

77. Farrell AM, Branfoot AC, Moss J, Papadaki L, Woodrow DF & Bunker CB. Scleredema diabeticorum

of Buschke confined to the thighs. Br J Dermatol 1996;134:1113-115.

78. Farrell AM, Woodrow D, Bryceson AD, Bunker CB & Cream JJ. Ectopic cutaneous schistosomiasis:

extragenital involvement with progressive upward spread. Br J Dermatol 1996;135:110-12.

79. Bunker CB. Malodorous wounds. Lancet 1996;348:1737.

80. Ramsay B, Terenghi G, Polak JM, Guiloff RJ & Bunker CB. Depleted cutaneous innervation in familial

amyloid. Clin Exp Dermatol 1996;21:449-450.

81. Review: Dermatology and the New Genetics. Moss C & Savin J. Br J Hosp Med 1996; 55:297.

82. Bunker CB & Bridgett CK. Depression and the Skin. In: Depression and physical illness.

Ed. Robertson and Katona. John Wiley & Sons Ltd. London 1997

83. Rowe A, Farrell AM & Bunker C. Constitutive endothelial and inducible nitric oxide synthase in

inflammatory dermatoses. Br J Dermatol 1997;136:18-23

84. Mallon E & Bunker CB. Slides in Dermatology: 1 MRCP. Br J Hosp Med. 1997;57:159-161

85. Mallon E & Bunker CB. Slides in Dermatology: 2 MRCP. Br J Hosp Med. 1997;57:262-264

86. Bunker CB & Peters J. Dermatology Day Care. Skin Care in Focus. 1997;1:8-9

87. Bunker CB. Raynaud’s phenomenon. In: Inflammatory & Thrombotic problems in Vascular Surgery. Eds.

Greenhalgh R. M & Powell J. T. Saunders. London. 1997; 201-214.

88. Mallon E, Ross JS, Hawkins DA, Dinneen M, Francis N & Bunker CB. Biopsy of male genital dermatoses.

Genitour Med 1997;73:421.

89. Review: Cutaneous Disorders of the Lower Extremity. Dockery GL & Crawford ME. Br J Dermatol 1997; 301.

90. Fearfield LA & Bunker CB. Pityriasis versicolor associated with oral lithium therapy. Clin Exp Dermatol

1997;22:57-59.

41

91. Fearfield LA, Gazzard B & Bunker CB. Aquagenic urticaria and human immunodeficiency virus infection:

treatment with stanozolol. Br J Dermatol. 1997;137:620-622.

92. Gooptu C, Woollons A, Ross J, Price M, Wojnarowska F, Morris PJ, Wall S & Bunker CB. Merkel cell

carcinoma arising after therapeutic immunosuppression. Br J Dermatol 1997;137:637-641.

93. Farrell AM, Black MM, Bracka A & Bunker CB. Pyoderma gangrenosum of the penis. Br J Dermatol 1998;138:

337-340.

94. Rowe A & Bunker C.B. Interleukin-4 and the interleukin-4 receptor in allergic contact dermatitis.

Contact Dermatitis 1998;38:36-39.

95. Review: ABC of Dermatology (3rd edn). Buxton PK. Hospital Medicine 1998; 59:664.

96. Farrell AM, Ross JS, Thomas JM, Fisher C & Bunker CB. Acquired ichthyosis, alopecia and loss of hair

pigment associated with leiomyosarcoma. J Eur Acad Dermatol Venereol 1998;10:159-163.

97. Farrell AM, Ross JS, Bunker CB, Staughton RCD. Crusted scabies with scalp involvement in HIV-1 infection.

Br J Dermatol 1998;138:192-193.

98. Smith GL, Bunker CB, Dinneen MD. Fournier’s gangrene. Br J Urol 1998;81:347-355.

99. Mallon E & Bunker CB. Management of penile erosions and ulcers. Postgrad Mid East Doct 1998; 21:

163-168

100. Mallon E & Bunker CB. Management of common herpes skin infections. Prescriber 1998; July: 33-36.

101. Mallon E & Bunker CB. Management of cold sores, shingles and chickenpox. Prescriber 1998; July: 37-42 102. Mallon E, Young D, Bunce M, Gotch FM, Easterbrook PJ, Newson R & Bunker CB. HLA-Cw*0602 and HIV

associated psoriasis. Br J Dermatol 1998;139:527-533.

103. Farrell AM, Latif F, Odularu O, Bhatt HR & Bunker CB. Screening of cobalamin metabolism in

methotrexate-treated psoriasis. Br J Dermatol 1998;138:1097-8.

104. Farrell AM & Bunker CB. Cutaneous eruption due to indoramin. Clin Exp Dermatol 1998;23:233.

105. Farrell AM, Shanson D, Roberts NM, Ross JS, Fry C, Cream JJ, Staughton RCD & Bunker CB. An outbreak

of methicillin-resistant staphylococcus aureus (MRSA) in a dermatology unit. Clin Exp Dermatol 1998;23:249-53.

106. Bunker CB & Staughton RCD. Dermatology. Chelsea & Westminster AIDS Care Handbook. Ed. Gazzard

B. Mediscript London, 1999.

107. Mallon E, Osborne G, Dinneen M, Lane RJM, Glaser M & Bunker CB. Dermatomyositis in association with

transitional cell carcinoma of the bladder. Clin Exp Dermatol 1999;24:94-96

108. Griffiths DJ, Cooke SP, Herve Rigby SP, Mallon E, Hajeer A, Lock M, Emery V, Taylor P, Pantelidis P, Bunker CB,

duBois R, Weiss RA & Venables PJW. Detection of human retrovirus-5 in patients with arthritis and systemic

lupus erythematosus. Arthr Rheum 1999;42:448-54.

109. Farrell AM, Ross JS & Bunker CB. Eosinophilic fasciitis associated with autoimmune thyroid disease and

myelodysplasia treated with pulsed methylprednisolone and antihistamines. Br J Dermatol 1999;140:1185-1187.

110. Farrell AM, Moss G, Woodrow D & Bunker CB. Benign cutaneous Degos’ disease. Br J Dermatol 1998;139:708-

12.

111. Rowe A, Mallon E, Rosenberger P, Barrett M, Walsh J & Bunker CB. Depletion of cutaneous peptidergic

innervation in HIV-associated xerosis. J Invest Dermatol 1999;112:284-9.

112. Fearfield LA & Bunker CB. Familial naevus sebaceous of Jadassohn. Br J Dermatol 1998;139:1119-20.

113. Fearfield LA, Ross JR, Farrell AM, Costello C, Bunker CB & Staughton RCD. Pyoderma gangrenosum associated

with Takayasu’s arteritis responding to cyclosporin. Br J Dermatol 1999;14:339-343.

114. Fearfield LA, Rowe A, Francis N, Bunker CB & Staughton RCD. Itchy folliculitis and human

immunodeficiency virus infection: clinicopathological and immunological features, pathogenesis and treatment. Br

J Dermatol 1999;141:3-11.

115. Bunker CB. Review of Dermatology Journals. Sex Trans Inf 1999; 75:281-282.

116. Fox PA, Barton SE, Francis N, Youle M, Henderson DC, Pillay D, Johnson MA, Fearfield L, Gazzard BG & Bunker

CB. Chronic erosive herpes simplex virus infection of the penis, a possible immune reconstitution disease. HIV

Medicine 1999;1:10-18.

117. Bunker CB. Male genital dermatoses. Dermatology in Practice 1999; Oct:14-17.

118. Mallon E, Newson R & Bunker CB. HLA-Cw6 and the genetic predisposition to psoriasis: a meta analysis of

serological studies. J Invest Dermatol 1999;113:693-5.

119. Porter WM, Roberts NM &Bunker CB. Adverse drug reactions; appearance and causes of common skin rashes.

Prescriber 1999;10:91-94

120. Porter WM, Roberts NM & Bunker CB. Adverse drug reactions; identifying severe skin reactions to drug therapy.

Prescriber 1999;10:119-122

121. Farrell AM, McGregor JM, Staughton RCD & Bunker CB. Jessner’s lymphocytic infiltrate treated with auranofin.

Clin Exp Dermatol 1999;24:500.

42

122. Fearfield LA & Bunker CB. Cutaneous paraneoplastic syndromes-Part 1. E J Pall Care 1999;6:82-86.

123. Fearfield LA, Bunker CB. Cutaneous paraneoplastic syndromes – Part 2. Eur J Pall Care 1999; 6: 117-120

124. Mallon E, Hawkins DA, Dinneen M, Francis N, Newson R, Fearfield LA & Bunker CB. Circumcision and genital

dermatoses. Arch Dermatol 2000;136:350-354.

125. Porter W & Bunker CB. Treatment of pearly penile papules with cryotherapy. Br J Dermatol; 2000;142:847-8.

126. Mallon E & Bunker CB. HIV associated psoriasis. Aids Patient Care STDS. 2000;14:239-46.

127. Fearfield LA, Smith JR, Bunker CB & Staughton RCD. Association of multiple familial cutaneous leiomyoma with a

uterine symplastic leiomyoma. Clin Exp Dermatol 2000;25:44-47.

128. Fearfield LA, Nelson M, Francis N & Bunker CB. Cutaneous squamous cell carcinoma with zosteriform

metastases in a human immunodeficiency virus-infected patient. Br J Dermatol 2000;142:573-4.

129. Fearfield L, Bunker CB. Radiotherapy and erythema nodosum. Br J Dermatol. 2000;142:177-199

130. Morris-Jones R, Fearfield L, Nelson M, Haskins DA, Dinneen M, Clark P, Bower M and Bunker CB. Acute stridor

and phimosis secondary to Kaposi’s sarcoma. Retinoids 2000;16:41-42.

131. Jain J, Nanchahal J & Bunker C. Pyoderma gangrenosum occurring in a lower limb fascio-cutaneous flap - a lesson

to learn. B J Plas Surg. 2000;53:437-440.

132. Sidwell R, Doe P, Sinnett D, Francis N & Bunker CB. Lymphocytoma cutis and chronic sepsis. Br J Dermatol

2000;143:909-910.

133. Mallon E, Bunce, Savoie H, Rowe A, Newson R, Gotch F & Bunker C.B. HLA-C and guttate psoriasis. Br J Dermatol 2000;143:1177-1182.

134. Porter WM, O’Gorman-Lalor O, Lane RJ, Francis N & Bunker CB. Barraquer-Simons lipodystrophy, Raynaud’s

phenomenon and cutaneous vasculitis. Clin Exp Dermatol 2000;25:277-80.

135. Osborne GE, Chinn RJ, Francis ND, Bunker CB. Magnetic resonance imaging in the investigation of penile

lymphangioma circumscriptum. Br J Dermatol 2000;143:467-8.

136. Porter WM, Hawkins DA, Dinneen M & Bunker CB. Zoon’s balanitis and carcinoma of the penis.

Int J STD AIDS 2000;11:484-5.

137. Osborne GE, Francis ND, Bunker CB. Synchronous onset of penile lichen sclerosus and vitiligo.

Br J Dermatol 2000;143:218-9.

138. Fearfield LA, Farrell AM, Agnew K, Ross J, Roberts N & Bunker CB. Topical lauromacrogols and cutaneous

neuronal function. J Dermatol Treat 2000;11:69-72.

139. Review: Text Atlas of the Pathology of the Foot. Caputo R, Veraldi S & Annoni F. Clin Exp Dermatol 2000;25:454.

140. Fearfield LA & Bunker CB. Bone marrow involvement in cutaneous mastocytosis. Br J Dermatol 2001;144:561-6.

141. Porter WM, Du P Menage H, Philip G & Bunker CB. Porokeratosis of the penis. Br J Dermatol 2001;144:643-4.

142. Porter WM, Bewley A, Dinneen M, Walker CC, Fallowfield M, Francis N & Bunker CB. Nodular lichen simplex

of the scrotum treated by surgical excision. Br J Dermatol 2001;144:915-916.

143. Porter WM & Bunker CB. The dysfunctional foreskin. Int J STD & AIDS 2001;12:216-20.

145. Sidwell RU, Francis N & Bunker CB. Hormonal influence on reticular erythematous mucinosis. Br J Dermatol

2001;144:633-4.

146. Porter WM, Sidwell RU, Catovsky D & Bunker CB. Cutaneous presentation of chronic lymphatic leukaemia and

response to UVB phototherapy. Br J Dermatol 2001;144:1092-1094.

147. Bunker CB. Topics in penile dermatology. Clin Exp Dermatol 2001;26:469-79

148. Bunker CB. Scientific evidence and expert clinical opinion for investigation and management of Stage I malignant

melanoma. In: Key Advances in the Effective Management of Malignant Melanoma. UK Key Advances In Clinical

Practice series (2001) Ed. Mackie R, Murray D, Rosin D, Hancock B & Miles A. Aesculapius Medical Press. London

149. Morris-Jones R, Mallon E, Francis N, Staughton RCD, Bunker CB & Nelson M. Reticular erythematous mucinosis

associated with human immunodeficiency virus infection. Retinoids 2001;17:5-57

150. Porter WM, Dawe SA & Bunker CB. Dermatitis herpetiformis and cutaneous T-cell lymphoma. Clin Exp Dermatol

2001;26:305-6.

151. Porter WM, Dinneen M & Bunker C. Chronic penile lymphoedema: A report of 6 cases. Arch Dermatol 2001;

137:1108-10. 152. Bunker C. Skin conditions of the male genitalia. Medicine 2001;29:7: 9-13.

153. Porter WM, Dinneen M, Hawkins DA & Bunker CB. Erosive penile lichen planus responding to circumcision

JEADV 2001;15;266-68.

154. Grabczynska SA, Toh CT, Francis N, Costello C & Bunker CB. Rosai-Dorfman disease complicated by autoimmune

haemolytic anaemia: case report and review of a multisystem disease with cutaneous infiltrates. Br J Dermatol.

2001;145:323-6.

155. Fearfield LA, Rowe A, Francis N, Fisher C, Gore ME & Bunker CB. Clinicopathological features of relapsing very

thin melanoma. Clin Exp Dermatol 2001;26:686-695.

43

156. Bunker CB & Staughton RCD. Dermatology. Chelsea & Westminster AIDS Care Handbook. Ed. Gazzard B.

Mediscript, London, 2002.

157. Bunker CB. Dermatology. Medicine at a Glance. Ed. Davey P. Blackwells, Oxford 2002.

158. Davison SC, Bunker CB & Basarab T. Etanercept for severe psoriasis and psoriatic arthritis: observations on

combination therapy. Br J Dermatol 2002;147: 808-840.

159. Qazi NA, Morlese JF, Walsh JC, Bunker CB, Francis N, Nelson M. Severe cutaneous ulceration secondary to

cytomegalovirus inclusion disease during successful immune reconstitution with HAART. Case Report. The AIDS

Reader, 2002;12:452-457.

160. Sidwell RU, Ibrahim MAA & Bunker CB. A case of common variable immunodeficiency presenting with

furunculosis. Br J Dermatol 2002;147:364-367.

161. Porter, WM, Francis N, Hawkins D, Dinneen M & Bunker CB. Penile intraepithelial neoplasia: clinical spectrum and

treatment of 35 cases. Br J Dermatol 2002;147:1159-1165. 162. Edmonds EVJ, Francis N & Bunker CB. A case of Fox-Fordyce disease. Retinoids 2003;19:15-16.

163. Fearfield L, Stephenson A, Bunker C, Thomas M & Gore M. Skin cancer and melanoma. In: Cancer in Primary Care.

Edited by Gore M and Russell D. Martin Dunitz 2003, London & New York.

164. Dawe S, Phillips R, Porter W, Cream J & Bunker CB. Sweet’s syndrome as a complication of radiotherapy for

squamous carcinoma of the pharynx. Br J Dermatol 2003;149:884.

165. Agnew KL & Bunker CB. Multiple squamous carcinoma in a psoriatic associated with ciclosporin, alcohol abuse and

ultraviolet radiation exposure with were suppressed by acitretin. JEADV, 2003;17: 97-116.

166. Sidwell RU, Francis N, Grahame R, Pope FM & Bunker CB. Connective tissue naevus (collagenoma) in a patient

with benign joint hypermobility syndrome (Ehlers-Danlos syndrome type III). Clin Exp Dermatol 2003;28:323-325.

167. Osuji N, Fearfield L, Matutes E, Wotherspoon AC, Bunker C & Catovsky D. Granulomatous slack skin disease –

disease features and response to Pentostatin. Br J Haematol 2003;123:297-304.

168. Sidwell RU, Swift S, Yan C-L, Porter W, Thompson EM, Clark JA & Bunker CB. Treatment of toxic epidermal

necrolysis with intravenous immunoglobulin. Int J Clin Pract 2003;57:643-645.

169. Sidwell RU, Seet J-E, Francis N & Bunker CB. Giant actinic porokeratosis of the scalp. Br J Dermatol 2003;149:654.

170. Bunker CB. Male genital skin disease. Saunders (London) 2004.

171. Bunker CB. Skin Disease. In: Medicine 2e. (Ed. Axford J.) Blackwell Scientific Publications. Oxford 2004

172. Bunker CB & Gotch F. HIV and AIDS. In: Textbook of Dermatology: Rook/Wilkinson/Ebling. 7th Edition. Oxford,

Blackwells. 2004.

173. Bunker CB & Neill SA. The Umbilicus, Perianal and Genital Regions. In: Textbook of Dermatology:

Rook/Wilkinson/Ebling. 7th Edition. Oxford, Blackwells. 2004.

174. Heaton NR, Edmonds EV, Francis ND, Bunker CB, Bowling JC, Morar N. Fatal toxic epidermal necrolysis due to

lansoprazole.Clin Exp Dermatol. 2004;29:612-3.

175. Bunker CB. Second Cite A review of recent journal highlights. Clin Exp Dermatol 2004;29:213-4.

176. Davison SC, Francis N, McLean K & Bunker CB. Epidermodysplasia verruciformis-like eruption associated with

HIV. Clin Exp Dermatol 2004;29:311-2.

177. Agnew KL, Ruchlemer R, Catovsky D, Matutes E & Bunker CB. Cutaneous findings in chronic lymphocytic

leukaemia. Br J Dermatol 2004;150:1129-35.

178. Bunker CB, Staughton RCD. Genital inflammatory papules and nodules: In Edwards. Genital Dermatology. Atlas.

Lippincott Williams & Wilkins. Philadelphia. 2004.

179. Edmonds EV, Riaz SN, Francis N, Bunker CB. Nodular prurigo responding to topical tacrolimus. Br J Dermatol

2004;150:1216-7

180. Bunker CB. Systemic steroids in the treatment of alopecia areata. Br J Dermatol 2004;151:246-7.

181. Bunker CB, Neill S & Staughton RCD. Topical tacrolimus, genital lichen sclerosus and risk of squamous cell

carcinoma. Arch Dermatol 2004;140:1169.

182. Phan PT, Francis N, Madden N & Bunker CB. Kissing naevus of the penis. Clin Exp Dermatol 2004;29:471-2.

183. Guest M, Parmar JH, Bunker C, Rowe A & Davies AH. Confirmation of peripheral neuropathy in patients with

venous ulceration through immunohistochemistry. Int J Angiol 2004;13:176-181.

184. Bunker CB. Non-venereal penile dermatoses. In: Kumar B, Gupta S. Eds. Sexually Transmitted Infections. New

Delhi, Elsevier, 2005; pp 539-564

185. Bunker CB. Diagnosis and management of penis pre-cancer: combined clinics and topical chemotherapy. In: The

effective management of urological malignancies. Eds Anderson J, Oliver RTD, Miles A. Aesculapius Medical Press.

London 2005.

186. Bunker CB. Dermatology. In: Medicine at a Glance 2e Edited by Davey P. Blackwell Scientific Publications,

Oxford, 2005.

44

187. Agnew KL, Blunt D, Francis ND & Bunker CB. Magnetic resonance imaging in eosinophilic fasciitis. Clin Exp

Dermatol 2005;30:435-6.

188. Sidwell RU, Francis N & Bunker CB. Keloid development within adolescent striae distensae. Clin Exp Dermatol

2005;30:94-5.

189. Bunker CB. Skin conditions of the male genitalia. Medicine 2005;33:10:68-71.

190. Agnew K, Gilchrest B & Bunker CB. Fast Facts-Skin Cancer. Health Press, London UK, 2005.

191. Jones J, Brenner C, Chinn R & Bunker CB. Radiological associations with dermatological disease. Br J Radiol

2005;78:662-71. 175.

192. Leary A, Bunker CB, Gore M. Melanoma. GP New Contract Clinical Review. March 2005.

http://www.gponline.com/newContract/clinical_review_full.cfm?ID=12033

193. Bowling JCR, Saha M, Bunker CB. Herpetic whitlow: a forgotten diagnosis. Clin Exp Dermatol 2005;30:609-10.

194. Bowling JCR, Powles A, Searle A, Nasiri N, Bunker CB. Spontaneous regression of extramammary Paget’s disease

after excision of primary apocrine carcinoma in an immunosuppressed patient. Br J Dermatol 2005;153:676-7.

195. Sidwell RU, Green JS, Agnew K, Francis ND, Roberts NM, Yates VM, Madden N & Bunker CB. Subcutaneous

granuloma annulare of the penis in two adolescents. J Pediatr Surg 2005;40:1329-31.

196. Bunker C. B. Specialist Private Practice in Dermatology: Ethical Aspects. British Association of Dermatologists

2005. 197. Bowling JC, Francis N & Bunker CB. Solitary anogenital xanthogranuloma. Clin Exp Dermatol 2005;30:716-17.

198. Lally A, Hollowood K, Bunker CB & Turner R. Penile pyoderma gangrenosum treated with topical tacrolimus. Arch

Dermatol 2005;141:1175-76.

199. Sidwell RU, Francis N and Bunker CB. Diffuse trichostasis spinulosa in chronic renal failure. Clin Exp Dermatol

2006;31:86-88.

200. Topham EJ, Francis N, Bunker CB. Medulloblastoma metastasing to the skin. Br J Dermatol 2006;154:554-5.

201. Bunker CB. Management of penile dermatoses. Expert Review of Dermatology 2006;1:241-260.

202. Sidwell RU, Johnson N. McI, Francis N & Bunker CB. Cutaneous sarcoidal granulomas developing after Artecoll

facial cosmetic filler in a patient with newly diagnosed systemic sarcoidosis. Clin Exp Dermatol 2006;31:208-11.

203. Malhomme de la Roche HJ & Bunker CB. Digitate dermatosis responding to bicalutamide therapy. Clin Exp

Dermatol. 2006;31:590.

204. Saha M, Barlow R & Bunker CB. Angiokeratoma circumscriptum of the penis. Br J Dermatol. 2006;154:775-6.

205. Saha M, Azadian BS, Ion L & Bunker CB. Mycobacterium chelonae infection complicating cosmetic facial surgery.

Br J Dermatol 2006;155:1097-8.

206. Patalay R & Bunker C. Penile Problems. Practitioner 2006;250:63-6.

207. Fearfield LA, Larkin JMG, Rowe A, A’Hern R, Fisher C, Francis N, MacKie R, McCann B, Gore ME, Bunker CB.

Expression of p16, CD95, CD95L and HPA in relapsing and non-relapsing very thin melanoma. Br J Dermatol 2007;

156:440-7.

208. Burge S, Bunker C & Eedy D. Modernising Medical Careers. The Times 2007 (Mar 21).

209. Bunker C. B. Specialist Private Practice in Dermatology: Ethical Aspects. British Association of Dermatologists

2007.

210. Dungarawalla M, Field-Smith A, Jameson C, Riley U, Chapman A, Bunker CB, Dearden CE, Matutes E. Cutaneous

Mycobacterium chelonae infection in chronic lymphocytic leukaemia. Br J Haematol 2007;92 (3 Suppl):ECR03.

211. Singh, S and Bunker CB. Common penile dermatoses in old age. The Age of Skin 2007;8 (Jan): 6-9.

212. Patalay R & Bunker CB. How to spot and treat male genital dermatoses. Br J Sex Med 2007;30: 213. Bunker CB. Male genital dermatology. Fitzpatrick’s Dermatology in General Medicine, 7th edition. Wiley 2007.

214. Webster RM, Sarwar, N, Bunker CB & Brock CS. A case series of HIV-positive patients with malignant melanoma.

J HIV Therapy 2007;12:75-8.

215. Bunker CB. Male genital lichen sclerosus and topical tacrolimus. Br J Dermatol 2007;157:1079-80.

216. Singh S & Bunker CB. Squamous cell carcinoma on the scalp following treatment with 5% imiquimod cream. Clin

Exp Dermatol 2007;32:594-5.

217. Bunker CB. Obituary: Jeffrey Joseph Cream. BMJ 2008;336:1255.

218. Bunker CB. Obituary: Jeff Cream. BAD Newsletter 2008 (Spring):30.

219. Schmulewitz L, Attard N, Fearfield L, Westaby D, Prasad P, Thomas HJW, Bunker CB. An unusual cutaneous-

polyposis syndrome stabilised with acitretin. Br J Dermatol 2008;l:159:228-30.

220. Gleeson C, Chan I, Griffiths W, Bunker CB. Eruptive seborrhoeic keratoses associated with erythrodermic pityriasis

rubra pilaris. JEADV 2008 May 13 [Epub ahead of print]. JEADV 2009;23:217-8.

221. Dewan P, Francis N, Lear J, Bunker CB. Angiolymphoid hyperplasia with eosinophilia affecting the penis. Br J

Dermatol 2008;159:755-7.

222. Singh S & Bunker CB. Male genital dermatoses in old age. Age Ageing 2008;37:500-504

http://www.gponline.com/newContract/clinical_review_full.cfm?ID=12033

45

223. Scott C, Staughton RCD, Bunker CB, & Asboe D. Acne vulgaris and acne rosacea as part of immune reconstitution

disease in HIV-1 infected patients starting antiretroviral therapy. Int J STD & AIDS 2008;19:493-495.

224. Saha M, Edmonds E, Martin J & Bunker CB. Penile lymphoedema in association with asymptomatic Crohn’s disease.


225. Bunker CB. Topical gentian violet in dermatology. J Am Acad Dermatol 2009;60:347-8.

226. Bunker CB, Edmonds E, Hawkins D, Francis N & Dinneen M. Re: Lichen sclerosus: review of the literature and

current recommendations for management. JM Pugliese et al. J Urol 2007;178:2268-2276. J Urol 2009;181:1802-3

227. Edmonds E, Mavin S, Francis N, Ho-Yen D, Bunker C. Borrelia burgdorferi is not associated with genital lichen

sclerosus in men. Br J Dermatol 2009;34:88-90.

228. Chan WC, Veraitch O, Radford W, Azadian B, Mortimer P, Shepherd J & Bunker CB. Chronic lymphoedema

complicated by septic arthritis of the hip. Br J Dermatol 2009;160:1130-2).

229. Chan I, Hawkins, D & Bunker CB. Balanoposthitis. BMJ Point-of-Care 2009;http://www.pointofcare.bmj.com.

230. Singh S, Kaye S, Francis ND, Peston D, Gore ME, McClure MO, Bunker CB. Revisiting the past: utilising archival

tissue for the detection and quantification of gene expression. Br J Dermatol 2009;160:885-6.

231. Bunker CB. Skin conditions of the male genitalia. Medicine 2010;38,294-299.

232. Meys R Gotch FM & Bunker CB. Human papillomavirus in the HAART era of HIV: an immune reconstitution

associated disease (IRAD)? Br J Dermatol 2010;162:6-11.

233. Goolamali SI, Edmonds EV, Francis N, Bunker CB. Myotonic dystrophy and basal cell carcinomas: coincidence or

true association? Clin Exp Dermatol 2009;34:e370.

234. Singh S, Kaye S, Gore ME, McClure MO, Bunker CB. The role of human endogenous retroviruses in melanoma. Br J

Dermatol 2009;161:1225-1231.

235. Chapman A, Williams G, Soni N, Bunker CB. G-CSF in toxic epidermal necrolysis (TEN). Br J Dermatol

2010;162:860-5.

236. Rajapakse Y, Bunker C, Ghattaura A, Jallali N, Henton J, James S, Harris P& Searle A. Case report: pyoderma

gangrenosum following deep inferior epigastric perforator (Diep) free flap breast reconstruction. J Plast Reconstr

Aesthet Surg 2010;63(4):e395-6

237. Bunker CB & Gotch F. HIV and AIDS. In: T.Burns, S. Breathnach, N.Cox and C. Griffiths, (eds.) Rook’s Textbook

of Dermatology. 8th edition. Wiley-Blackwell, New York. 2010;35:1-47.

238. Bunker CB. & Neill SA. The genital, perianal and umbilical regions. In: T.Burns, S. Breathnach, N.Cox and C.

Griffiths, (eds.) Rook’s Textbook of Dermatology. 8th edition. Wiley-Blackwell, New York. 2010;71:1-102.

239. Parks T, Ali I, Mahtani KR, Esmail H, Chandrakumar A, Singh S, Leon-Villapalos J, Asher R, Bunker C, Heneghan

C, Venning V. Toxic epidermal necrolysis associated with an influenza-like illness and osteltamivir phosphate.

http://www.bmj.com/cgi/eletters/339/dec07_2/b5106 - 227773

http://www.bmj.com/rapid-response/2011/11/02/toxic-epidermal-necrolysis-associated-influenza-illness-and-

oseltamivir-ph

240. Bunker CB. Dermatology. In: Medicine at a Glance 3e. Edited by Davey P. Wiley-Blackwell, Oxford, 2010.

241. Patalay R, Fields P, Kazmi, Francis ND, Whittaker S, Bunker CB. A psoriasiform rash. (Clinicopathological case).


242. Dewan P, Bunker CB et al. Mycobacterium chelonae infection after craniofacial surgery. Clin Exp Dermatol 2010; 35(3):e30-1.

243. Bunker C. B. Specialist private practice in Dermatology: ethical aspects. British Association of Dermatologists 2010.

244. Morar N, Willis-Owen SA, Maurer T & Bunker CB. HIV associated psoriasis: pathogenesis, clinical features and

management. Lancet Inf Dis 2010;10:470-478.

245. de Koning MNC, ter Schegget J, Kamp M, Kleter B, Feltkamp MCW, Eekhof JAH, Bavinck JNB, Purdie KJ, Harwood CA,

Meys R, Bunker CB & Quint WGV. Evaluation of a novel broad-spectrum PCR-multiplex genotyping assay for

identification of skin wart HPV. J Clin Microbiol 2010;48:1706-11.

246. Rao A & Bunker C. Efficacy and safety of tacrolimus ointment 0.1% vs. betamethasone 17-valerate 0.1% in the

treatment of chronic paronychia: an unblinded randomized study. Br J Dermatol 2010;163:208.

247. Edwards S & Bunker CB. Other conditions affecting the male genitalia. In: ABC of Sexually Transmitted Infections.

Ed. Rogstad KE. Sixth Edition. Wiley-Blackwell 2011, pp 35-41.

248. Bunker CB. Review. A Colour Handbook: Dermatology. Rycroft RJG, Robertson SJ & Wakelin SH. Second edition.

Manson Publishing 2010. London. UK. Br J Hosp Med 2010;71:596.

249. Edmonds EVJ & Bunker CB. Nuclear magnetic resonance spectroscopy of urine in male genital lichen sclerosus. Br J

Dermatol 2010;163:1355-6.

250. Bunker CB. Re: Sanjay Kulkarni, Guido Barbagli, Deepak Kirpekar et al. Lichen sclerosus of the male genitalia and

urethra: surgical options and results in a multicenter international experience with 215 patients. Eur Urol

2009;55:945–956. Eur Urol 2010;58:e55-6.


http://www.bmj.com/cgi/eletters/339/dec07_2/b5106#227773

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Rao%20A%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22Bunker%20C%22%5BAuthor%5D

46

251. Meys R, Macedo C, Jones R, Day S, Weir J, Gotch FM & Bunker CB. Cutaneous HPV related immune reconstitution

associated disease in HIV: an under-recognised phenomenon. Br J Dermatol 2011;164:458-9. Erratum: Br J

Dermatol 2011;165:228

252. Perrett CM, Macedo C, Francis N, Ion L & Bunker CB. Atypical fibroxanthoma in an HIV-infected individual. J

Cutan Pathol 2011;38:357-9.

253. Gleeson C, Morar N, Staveley I & Bunker CB. Treatment of cutaneous sarcoid with topical gel PUVA. Br J

Dermatol 2011;164:892-4.

254. Dadzie O & Bunker CB. Dermatology. Medicine at a Glance: Core cases. Ed. Davey P. Wiley-Blackwell 2011.

255. Bunker CB. Comments on the BAD guidelines for the management of lichen sclerosus Br J Dermatol 2011;164:894-

5.

256. Edmonds EVJ, Oyama N, Chan I, Francis N, McGrath JA & Bunker CB. Extracellular cellular matrix protein 1

(ECM1) autoantibodies in male genital lichen sclerosus (MGLSc). Br J Dermatol 2011;165:218-9.

257. Edmonds EVJ, Barton G, Buisson S, Francis N, Gotch F, Game L, Haddad H & Bunker CB. Gene expression profiling

in male genital lichen sclerosus (MGLSc). Int J Exp Pathol 2011;92:320-325.

258. Rao A & Bunker CB. Male genital skin biopsy. Int J STD & AIDS 2011;22:418-9.

259. Edmonds E, Hunt S, Hawkins D, Dinneen M, Francis N & Bunker CB. Clinical parameters in male genital lichen

sclerosus: a case series of 329 patients. J Eur Acad Dermatol Venereol 2012;26:730-7; .JEADV 2011; Jun 27. doi:

10.1111/j.1468-3083.2011.04155.x. [Epub ahead of print]

260. Tewari A & Bunker CB. Sweet’s syndrome preceding carcinoid and myeloma by more than a decade. Cutis

2013;92:E1.

261. Robey RC, Mletzko S, Bower M, Meys R, Boffito M, Nelson M, Bunker CB & Gotch FM. Ex-Vivo Recognition of

Late-Lytic CD8 Epitopes Specific for Kaposi's Sarcoma-Associated Herpesvirus (KSHV) by HIV/KSHV-Coinfected

Individuals. Viral Immunol 2011;24:211-20.

262. Bunker CB. Review. A Colour Handbook: Acute Adult Dermatology. Creamer D, Barker J & Kerdel FA. Manson

Publishing 2011. London. UK. Br J Hosp Med 2011;72:357.

263. Bunker CB & Francis N. Pseudoeptheliomatous and keratotic micaceous balanitis: comment. Clin Exp Dermatol

2012;37:434-5.

264. Bunker CB. Keratoacanthoma, trauma and cryotherapy. Dermatol Surg 2011;37:1709.

265. Bunker CB. Diseases and disorders of the male genitalia. In: Goldsmith LA. Katz SI, Gilchrest BA, Paller AS,

Leffell DJ & Wolff K. Eds. Fitzpatrick’s Dermatology in General Medicine, 8th edition. McGraw Hill 2012, pp 852-

877.

266. Bunker CB. Non-venereal penile dermatoses. In: Gupta S. & Kumar B. Eds. Sexually Transmitted Infections. 2nd

Edition. Elsevier, New Delhi, 2012, pp 703-727.

267. Lowe SM, Katsidzira L, Meys R, Sterling JC, de Koning M, Quint W, Nathoo K, Munyati S, Ndhlovu CE, Bunker CB,

Corbett EL, Miller RF & Ferrand RA. Epidermodysplasia verruciformis: a common manifestation of HIV infection

among vertically-infected adolescents in Zimbabwe. Clin Infect Dis 2012;54:e119-23. Epub 2012 Apr 3

268. Bunker CB. Development of male genital lichen sclerosus in penile reconstruction skin grafts after cancer surgery: an

unreported complication. BJU Int 2012;109:E29-31.

269. Bunker CB. Occlusion, urine and genital lichen sclerosus. Indian J Dermatol Venereol Leprol 2012;78:367-8.

270. Calonje E, Neill S, Bunker C, Francis N, Chaux A & Cubilla AC. Diseases of the anogenital skin. In: McKee’s

Pathology of the Skin. Eds Calonje E, Brenn T, Lazar A & McKee P 4th Edition. Elsevier Saunders. London. 2012;

Chapter 12. 438-519 pp452-456).

271. Ayer J, Matthews S, Francis N, Walker NP, Dinneen M & Bunker CB. Successful treatment of Buschke-Lowenstein

tumour of the penis with carbon dioxide laser vaporisation. Acta Derm Venereol 2012;92:656-7.

272. Chandrakumar A & Bunker CB. Dermatology. In: Oxford Desk Reference: Acute Medicine. Eds Leach R, Bell, D &

Moore K. OUP. Oxford, 2016 Chapter 17. 651-687.

273. Bunker CB. Review. Skin Diseases in the Elderly: A Colour Handbook. Evans CC & High WA. Manson Publishing

2012. London. Br J Hosp Med 2012;73:237.

274. Bunker CB, Patel, N & Shim TN. Urinary voiding symptomatology (micro-incontinence) in male genital lichen

sclerosus (MGLSc). Acta Derm Venereol 2013;93:216–256.

275. Shim TN & Bunker CB. The aetiopathogenesis of male genital lichen sclerosus (MGLSc). Nepal J Derm Ven Leprol

2013;11: 1-6.

276. Chandrakumar A, Weir J, Bunker CB & Agnew K. An incidental scalp finding: agminate blue naevus. Clin Exp

Dermatol 2013;38:108-10.

277. Bunker CB & McLelland J. Re: Measure your team's performance, and publish the results. BMJ 2012;345; doi:

http://dx.doi.org/10.1136/bmj.e4590. BMJ 2012;345:e4590.

http://www.bmj.com/content/345/bmj.e4590/rr/594065

http://dx.doi.org/10.1136/bmj.e4590


47

278. Bunker CB. Re: Personal View. The UK needs office Dermatologists. The UK needs office dermatologists. BMJ

2012;345doi: http://dx.doi.org/10.1136/bmj.e6006 BMJ 2012;345:e6006.

http://www.bmj.com/content/345/bmj.e6006?tab=responses

279. Bunker CB & Griffiths T. Re: Head to Head: Should all advertising of cosmetic surgery be banned? No. BMJ

2012;345doi:http://dx.doi.org/10.1136/bmj.e7508. BMJ 2012;345:e7508.


280. Bunker CB & Griffiths T. Cosmetic surgery advertising. Non-surgical invasive procedures such as dermal fillers

should also be regulated. BMJ 2012;345:e7996. http://dx.doi.org/10.1136/bmj.e7996

281. Shim TN & Bunker CB. Male genital lichen sclerosus and hepatitis C. Br J Dermatol 2012;167:1398-9.

282. Singh S, Kaye S, Francis N, Peston D, McClure & Bunker CB. Human endogenous retrovirus K (HERV-K) rec

mRNA is expressed in primary melanoma but not in benign naevi or normal skin. Pig Cell & Mel Res 2013;26:426-8.

283. Bunker CB. Support for article: Sentinel node biopsy for melanoma: unnecessary treatment? BMJ 2013;346doi:. BMJ

2013;346:e8645.


284. Bunker CB. Re: Regulating the NHS market in England. What about conflict of interest? BMJ 2013;346:f1608.

http://www.bmj.com/content/346/bmj.f1608?tab=responses

285. Bunker CB. Re: Act now against new NHS competition regulations. BMJ 2013;346:f1819

http://www.bmj.com/content/346/bmj.f1819/rr/637740

286. Bunker CB. Re: Malignant and premalignant lesions of the penis. BMJ 2013;346:f1149.


287. Chan I, Hawkins, D & Bunker CB. Balanoposthitis. BMJ Point-of-Care 2009;http://www.pointofcare.bmj.com. Point

of Care (US version) http://online.epocrates.com. Best Practice (rest-of-world version)


288 Levell NJ, Jones SK & Bunker CB. Dermatology. Consultant Physicians working with patients. Clinical Medicine

2013 81-89.

289. Bunker CB. Malignant and premalignant lesions of the penis: Penile cancer can be prevented or treated pre-emptively.

BMJ 2013;346:f2129. http://bmj.com/cgi/content/full/bmj.f2129

290. Dinneen EP, Bunker CB & Dinneen MD. Male circumcision-when is it justified? Trends in Urology & Mens Health

2013;4: 22-25.

291. Bunker CB. Skin conditions of the male genitalia. Medicine 2014;42:372-377.

292. Shim TN, Minhas S, Muneer A & Bunker CB. Atypical presentation of genital herpes simplex (HSV-2) in 2 patients

with chronic lymphocytic leukemia. Acta Derm Venereol 2014;94: 246–247

293. Bunker CB & Piquet V. HIV and AIDS. In: Griffiths C, Barker J, Bleiker T, Chalmers R Creamer D. eds. Rook's

Textbook of Dermatology. 9th ed. Oxford: Wiley-Blackwell; 2016. P.31.1-37

294 Bunker CB & Porter WM. Dermatoses of the male genitalia. In: Griffiths C, Barker J, Bleiker T, Chalmers R Creamer

D. Rook's Textbook of Dermatology. 9th ed. Oxford: Wiley-Blackwell; 2016. P. 111.1-41.

295. A segmental rash in a young male: A Quiz. Merika, EE, Bunker CB, Francis, N & Singh S. Acta Derm Venereol

2014;94: 253–254.

296. Bunker CB. Atopy, the barrier, urine and genital lichen sclerosus (LS). Br J Dermatol 2013;169:953.

297. Agnew K, Bunker CB & Aaron S. Fast Facts-Skin Cancer. Health Press, London UK, 2013.

298. Shah M & Bunker CB. Male Dermatoses. ABC of Sexual Health. Wiley 2013 (in press).

299. Creamer D, Walsh SA, Dziewulski P, Exton LS, Lee HY, Dart JK, Setterfield J, Bunker CB, Ardern-Jones MR,

Watson KM, Wong GA, Philippidou M, Vercueil A, Martin RV, Williams G, Shah M, Brown D, Williams P, Mohd

Mustapa MF & Smith CH. UK guidelines for the management of Stevens-Johnson syndrome/toxic epidermal

necrolysis. Br J Dermatol 2016;174: 1194-227.

300. Sidwell RU, Chan I, Francis N & Bunker CB. Trichophyton erinacei kerion barbae with direct osculatory transfer.

Clin Exp Dermatol 2014;39:38-40

301. Bunker CB. Dermatology. HIV for non-HIV specialists. MEDFASH 2e 2013 (in press).

302. Merika EE, Darling MI, Craig P, Paul M, Francis N, Lachmann H, Porter7 W & C.B. Bunker. Primary cutaneous

amyloidosis of the glans penis. Two case reports and a review of the literature. Br J Dermatol 2014;170:730-4.

303. Shim TN, Andrich DE, Mundy AR & Bunker CB. Lichen sclerosus associated with perineal urethrostomy. Br J

Dermatol 2014;170:222-3.

304. Wilmot M-C, Perrett CM, Calonje E, Weir J & Bunker CB. A crusted lesion on the penis. Clin Exp Dermatol

2014;39:238-9.

305. Bunker CB & Shim TN. Male genital oedema in Crohn's disease. J Am Acad Dermatol 2014;70:385.

306. Bunker CB. Commissioning-a wasteful process but we must get involved. NHSCA Editorial 2013 (Sept);18-19.

307. Rashidghamat E, Bunker CB, Bower M & Banerjee P. Kaposi Sarcoma in HIV-negative men who have sex with men.


http://www.bmj.com/content/345/bmj.e6006?tab=responses





http://www.bmj.com/content/346/bmj.f1608?tab=responses




http://online.epocrates.com/


http://bmj.com/cgi/content/full/bmj.f2129

48

Br J Dermatol 2014;171:1267-8.

308. Abela C, Hartmann CE, De Leo A, de Sica Chapman A, Shah H, Jawad M, Bunker CB, Williams GJ, Leon-Villapalos

J. Toxic epidermal necrolysis (TEN): The Chelsea and Westminster Hospital wound management algorithm. J Plast

Reconstr Aesthet Surg 2014;67:1026-32.

309. Edwards S, Bunker C, Ziller F, van der Meijden WI. 2013 European guideline for the management of balanoposthitis.

Int J STD AIDS 2014;25:615-626.

310. Eedy D & Bunker CB. Dermatology in the new NHS. Br J Healthcare Mgt 2014;20:312-14.

311. Bower M, Palfreeman A, Alfa-Wali M, Bunker C, Burns F, Churchill D, Collins S, Cwynarski K, Edwards S,

Fields P, Fife K, Gallop-Evans E, Kassam S, Kulasegaram R, Lacey C, Marcus R, Montoto S, Nelson M,

Newsom-Davis T, Orkin C, Shaw K, Tenant-Flowers M, Webb A, Westwell S & Williams M. British HIV

Association guidelines for HIV-associated malignancies 2014. HIV Med 2014;15 Suppl 2:1-92.

312. Dhoot S, Balachandran K, Tittle V, Bunker C, Nelson M, Kelleher P & Bower M. Immunological function in HIV-

seronegative men who have sex with men (MSM) with Kaposi's sarcoma (KS). HIV Med 2014;15:55-55. 313. Bunker CB & Shim TN. Male genital lichen sclerosus. Indian J Dermatol 2015;60:111-117.

314. Veitch D, Kravvas G, Hughes S & Bunker CB. A rare colocalisation of lichen planus and vitiligo. Case Reports in

Dermatological Medicine 2015; 2015: Article ID 840193. http://www.hindawi.com/journals/cridm/2015/840193/

315. Doiron P & Bunker CB. Important topics in male genital dermatology. Dermatology in Practice 2015;21:92-95.

316. Thomas LJ, Shim TN, Borysiewicz C, Dinneen M, Fawcett H, Roy A, Francis N & Bunker CB. Male genital lichen

sclerosus in recipients of bone marrow transplants. 2016;41:495-7.

317. Kravvas G, Veitch D, Fawcett H & Bunker CB. Porokeratosis of Mibelli: case report of an uncommon penile lesion.


318. Bunker CB. Private practice in Dermatology. Ethical aspects: a guide for members. British Association of

Dermatologists 2016.

319. Turnbull N, Shim T, Patel N, Mazzon & Bunker C. Primary melanoma of the penis in three patients with lichen

sclerosus. JAMA Dermatol 2016; JAMA Dermatol. 2016;152:226-7.

320. Shabbir M, Watkin N, Bunker CB & Muneer A. Premalignant lesions of the penis. In: A. Muneer et al. (eds.),

Textbook of Penile Cancer,. Springer-Verlag London, 2016 (in press).

321. Ziada M, Bunker CB & Muneer A. Premalignant penile lesions. J Clin Urol 2016 (in press).

http://uro.sagepub.com/cgi/reprint/9/4/216.pdf?ijkey=hOAvzyojdVQPiJY&keytype=finite

322. Meys R, Purdie KJ, de Koning MNC, Quint KD, Little AM, Baker F, Francis N, Asboe D, Hawkins D, Marsh SGE,

Harwood CA, Gotch FM & Bunker CB. HLA immunogenotype determines persistent HPV infection in anti-retroviral

treated HIV. J Infect Dis 2016;213:1717-24.

323. Noy ML, Hughes S & Bunker CB. Another face of demodicosis. Clin Exp Dermatol 2016;41:958-959.

324. Chan I, Hawkins, D & Bunker CB. Balanoposthitis. BMJ Point-of-Care 2016;http://www.pointofcare.bmj.com.

325. Bunker CB. EDF lichen sclerosus guidelines. JEADV 2016;31:e97-98

326. Doiron P & Bunker CB. Response to "Expanding the benefits of HPV vaccination to boys and men”. Lancet

2016;388:659.

327. Christodoulidou M, Bunker CB, Trevisan G, & Muneer A. BMJ Case Rep 2016 Aug 24;2016. pii: bcr2016216913.

doi: 10.1136/bcr-2016-216913.

328. Tull T, Noy M, Bunker CB, Francis ND, & Morar N. Sebopsoriasis in HIV positive patients: A case series of four

patients. Br J Dermatol 2016 (in press). Jul 22. doi: 10.1111/bjd.14874. [Epub ahead of print]

329. Shim TN, Ali I, Muneer A. & Bunker CB. Benign male genital dermatoses. Br Med J 2016

http://bmj.com/cgi/content/full/bmj.i4337?ijkey=LJqWPYX4jR74VXD&keytype=ref 330. Creamer D, Walsh SA, Dziewulski P, Exton LS, Lee HY, Dart JK, Setterfield J, Bunker CB, Ardern-Jones MR,



necrolysis. J Plast Reconstr Aesthet Surg 2016;69:736-41.

331. Creamer D, Walsh SA, Dziewulski P, Exton LS, Lee HY, Dart JK, Setterfield J, Bunker CB, Ardern-Jones MR,



necrolysis. Br J Dermatol 2016;174:1194-1227.

332. Doiron PR & Bunker CB. Obesity related male genital lichen sclerosus. JEADV 2017;31:876-879.

333. Kravvas G, Veitch D, Doiron PR, Freeman A, Muneer A, Dinneen M, Francis N & Bunker CB. Recurrent penile

squamous cell carcinoma in an elderly circumcised man. Clin Exp Dermatol 2017;42:360-362.

334. Bunker CB. Guidelines for the management of TEN and SJS. MIMS Dermatology 2017;13:6.

335. Doiron PR, Menage HP, Freeman A, Muneer A & Bunker CB. Peri-meatal PeIN and urethral SCC: a case report.

JEADV 2017 Mar 10. doi: 10.1111/jdv.14207. [Epub ahead of print] PMID: 28295605



http://www.hindawi.com/journals/cridm/2015/840193/


49

336. Kravvas G, Shim TN, Doiron PR, Freeman A, Jameson C, Minhas S, Muneer A, Bunker CB. The diagnosis and

management of male genital lichen sclerosus: a retrospective review of 301 patients. JEADV 2018;32:91-95.

337. Schartau P, Carr J, Muneer A & Bunker CB. Male genital dermatoses: a practical guide for GPs. Innovait 2018 (in

press).

338. Shim TN, Doiron PR, Francis N, Minhas S, Muneer A, Hawkins D, Dinneen, M & Bunker. CB Penile lymphoedema:

approach to investigation and management. Clin Exp Dermatol 2018 (in press).

339. Lewis FM, Tatnall FM, Velangi SS, Bunker CB, Kumar A, Brackenbury F, Mohd Mustapa MF, & Exton LS. British

Association of Dermatologists guidelines for the management of lichen sclerosus 2018. Br J Dermatol 2018;178:839-

853.

340. Watchorn RE & Bunker CB. Genital diseases in the mature man. Clin Dermatol 2018 (in press).

341. Christodoulidou M, Parnham A, Khetrapal P, Freeman A, Jameson C, Mitra A, Malone P, Nigam R, Bunker CB &

Muneer A. Management of Penoscrotal Extramammary Pagets disease - A single centre UK experience. Urologic

Oncology: Seminars and Original Investigations 2018 (in press).

CITATIONS:

BJD Virtual Issue Number 4, August 2012 Top cited Melanoma articles

For the fourth Virtual Issue, the BJD has collated the top 10 most cited melanoma research articles since 2009. Over

the last three years the BJD has attracted the submission of high impact, good quality papers on this subject which

includes the revised UK guidelines for the management of cutaneous melanoma.

10. Singh S.; Kaye S.; Gore M. E.; et al. The role of human endogenous retroviruses in melanoma. British Journal of

Dermatology 2009;161;1225-1231.

SUBMITTED PAPERS AND OTHER CONTRIBUTIONS:

1. Phan P-A, Bunker CB. Dysgeusia due to doxycycline. Br J Dermatol

2. Farrell AM, Francis N, Bunker CB. Zoon’s balanitis and vulvitis: an immunohistochemichal study. Br J Dermatol

3. Borysiewycz C. & Bunker CB. Dermatology. Chelsea & Westminster AIDS Care Handbook. Ed. Gazzard B.

Mediscript, London, 2012 (in press

MANUSCRIPTS IN PREPARATION:

1. Bunker CB. Levene GML. Bowen’s disease of the penis treated with 5-fluorouracil.

2. Trendell-Smith N. Bunker CB. et al. Female pattern androgenic alopecia.

3. Bunker CB, Papadaki L, Leslie TA, Miller JA & Dowd PM. Scleredema of Buschke.

4. Mallon E, Francis N, Bunker CB. The spectrum of cutaneous CMV infection in HIV disease.

5. Farrell AM, Trendell-Smith NJ, Francis N, Bunker CB. Are idiopathic scrotal cysts idiopathic? An

immunohistochemichal study. Br J Dermatol

6. Jones J, Thompson P, Sohail M, Jenkins C & Bunker CB. Sclerosing lymphangitis of the penis

7. Phan P-A, Francis N, Warrell D, Bunker CB. Delayed persistent and recurrent cutaneous reactions to jellyfish sting

8. Saha M, Bunker CB. A case of dermatomyositis in a patient with primary biliary cirrhosis.

9. Bunker CB. Sorting out penile rashes. Trends in Urology, Gynaecology and Sexual Health.

PUBLICATIONS-ABSTRACTS AND PROCEEDINGS OF MEETINGS:

1. Bunker CB & Dowd PM. Topical minoxidil does not increase scalp blood flow in androgenic alopecia.

Br J Dermatol 1987;116:447.

2. Bunker CB, Lanigan S, Gilkes JJH. Report of a comparative study of the efficacy of Varidase Topical

versus benzoyl peroxide 20% in the cleansing of leg ulcers using reflex metrography. In: A biological

http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2133.2009.09415.x/full

50

approach to the wound healing process: a clinical update (Rue Y. ed.) Andover: Medifax International

1987;23-27.

3. Newton JA, Bunker CB, Kilborn J, Patel A, Conway GS, Jacobs HS, Greaves MW & Dowd PM. The prevalence of polycystic ovaries in patients with acne vulgaris. Br J Dermatol 1988;119 (suppl):34.

4. Bunker CB, Maurice PDL, Sharp JC et al. Scleroderma and polymyositis overlap syndrome associated

with IgG lambda paraproteinaemia and cutaneous amyloid deposition. Br J Dermatol 1988; 119 (suppl):

70-71.

5. Bunker CB & Dowd PM. Giant cell arteritis and systemic lupus erythematosus. Br J Dermatol 1988;

119 (suppl):71-72.

6. Rustin MHA, Bunker CB, Gilkes JJH et al. Extensive linear epidermal naevi and polyostotic fibrous

dysplasia. Br J Dermatol 1988; 119 (suppl):75-76.

7. Bunker CB, Newton JA, Kilborn J et al. Women with acne who have polycystic ovaries (PCO) have

endocrinological differences from other women with PCO. Br J Dermatol 1989;120:293.

8. Dowd PM, Lanigan S, Rustin MHA & Bunker CB. Topically applied hexyl nicotinate lotion

increases the cutaneous blood supply in patients with Raynaud’s phenomenon. Br J Dermatol 1988;120:

311-312.

9. Maurice PDL, Bunker CB & Dowd PM. Isotretinoin in the treatment of systemic sclerosis.

Pharmacology and the Skin Vol 3 Pharmacology of Retinoids in the Skin. Eds. Reichert U and Shroot B.

Karger. Basel. 1989;235-239.

10. Bunker CB, Maurice PDL, Little S et al. Isotretinoin given in the treatment of systemic sclerosis may

hasten the decline in pulmonary function. Thorax 1989;44:346-347P.

11. Bunker CB. Foreman J & Dowd PM. Digital cutaneous vascular responses to histamine, compound

48/80 and neuropeptides in normal subjects and Raynaud’s phenomenon. J Invest Dermatol 1989;92:409.

12. Bull HA, Bunker CB & Dowd PM. Mechanisms of action of vasoactive neuropeptides on human

cutaneous endothelial cells. J Invest Dermatol 1989;92:409.

13. Bunker CB, Foreman J & Dowd PM. Digital cutaneous vascular responses to histamine, compound

48/80 and neuropeptides in normal subjects and Raynaud’s phenomenon. Clin Res 1989;37:632A .

14. Bull HA, Bunker CB & Dowd PM. Mechanisms of action of vasoactive neuropeptides on human

cutaneous endothelial cells. Clin Res 1989;37:697A.

15. Bunker CB, Cooper F & Dowd PM. A double-blind placebo controlled trial of topical hexyl nicotinate in

primary Raynaud’s phenomenon. Br J Dermatol 1989;121 (Suppl.34):51-52.

16. Bunker CB, Foreman J, Reavley C, O’Shaughnessey D & Dowd PM. Calcitonin gene-related peptide in

the treatment of severe Raynaud’s phenomenon. Br J Dermatol 1989;121 (Suppl.34):43-44.

17. Bunker CB, Foreman JC, O’Shaughnessy D et al. Calcitonin gene-related peptide in Raynaud’s

phenomenon. Skin Pharmacol 1989;2:47.

18. Bull HA, Bunker CB & Dowd PM. Calcitonin gene-related peptide down-regulates cutaneous

endothelial responses to Substance P and histamine. Skin Pharmacol 1989;2:48.

19. Bunker CB, Foreman JC, O’Shaugnessy D et al. Calcitonin gene-related peptide in Raynaud’s

phenomenon. Regulatory Peptides 1989;26:51.

20. Bull HA, Bunker CB & Dowd PM. Cutaneous endothelial cell responses to substance P and histamine

are attenuated by calcitonin gene-related peptide. Regulatory Peptides 1989;26:62.

21. Bunker CB, Foreman JC & Dowd PM. Digital vascular responses to neuropeptides and histamine at

low temperatures in Raynaud’s phenomenon. J Invest Dermatol 1990;94:511.

22. Bunker CB, Foreman JC & Dowd PM. Digital vascular responses to neuropeptides and histamine at

low temperatures in Raynaud’s phenomenon. Clin Res 1990;

23. Bunker CB, Cerio R, Bull HA, Evans J, Foreman JC & Dowd PM. Mast cells after capsaicin

application in normal human skin. Br J Dermatol 1990;123 (Suppl 37):119.

24. Bunker CB, Reavley C, O’Shaughnessy D & Dowd PM. Intravenous calcitonin gene-related peptide

in severe Raynaud’s phenomenon. Br J Rheumatol 1990;29 (Suppl 2):1.

25. Bunker CB, Foreman JC & Dowd PM. Neuropeptides and histamine induced vascular responses in

Raynaud’s phenomenon: the effect of low temperature. Skin Pharmacol 1990;3:188-189.

26. Bunker CB, Foreman JC & Dowd PM. Effect of topical steroid on the intradermal vascular responses

to neuropeptides, histamine and substance 48/80. Skin Pharmacol 1990;3:189.

27. Bunker CB, Foreman JC & Dowd PM. Topical steroid and the vascular responses to intradermal

neuropeptides, histamine and compound 48/80. Br J Dermatol 1990;123:814.

28. Bunker CB, Terenghi G, Springall DR, Polak JM & Dowd PM. Calcitonin gene-related peptide and

endothelin in digital skin in Raynaud’s phenomenon. Br J Dermatol 1990;123:814.

51

29. Brickell PM, Maschio A, Katz D, Bunker CB & Craig RK. Expression of milk protein genes in the

sebaceous glands of transgenic and normal mice during lactation. Br J Dermatol 1990;123:826.

30. Bunker CB & Robinson TWE. Erythrokeratoderma variabilis. Br J Dermatol 1991;125 (suppl 38):62.

31. Bunker CB & Gilkes JJH. Granulomatous cheilitis and Crohn’s disease. Br J Dermatol 1991; 125 (suppl 38):75.

32. Bunker CB, Rubin A, Cambridge G, Spiro S & Gilkes JJH. Wegener’s granulomatosis. Br J Dermatol

1991;125 (suppl 38):72.

33. Bunker CB, Miller JA, Kurtz A & Dowd PM. Scleredema of Buschke. Br J Dermatol 1991;125 (suppl 38):71.

34. Bunker CB, Katz D, Tobias J, Brook C & Levene GM. Histiocytosis X. Br J Dermatol 1991;125 (suppl 38):73.

35. Goldsmith PC, Bunker CB & Dowd PM. Irritant contact dermatitis due to water. Br J Dermatol 1991;

125 (suppl 38):48.

36. Bunker CB, Tomlinson MC, Johnson N.McI & Dowd PM. Isotretinoin and the lung. Br J Dermatol 1991;

125 (suppl 38):29.

37. Bunker CB, Foreman JC & Dowd PM. Digital vascular responses to endothelin in Raynaud’s

phenomenon. Skin Pharmacol 1991;125:481.

38. Bull HA, Courtney PF, Bunker CB, Rustin MHA, Pearce F & Dowd PM. Basophil histamine receptors (H3)

in atopic dermatitis. J Invest Dermatol 1991;96:627A.

39. Bull HA, Courtney PF, Bunker CB, Rustin MHA, Pearce F & Dowd PM. Basophil histamine receptors (H3)

in atopic dermatitis. Clin Res 1991;39:535A.

40. Bunker CB, Rustin MHA, Smith N & Levene GM. An indolent cutaneous prodrome of human T

lymphotropic virus type 1 (HTLV1) infection associated adult T cell leukaemia/lymphoma. In: Dermatology

in Europe 1989. Proceedings of the Ist Congress of the European Academy of Dermatology and Venereology,

Florence, Italy. 25-28 September 1989 (Ed. Panconesi E.) Blackwell Scientific Publications. Oxford; 1991, 642

41. Bunker CB, Smith NP, Russell RCG & Dowd PM. peculiar tumour. In: Dermatology in

Europe 1989. Proceedings of the Ist Congress of the European Academy of Dermatology and Venereology,

Florence, Italy. 25-28 September 1989 (Ed. Panconesi E.) Blackwell Scientific Publications. Oxford; 1991, 643.

42. Heagerty A, Bunker C, Rustin M & Dowd P. Treatment of Morphoea with Colchicine. In: Dermatololgy in

Europe 1989. Proceedings of the Ist Congress of the European Academy of Dermatology and Venereology, Florence,

Italy. 25-28 September 1989 (Ed. Panconesi E.) Blackwell Scientific Publications. Oxford; 1991, 694.

43. Bunker CB, Reavley C, O’Shaughnessy D & Dowd PM. Calcitonin gene-related peptide in the

treatment of Raynaud’s phenomenon. In: Dermatology in Europe 1989. Proceedings of the Ist Congress of

the European Academy of Dermatology and Venereology, Florence, Italy. 25-28 September 1989 (Ed.

Panconesi E.) Blackwell Scientific Publications. Oxford; 1991, 695.

44. Terenghi G, Bull HA, Bunker CB, Springall DR, Zhao Y, Wharton J, Dowd PM & Polak JM.

Endothelin in human skin-immunohistochemical, receptor binding and functional studies. Proceedings of 2nd

International Conference on Endothelin, Japan, Dec 1990;17:S455-457. Lippincott Raven (1991).

45. Bunker CB, Goldsmith PC, Leslie T, Bull HA, Foreman JC & Dowd PM. Cutaneous vascular

responses to endothelin in normal skin and in Raynaud’s phenomenon. Br J Dermatol 1991;125:481.

46. Terenghi G, Bull HA, Bunker CB, Springall DR, Zhao Y, Wharton J, Dowd PM & Polak J.M. (1991)

Endothelin-1 in human skin: immunolocalization, receptor binding and functional studies. J Cardiovas

Pharmac 1991;17 (suppl), S467-S470.

47. Bunker CB, Wilkinson LS, Bull HA, Goldsmsith PC, Cambridge G, Brickell PM, Coleridge-Smith PD, Edwards JCW,

Dowd PM. Tumour Necrosis Factor Alpha Expression in human skin. J Invest Dermatol 1991; 96: 1025A

48. Bull HA, Wilkinson LS, Bunker CB, Edwards JCW & Dowd PM. Regulation of expression of the CD34 antigen in

human dermal microvascular endothelial cells. J Invest Dermatol 1992;98:529.

49. Bunker CB, Hayes N, Foreman JC & Dowd PM. CGRP(8-37) is an antagonist of CGRP in human skin.

J Invest Dermatol 1992;98:563.

50. Bunker CB, Hayes N, Foreman JC & Dowd PM. CGRP(8-37) is an antagonist of CGRP in human skin.

Clin Res 1992;40:532A.

51. Goldsmith PC, Bunker CB, Leslie TA, Terenghi G, Abadia Molina F, Polak J & Dowd PM. Cutaneous nerve fibre

depletion in vibration white finger. Br J Dermatol 1992;127:424.

52. Goldsmith PC, Bunker CB, Leslie TA, Bull HA, Foreman JC & Dowd PM. Inhibition of the endothelin-1

mediated flare in the skin following application of topical 0.05% clobetasol propionate. Br J Dermatol 1992;

127:425.

53. Goldsmith PC, Bunker CB, Leslie TA, Terenghi G, Abadia Molina F, Polak J & Dowd PM. A study of

immunoreactive nerves in vibration white finger. Skin Pharmacol 1992;5:196-197.

54. Leslie TA, Bunker CB, Hayes N, Levell NJ, Foreman JC and Dowd PM. Capasaicin Modulates The Cutaneous

Vascular response to Endothelin-1. Skin Pharmacol 1992;5:196-197.

52

55. Goldsmith PC, Abadia-Molina F, Bunker CB, Leslie TA, Terenghi G, Polak JM, Dowd PM. Depletion of cutaneous

CGRP and PGP 9.5 in immunoreactive nerves in vibration white finger. Neuropeptides 1993;24;206

57. Markus H, Bunker CB, Kouris K, Costa D & Harrison M. Tc-99m-HMPHD SPECT in Behcets syndrome

with and without central nervous system involvement. J Neurol (in press)

58. Smith R, Asboe D, Ross J, Fisher M, Bunker CB & Gazzard BG. Infective panniculitis as a manifestation of

pseudomonas infection in a patient with acquired immune deficiency syndrome. The Medical Society for the

Study of Venereal Diseases, Zurich 1993.

59 Leslie TA, Bunker CB, Hayes N, Levell NJ, Foreman JC & Dowd PM. Cold challenge modulates

cutaneous responses to endothelin-1 after capsaicin treatment. Skin Pharmacol 1994;7:159.

60. Ross JS, Aqel NM & Bunker CB. Cutaneous manifestations of Kikuchi’s disease. Br J Dermatol 1993;

129 (Suppl 42):60.

61. Smith RA, Ross JS, Branfoot AC, Asboe ID, Gazzard BG & Bunker C.B. Panniculitis with

pseudomonas septicaemia in AIDS. Br J Dermatol 1993;129 (suppl 42):63.

62. Bewley AP, Bracka A, Staughton RCD & Bunker CB. Extramammary Paget’s disease of the scrotum:

treatment with topical 5-fluorouracil and plastic surgery. Br J Dermatol 1994;13:445-6.

63. Rowe A, Sadri R, Farrell A, Roberts N, Ross J & Bunker CB. Interleukin-4 in atopic dermatitis. Br J

Dermatol 1994;131:435-6.

64. Rowe A, Sadri R, Farrell A, Roberts N, Ross J & Bunker CB. In situ localisation of interleukin-4 mRNA

and proteins in atopic dermatitis. Skin Pharmacol 1995;8:269.

65. Rowe A, Farrell AM, Kazmi SH & Bunker CB. Localisation of inducible nitric oxide synthase in psoriatic dermal

microvasculature. Br J Dermatol 1995;132:637.

66. Rowe A, Farrell AM, Kazmi SH & Bunker CB. Expresssion of inducible nitric oxide synthase in atopic

dermatitis. J Invest Dermatol 1995;104:650.

67. Farrell AM, Shanson D, Roberts NM, Ross JS, Fry C, Cream JJ, Staughton RCD, Bunker CB.

Outbreak of MRSA in a Dermatology Unit. Br J Dermatol 1995;133:38.

68. Farrell AM, Bunker CB, Latif F, Odularu O & Bhatt HR. Screening of cobalamin (Cbi) metabolism in

methotrexate (MTx)-treated psoriatics. Skin Pharmacol 1996;9:147.

69. Paul W, Roberts N, Farrell A, Fearfield L, Page CP & Bunker CB. The effects of L-5 on the erythema

and extravasation due to histamine and bradykinin in human skin. Skin Pharmacol 1996;9:148.

70. Rowe A & Bunker CB. Localisation of iNOS mRNA in psoriatic lesions by in situ hybridisation. Br J

Dermatol 1996;135:841.

71. Miles R, Farrell AM, Staughton RCD, Bunker CB & Aspinall R. Changes in the peripheral T cell V

repertoire in psoriasis. Br J Dermatol 1996;134:569.

72. Rowe A, Choudhury AI, Farrell AM & Bunker CB. Localisation of IL-4 receptors in inflammatory skin

disease. Br J Dermatol 1996;134:588-9.

73. Rowe A, Choudhury AI, Roberts NM, Farrell AM & Bunker CB. Expression of interleukin-4 Receptors in T

lymphocytes and mast cells in inflammatory skin disease. J Invest Dermatol 1996:106:933.

74. Farrell AM & Bunker CB. Oral gold therapy in cutaneous lupus erythematosus (revisited) Br J Dermatol 1996;

135 (suppl 47):41.

75. Fearfield LA, Farrell AM, Roberts NM, Ross JS, Hayes N, Foreman J & Bunker CB. Do lauramacrogols

alter cutaneous neuronal function when used clinically in a bath oil? Br J Dermatol 1996;135 (suppl 47):38.

76. Farrell AM, Francis N & Bunker CB. Zoon’s balanitis: an immunohistochemical study. Br J Dermatol

1996;135 (suppl 47):57

77. Farrell AM, Trendell-Smith NJ, Francis N & Bunker CB. Are “idiopathic scrotal cysts” idiopathic? An

immunohistochemical approach. Br J Dermatol 1996;135 (suppl 47):57.

78. Gooptu C, Woolllons A, Ross J, Price M, Wojnarowska F, Morris P, Wall S & Bunker CB. Merkel cell carcinoma

arising after therapeutic immunosuppression. Br J Dermatol 1996;135 (suppl 47):61.

79. Simpson-Dent SL, Moss J, Woodrow DF & Bunker CB. The ultrastructural pharmacology of vascular permeability in

human skin. J Invest Dermatol 1997;108:663.

80. Mallon E, Young D, Gotch F & Bunker CB. HLA-C locus genotyping of psoriasis in HIV disease using sequence-

specific amplification primers. Br J Dermatol 1997;136:462.

81. Fearfield LA, Francis N, Rowe A, Bunker CB & Staughton RCD. Itchy folliculitis in HIV. Br J Dermatol

1997:137:20.

82. Fearfield, LA, Henry K, Costello C & Bunker CB. Bone Marrow involvement in cutaneous mastocytosis.

JEADV 1997;9:S176.

83. Bunker CB. HIV related skin diseases in man. Proceedings of Br Vet Derm. Study Group October 1997. p.5.

84. Mallon E, Bunce M, Savoie H, Gotch F, Easterbrook PJ & Bunker CB. HLA-CW*0602 and guttate psoriasis.

53

J Invest Dermatol 1998;110:618.

85. Rowe A, Mallon E, Rosenberger P, Barrett M, Walsh J & Bunker CB. Decreases in cutaneous peptidergic

innervation in HIV-associated xerosis. J Invest Dermatol 1998;110:667.

86. Fearfield LA, Francis N, Rowe A, Bunker CB & Staughton RCD. Eosinophil chemokines in HIV-

associated eosinophilic folliculitis. J Invest Dermatol 1998;110:659.

87. Simpson-Dent SL, Moss J, Woodrow DF & Bunker CB. The ultrastructural pharmacology of endothelin-1in human

cutaneous vasculature. J Invest Dermatol 1998;110: 664.

88. Mallon E, Bunce M, Savoie H, Wojnarowska F, Welsh K, Easterbrook PJ, Gotch F & Bunker CB. HLA-Cw*0602

and psoriasis. 5th European Congree on Psoriasis. 7th International psoriasis symposium. Milan. 1998, p.56.

89. Mallon E, Griffiths DJ, Bunker CB, Weiss RA & Venables PJW. Human Retrovirus-5 and psoriasis. 5th

European Congress on Psoriasis. 7th International psoriasis symposium. Milan. 1998, p. 64.

90. Fearfield LA, Agnew K & Bunker CB. A randomised, double-blind, crossover study of the antipruritic actions of

topical lauramacrogols. Br J Dermatol 1998;138:753.

91. Rowe A, Mallon E, Aladeshi A, Walsh J & Bunker CB. Cutaneous mast cell distribution is unchanged in HIV-

associated xerosis. Br J Dermatol 1998;138;743.

92. Mallon E, Hawkins DA, Dinneen M, Fearfield L, Francis N & Bunker CB. Circumcision and genital

dermatological morbidity. Br J Dermatol 1998;139 (Suppl 51):65.

93. Kooner, Sweeney O, Mallon E, Francis N, Bunker CB & Dinneen M. Zoon’s plasma cell balanitis-conservative

treatment is warranted. Br J Urol 1998; in press

94. Rowe A, Mallon E & Bunker CB. Expression of the mitotic suppressor p15INK4b is altered in psoriatic epidermis.

Br J Dermatol 1999;140:810.

95. Mallon E, Griffiths DJ, Venables PJW, Bunker CB & Weiss RA. Human retrovirus-5 is not involved in the

pathogenesis of psoriasis. J Invest Dermatol 1999;112;651.

96. Rowe A, Schilling JP, Mallon E & Bunker CB. Epidermal HLA class I variable chain expression is down-

regulated in chronic plaque and guttate psoriasis. J Invest Dermatol 1999;112;646.

97. Trendell-Smith NJ, Simpson-Dent S, Mallon E, Fearfield LA, Staughton RCD, Francis N & Bunker CB. Female

pattern androgenic alopecia - a histopathological study. Br J Dermatol 1999;141 (suppl 55):120-127.

98. Fearfield LA, Rowe A, Fisher C, Gore M & Bunker CB. Thin melanomas with unusual aggressive behaviour.

Br J Dermatol 1999;141 (suppl 55):43-88.

99. Porter WM, Dinneen M, Hawkins D, Francis N & Bunker CB. Disease spectrum in penile intraepithelial neoplasia.

Br J Dermatol 2000;143 (suppl 57):49-50. 100. Rowe A, Guest M, Allerston A, Davies AH & Bunker CB. Depletion of cutaneous innervation adjacent to venous

ulcers. J Invest Dermatol 2000;114:821. 101. Fearfield LA, Rowe A, Francis N, Fisher C, MacKie R, Gore ME & Bunker CB. CD95 and CD95 ligand expression

in very thin melanoma. J Invest Dermatol 2000;115:554. 102. Fearfield LA, Rowe A, Francis N, Fisher C, MacKie RM, Gore ME & Bunker CB. Clinicopathological features of

very thin melanoma with unusual aggressive behaviour and the expression of CD95 and CD95 ligand. Melanoma

Research 2001;11: (suppl ) S73-S74. 103. Hunt S, Porter WM, Hawkins D, Francis N, Dinneen M & Bunker CB. Chronic penile lymphoedema. Br J Dermatol

2001;145(suppl 59):62. 104. Agnew KL, Hunt SJ, Cream JJ, Staughton RCD & Bunker CB. The Fox Brothers: Founders of dermatology at

Westminster & Charing Cross Hospitals. Br J Dermatol 2001; 145(suppl 59):78. 105. Fearfield LA, Rowe A, Francis N, Fisher C, McCann B, MacKie RM, Gore ME & Bunker CB. Expression of p16 in

relapsing and non-relapsing very thin melanoma. J Invest Dermatol 2001;113:781

106. Rowe A, Guest M, Davies A & Bunker CB. Attenuation of GAP-43 and NF-200 innervation in chronic venous

ulceration. J Invest Dermatol 2001;117:441.

107. Mallon E, Bunce M, Rowe A, Newson R, Gotch F & Bunker C. HLA-Cw*0602 in the Pathogenesis of Psoriasis.

Proceedings of the World Congress of Dermatology 2002. Ann Dermatol Venereol 2002;129:1S607-1S842

108. Fearfield L, Rowe A, Francis N, Fisher C, McCann B, MacKie R, Gore M & Bunker C. Prognostic factors in very

thin melanoma. Proceedings of the 20th World Congress of Dermatology 2002. Ann Dermatol Venereol

2002;129:1S607-1S842.

109. Agnew K, Catovsky D, Costello C, Ruchlemer R & Bunker C. Cutaneous findings in thirty-seven patients with

chronic lymphocytic leukaemia. Proceedings of the World Congress of Dermatology 2002. Ann Dermatol Venereol

2002;129:1S607-1S842.

110. O’Donoghue NB, Bunker CB, Francis N & Fuller LC. Chronic erosive vegetative genital herpes simplex as an

immune reconstitution disease after initiation of HAART in two patients with HIV infection. Br J Dermatol

2002;147:52-3.

54

111. Hunt SJ, Francis N, Dinneen M, Hawkins D & Bunker CB. A retrospective study of 174 men with lichen sclerosus of

the penis. Br J Dermatol 2003;149(suppl):53-54.

112. Sykes K, Brenner C, Jones J, Bunker C & Chinn R. Skin disorders and their radiological manifestations. Educational

Exhibit 0268MS-e. www.rsna.org Radiological Society of North America Scientific Assembly Program 2003:726.

113. Bowling JCR, Bunker CB & Powles A. Spontaneous regression of extramammary Paget’s disease after excision of

underlying inguinal apocrine carcinoma. Br J Dermatol 2004;151 (suppl.68): 89.

114. Bunker C. The dysfunctional foreskin. JEADV 2004;18:70.

115. Phan P-A T, Francis N & Bunker CB. Kissing naevus of the penis: A historical and embryological review. J Am

Acad Dermatol 2004;50:P52.

116. Dyche J, Davison S, Breuer J, Leigh I, Lacey C, Bunker CB & Harwood, CA. Epidermodysplasia verruciformis

human papillomavirus types are frequently detected in skin lesions associated with HIV infection. J Am Acad

Dermatol 2004;50:P110.

117. Edmonds EV, Chan I, Pyama N, Neill SM, Black MM, McGrath JA and Bunker CB. Autoantibodies to extracellular

matrix protein 1 in male genital lichen sclerosus. J. Invest Dermatol 2005;124 (supplement) 4: A115.

118. Lally A, Hollowood K, Bunker CB & Turner R. Pyoderma gangrenosum of the penis treated with topical tacrolimus.

Br J Dermatol 2005; 153 (Suppl.1):17.

119. Goolamali, SI, Edmonds EVJ, Francis N, Nelson M, Bunker CB. Cutaneous lupus Erythematosus (LE) in HIV

Infection: minocycline induced or immune restoration disease (IRD)? P14.44 EADV 2005. Blackwell Publishing.

www.eadv.org.

120. Topham EJ, Bunker CB, Morar N. Radiotherapy induced vitiligo – an example of the Koebner phenomenon. P08.63

EADV 2005. Blackwell Publishing. www.eadv.org

121. Saha M, Barlow R and Bunker CB. A case of angiokeratoma circumscripta of the penis. P04.28. EADV 2005.

Blackwell Publishing. www.eadv.org.

122. Edmonds EVJ, Francis N, Hawkins D, Bunker CB. Herpes simplex virus type 2 immune reconstitution disease of the

scrotum successfully treated with topical imiquimod 5%. FC06.10 EADV 2005. Blackwell Publishing.

www.eadv.org.

123. Bunker CB. Male dyspareunia and the dysfunctional foreskin: 22nd IUSTI-Europe Conference on Sexually

Transmitted Infections. Int J STD & AIDS 2006;17 (Suppl 1):7-8.

124. Bunker CB, Cox J, Williams H & Edmonds EV. Urine metabolic profiling using high resolution nuclear magnetic

resonance (NMR) spectroscopy in male genital lichen sclerosus (MGLSc). J Invest Dermatol 2007;127:S39.

125. Edmonds EV, Buisson S, Barton G, Francis N & Bunker CB. Gene expression profiling in male genital lichen

sclerosus (MGLSc). J Invest Dermatol 2007;127:S85.

126. Edmonds EV, Francis N, Ho-Yen D, Bunker C. Borrelia Burgdorferi is not associated with male genital lichen

sclerosus in the UK. J Invest Dermatol 2007;127 (Suppl 2); S18.

127. Singh S, Kaye S, Francis ND, McClure MO, Bunker CB. Expression of human endogenous retrovirus K in

melanoma. J Invest Dermatol 2008; 128: S212.

128. Bunker CB, Singh S, Kaye S, Francis ND, McClure MO. Detection and quantification of gene expression in archival

formalin-fixed, paraffin-embeded skin tissue. J Invest Dermatol 2008; 128: S188.

129. Meys R, Asboe D, Gotch FM, Bunker CB. HPV associated mucocutaneous disease post HAART/IRD – patient

immunophenotype. J Invest Dermatol 2008;128:S190.

130. Meys R, Purdie KJ, de Koning MN, Quint WG, Cox A, Atkins M, Asboe D, Hawkins DA, Gotch FM, Harwood CA,

Bunker CB. Beta human papillomavirus (beta-HPV) types are common in persistent warts in HAART treated HIV

positive individuals. J Invest Dermatol 2009;129:S30.

131. Meys R, Fowles F, Little A-M, Marsh SGE, Asboe D, Hawkins DA, Gotch FM, Bunker CB. Immunogenetics of HIV-

associated HPV Disease after HAART. SID Montreal, J Invest Dermatol 2009;129:S82.

132. Singh S, Kaye S, Francis ND, Peston, D, Gore ME, McClure MO, Bunker CB. Quantification of Human Endogenous

Retrovirus K (HERV-K) Expression in Primary Melanoma, Normal Skin and Benign Naevi. J Invest Dermatol 2009;

129:S137.

133. Singh S, Bunker CB, Kaye S, Tristem M, Gore ME, McClure MO. Expression of Human Endogenous Retrovirus K

(HERV-K) mRNA and Production of Putative Viral Particles by Melanoma Cell Lines. J Invest Dermatol 2009;

129:S136.

134. De Koning M, ter Schegget J, Kamp M, Kleter B, Feltkamp M, Eekhof J, Bavinck JNB, Purdie K, Harwood C, Meys

R, Bunker CB, Quint W. A novel broad-spectrum PCR-luminex assay for identification of ward HPV. 25th

International Papilloma Virus Conference, 2009, MALMÖ, SWEDEN

135. Meys R, Mantovani C, Asboe D, Hawkinns D, Gotch FM, Terenghi G, Bunker CB. The neurocutaneous environment

of warts in HIV infection. J Invest Dermatol 2009;129:S103

http://www.rsna.org/

http://www.eadv.org/




55

136. Meys R, Purdie KJ, de Koning MN, Krishna SK, Kamp M, Nelson M, Asboe D, Hawkins DA, Quint WG, Gotch FM,

Harwood C, Bunker CB. The HPV profile of cutaneous warts in HIV infected patients. J Invest Dermatol 2010;130

(suppl 1):S125.

137. Meys R, Purdie KJ, de Koning MN, Krishna SK, Kamp M, Nelson M, Asboe D, Hawkins DA, Quint WG, Gotch FM,

Harwood C, Bunker CB. The HPV profile of genital warts in HIV infected patients. J Invest Dermatol 2010;130

(suppl 1):S125.

138. Krishna SK, Meys R, Purdie KJ, de Koning MN, Bardhan A, Gotch FM, Quint WG, Harwood C, Bunker CB.

Carcinoma in-situ of the penis and β-HPV types. J Invest Dermatol 2010;130 (suppl 1):S27.

139. Meys R, Weir J, Gotch F, Bunker CB. Cutaneous HPV-related immune reconstitution associated disease (IRAD) in

HIV: an underrecognized phenomenon. J Am Acad Dermatol 2011;64:AB107.

140. Chandrakumar A & Bunker C. Central nervous system disorder of unknown aetiology as a cuse of neuropathic

pruritus. Br J Dermatol 2011;165 (Suppl.1):34.

141. Goolamali S!, Mladkova N, Purdie KJ, de Koning MNC, Quint WGV, Francis N, Morar N, Meys R, Harwood CA &

Bunker CB. HPV is associated with non-melanoma skin cancer in HIV. J Invest Dermato1 2012;132 Suppl 1:S41.

142. Shim TN, Patel N & Bunker CB. Urinary voiding symptomatology (microicontinence) in male genital lichen

sclerosus. Br J Dermatol 2012;167 (Suppl.1):45-6.

143. Meys R, Purdie K, de Koning M, Quint W, Harwood CA & Bunker CB. Immune reconstitution-associated disease in

the dermatological care of the human immunodeficiency virus-infected patient: an under-recognised phenomenon. Br

J Dermatol 2012;167 (Suppl.1):114.

144. Shim T, Muneer A & Bunker CB. Chronic erosive and verrucous herpes simplex of the penis in in chronic

lymphocytic leukaemia. Br J Dermatol 2012;167 (Suppl.1):115-116.

145. Goolamali S, Mladkova N, Purdie K, de Koning M, Quint W, Francis N, Morar N, Meys R, Harwood CA & Bunker

CB. Human papillomavirus is associated with nonmelanoma skin cancer in human immunodeficiency virus. Br J

Dermatol 2012;167 (Suppl.1):120.

146. Goolamali SI, Mladkova N, Purdie KJ, de Koning MNC, Quint MGV, Francis N, Morar N, Meys R,

Harwood CA & Bunker CB. Human papillomavirus in non-melanoma skin cancer. J Invest Dermato1 2012;132

(Suppl 2):S61.

147. Shim T, de Koning M, Muneer A, Minhas S, Francis N, Jameson CF, Dinneen M, Purdie KJ, Goolamali SI, Harwood

CA & Bunker CB. HPV in male genital lichen sclerosus, penile carcinoma in situ and penile squamous carcinoma. J

Invest Dermatol 2013;133 (Suppl. 1):S195.

148. Goolamali SI, Mladkova N, Purdie KJ, Shim TN, de Koning MN, Quint WQ, Francis N, Morar, N, Meys R, Harwood

CA & Bunker CB. HPV in non-melanoma skin cancer/precancer in HIV. J Invest Dermatol 2013;133 (Suppl.

1):S173.

149. Shim TN, Hawkins D, Muneer A, Minhas S, Freeman A, Jameson C, Francis N, Dinneen M & Bunker CB. Male

genital dermatoses in immunocompromised patients. Br J Dermatol 2013;169 (Suppl. 1):99.

150. Wilmot M-C, Perrett C, Calonje E & Bunker CB. A case of acantholytic dermatosis localized to the male genitalia.

Br J Dermatol 2013;169 (Suppl. 1):16.

151. Shim TN, Hawkins D, Muneer A, Minhas S, Freeman A, Jameson CF, Francis N, Dinneen M, Bunker CB. Male

genital dermatoses in HIV. Sex Transm Infec 2013;89 (Suppl 1):A1-A428.

152. Merika EE, Lim DTA, Asboe D, Pozniak A, Boffito M, Bunker CB & N Morar N. Skin cancer in ageing HIV positive

patients. HIV Med 2013;14 (Suppl. 2):28.

153. Bunker CB. Selected topics in male genital dermatology. Australasian J Dermatol 2014;55 (Suppl.1):1-2.

154. Bunker CB. Toxic epidermal necrolysis. Australasian J Dermatol 2014;55 (Suppl.1):1-2.

155. Bunker CB. The aetiopathogenesis of male genital lichen sclerosus. Australasian J Dermatol 2014;55 (Suppl.1):1-2.

156. Bunker CB. HIV dermatology. Australasian J Dermatol 2014;55 (Suppl.1):1-2.

157. Simpson J, Harris P, Stamp G, James S, Bunker C & Fearfield L. A case series of pyoderma gangrenosusm after deep

inferior epigastric perforator-flap breast reconstruction. Br J Dermatol 2014;171(Suppl.1):19-20.

158. Shim TN, Brown SJ, Campbell LE, Francis N, Dinneen M, Hawkins D, Muneer, A, Minhas S, Freeman A, McLean

WHI & Bunker CB. Male genital lichen sclerosus and filaggrin. Br J Dermatol 2014;171(Suppl.1):35.

159. Shim TN, Francis N, Peston D, Phan S, Minhas S, Nuneer A, Dinneen M, Freeman A & Bunker CB. Cables 1, male

genital lichen sclerosus and penile cancer. Br J Dermatol 2014;171(Suppl.1):47-8.

160. Shim TN, Meys R, Goolamali SI, Tavarozzi, F, Francis N, Dinneen M, Freeman A, Jameson C, Muneer A, Minhas S,

De Koning MN, Purdie KJ, Gotch FM, Marsh SGE, Harwood CA & Bunker CB. Human leucocyte antigen and

human papilloma virus in male genital lichen sclerosus, penile precancer and penile cancer. Br J Dermatol

2014;171(Suppl.4):31.

161. Shim TN, de Koning MN, Gollamali SI Meys R, Francis N, Jameson C, Freeman A, Dinneen M, Minhas S, Muneer A,

Purdie KJ, Harwood CA & Bunker CB. Prevalence of human papillomavirus in male genital lichen sclerosus, penile

carcinoma in situ and penile carcinoma: correlation with p16INK4a status. Br J Dermatol 2014;171(Suppl.4):34-5.

56

162. Shim TN, Gollamali SI, Francis N, Dinneen M, Muneer A, Minhas S, Freeman A, Jameson C, Purdie KJ, Harwood

CA & Bunker CB. Immunosuppression, human papilloma virus and Merkel cell polyomavirus in male genital lichen

sclerosus, penile precancer and penile cancer. Br J Dermatol 2014;171(Suppl.4):35-6.

163. Goolamali SI, Shim T, Purdie K, Mladkova N, Francis N, Harwood CA & Bunker CB. Human papillomavirus (HPV),

Merkel cell polyomavirus (MCV), HIV and non-melanoma skin cancer. J Invest Dermatol 2014;134:S34.

164. Noy M, Bunker C, Fuller C, Shelley J, Weir J, & Fearfield L. Dermatological manifestations of syphilis. Br J

Dermatol 2015;173 (Suppl.1):149-50..

165. Goolamali SI, Meys R, Shim TN, Mletzko S, Fowles F, Tavarozzi F, Gotch F, Harwood CA & Bunker CB.

Immunogenetics of non-melanoma skin cancer/pre-cancer in HIV. J Invest Dermatol 2015;135 (Suppl. 2): S34 (193).

166. Doiron P, Morar N & Bunker CB. Use of biological therapy in HIV: a review of the evidence. Br J Dermatol

2016;175 (Suppl.1):149.

167. Fitzgerald M, Bunker CB, Pozniak A & Morar N. Cutaneous tuberculosis and HIV coinfection: a case series. Br J

Dermatol 2016;175 (Suppl.1):153.

168. Goolamali SI, Mladkova N, Purdie KJ, Shim TN, de Koning MNC, Quint WGV, Francis N, Morar N, Meys R,

Harwood CA & Bunker CB. Human papilloma virus (HPV) in non-melanoma skin cancer/pre-cancer in HIV. Br J

Dermatol 2016;175 (Suppl. S2) 35-69.

169. Goolamali SI, Shim TN, Purdie KJ, Mladkova N, Francis N, Harwood CA & Bunker CB. Human papilloma virus

(HPV), Merkel cell polyomavirus (MCV), HIV and non-melanoma skin cancer. Br J Dermatol 2016;175 (Suppl. S2)

35-69.

170. Goolamali SI, Meys R, Shim TN, Mletzko S, Fowles F, Tavarozzi F, Gotch FM, Marsh SGE, Harwood CA & Bunker

CB. Immunogenetics of non-melanoma skin cancer /pre-cancer in HIV. Br J Dermatol 2016;175 (Suppl. S2) 35-69.

171. Goolamali SI, Meys R, Shim TN, Mletzko S, Fowles F, Tavarozzi F, Gotch FM, Marsh SGE, Harwood CA & Bunker

CB. The immunogenetic profile of non-melanoma skin cancer (NMSC) and pre-cancer subtypes in HIV. Br J

Dermatol 2016;175 (Suppl. S2) 35-69.

172. Watchorn RE, van den Munckhof EHA, Quint KD, de Koning MNC, Quint WGV & CB Bunker. The balanopreputial

mycobiome in health and disease: male genital lichen sclerosus. Br J Dermatol 2018;178:e428-9.

173. Watchorn RE, van den Munckhof EHA, Quint KD, de Koning MNC, Quint WGV & CB Bunker. The balanopreputial

microbiome in male genital lichen sclerosus. J Invest Dermatol 2018;138(5S):S172

174. Shah M, Watchorn RE & CB Bunker. Circumcision is not always curative in male genital lichen sclerosus. Br J

Dermatol 2018; (Suppl. S2).

CITATIONS UNCERTAIN:

1. Topham E, Cunningham D & Bunker CB. Isotretinoin in the treatment and prophylaxis of acneiform dermatosis due to

cetuximab. J Am Acad Dermatol 2006;

2. Rickaby WR, Maruthappu T, Perret C & Bunker CB. Case report of an unusual skin tumour mimicking basal cell

carcinoma. Journal of Pathology July 2011;224

ABSTRACTS SUBMITTED:

1. Asfour L, Bunker CB, Fearfield L. Familial melanoma: the role of the Dermatologist and the future of genetics. BAD

2016

UNPUBLISHED ABSTRACTS:

1. Bunker CB, Rustin MHA, Smith N & Levene GM. An indolent cutaneous prodrome of human T-lymphotropic virus

type 1(HTLV1) infection associated adult T-cell leukaemia/lymphoma (ATLL). EADV 1989.

2. Bunker CB, Smith NP, Russell RCG & Dowd PM. Cock’s peculiar tumour. EADV 1989.

3. Severe Raynaud’s phenomenon treated with calcitonin gene-related preptide. EADV 1989.

4. Worrall JG, Rook,G, Bunker CB & Dowd PM. Terminal N-acetylglucosamine expression I psoriatic epidermis.

ESDR 1992. 5. Bunker CB, Reavley C, O’Shaughnessy D & Dowd PM. A randomised controlled study of intravenous

calcitonin gene-related peptide in the treatment of severe Raynaud’s phenomenon. Skin Pharmacol 1991.

57

6. Goldsmith PC, Bunker CB, Wilkinson LS et al. Tumour necrosis factor in the inflammatory response

of human skin. Skin Pharmacol 1991.

7. Foreman JC, Coulson ML, Hayes NA, Bunker CB & Dowd PM. The actions of endothelin-1 in

human skin: a pharmacological analysis. Skin Pharmacol 1991.

CONTRIBUTIONS TO OTHER MEDIA:

1. Polycystic ovaries and acne in women. British Medical Telivision 1990 (Feb)

2. BBC Radio 4 Medicine Today interview-Penis, 1994

3. BBC Radio 4 Medicine Today interview-HIV, 1994

4. Psoriasis and eczema video, 1995

58

PAPERS PRESENTED AT MEETINGS:

1. Varidase Topical versus benzoyl peroxide 20% in the cleansing of leg ulcers using reflex metrography. 1987

Bunker CB, Lanigan S & Gilkes JJH.

The Biology of the Wound Healing Process

The Royal College of Physicians, London

2. The prevalence of polycystic ovaries in patients with acne vulgaris 1988

Newton JA,. Bunker CB, Kilborn J et al.


3. The effect of isotretinoin in patients with systemic sclerosis. 1988

Maurice PDL, Bunker CB & Dowd P.M.

Centre International de Recherches Dermatologique Symposium, Cannes

4. Women with acne who have polycystic ovaries (PCO) have

endocrinological differences from other women with PCO. 1988

Bunker CB, Newton JA, Kilborn J et al.

British Society of Investigative Dermatology, Manchester

5. The prevalence of polycystic ovaries in patients with acne vulgaris 1988

Bunker CB, Newton JA, Kilborn J et al.

Residents Symposium, American Academy of Dermatology, Washington D. C.

6. The effect of isotretinoin on patients with systemic sclerosis. 1988

Maurice PDL, Bunker CB & Dowd P.M.

American Academy of Dermatology, Washington D. C.

7. Digital cutaneous vascular responses to histamine, 1989

compound 48/80 and neuropeptides in normal subjects and Raynaud’s phenomenon.

Bunker CB, Foreman J & Dowd PM.

Laser Doppler User’s Group, London

8. Digital vascular responses to histamine, compound 48/80 1989

and calcitonin gene-related peptide in patients with Raynaud’s phenomenon

Bunker CB, Dowd PM & Foreman JC.

European Society for Histamine Research, Breda, Holland

9. Calcitonin gene-related peptide in the treatment of severe Raynaud’s phenomenon. 1989

Bunker CB, Foreman J, Reavley C et al.

British Association of Dermatologists, Cambridge

10. Calcitonin gene-related peptide down-regulates cutaneous endothelial responses 1989

to Substance P and histamine.

Bull HA, Bunker CB & Dowd PM.

Skin Pharmacology Society, New York

11. An Hypercard based multiple choice question tutor for the Apple Macintosh 1989

Bunker CB.

Forum on Computers in Medicine, RSM, London

12. Treatment of morphoea with colchicine. 1989

Heagerty A, Bunker CB, Rustin MHA & Dowd PM.

European Academy of Dermatology and Venereology, Florence

13. Severe Raynaud’s phenomenon treated with calcitonin gene-related peptide. 1989

Bunker CB,. Foreman JC, O’Shaughnessy D et al.

59

European Academy of Dermatology and Venereology, Florence

14. The novel vasodilator calcitonin gene-related peptide in the treatment of severe Raynaud’s phenomenon 1989

Bunker CB, Foreman JC, Reavley C & Dowd PM.

Residents Symposium, American Academy of Dermatology, San Francisco

15. Mast cells after capsaicin application in normal human skin. 1990

Bunker CB, Cerio R, Bull HA, Evans J, Foreman JC & Dowd PM

British Association of Dermatologists (Dermatopathology), Warwick

16. Neuropeptide and histamine induced vascular responses in Raynaud’s phenomenon: 1990

the effect of low temperature

Bunker CB, Foreman JC & Dowd PM.

Skin Pharmacology Society, Hiroshima

17. The effect of topical steroid on the intradermal vascular responses to neuropeptides, 1990

histamine and substance 48/80.


Skin Pharmacology Society, Hiroshima

18. Action of vasoactive peptides on microvascular endothelium. 1991


British Microcirculation Society, Oxford

19. Receptor binding and mRNA expresssion of endothelin-1 by human cutaneous microvascular endothelium 1991

Bull HA, Terenghi G, Bunker CB, Properzi G, Facer P, Polak JM & Dowd PM.

European Society for Dermatological Research, Copenhagen

20. Tumour necrosis factor a expression in human skin. 1991

Bunker CB, Wilkinson LH, Bull HA, Goldsmith PC, Cambridge G, Brickell PM,

Coleridge-Smith PD, Edwards JCW & Dowd PM.


21. Digital vascular responses to endothelin in Raynaud’s phenomenon 1991


Skin Pharmacology Society, Pitlochry, Scotland

22. A randomised controlled study of intravenous calcitonin 1991

gene-related peptide in the treatment of severe Raynaud’s phenomenon.

Bunker CB, Reavley C, O’Shaughnessy D & Dowd PM.


23. Tumour necrosis factor in the inflammatory response of human skin 1991

Goldsmith PC, Bunker CB, Wilkinson LS et al.


24. The actions of endothelin-1 in human skin: A pharmacological analysis. 1991

Foreman JC, Coulson ML, Hayes NA, Bunker CB & Dowd PM.


25. Isotretinoin and the lung. 1991

Bunker CB, Tomlinson MC, Johnson N McI & Dowd PM.


26. Cutaneous vascular responses to endothelin in normal skin and in Raynaud’s phenomenon. 1991

Bunker CB, Goldsmith PC, T, Bull HA, Foreman JC & Dowd PM.

British Society for Investigative Dermatology, Leicester

60

27. Most women with acne have polycystic ovaries. 1992

Bunker CB, Newton J, Conway G, Jacobs H, Greaves M, Dowd. PM.

World Congress of Dermatology, New York

28. The action of a calcitonin gene-related peptide antagonist in human skin. 1992

Hayes N, Bunker CB, Marshall I, Dowd PM & Foreman JC.

European Society for Histamine Research, Malaga, Spain

29. Cutaneous nerve fibre depletion in vibration white finger. 1992

Goldsmith PC, Bunker CB, Leslie TA, Terenghi G, Abadia Molina F, Polak J, Dowd PM.

British Society for Investigative Dermatology, Sheffield

30. Inhibition of the endothelin-1 mediated flare in the skin following 1992

application of topical 0.05% clobetasol propionate.

Goldsmith PC, Bunker CB, Leslie TA, Bull HA, Foreman JC, Dowd PM

British Society for Investigative Dermatology, Sheffield

31. A study of immunoreactive nerves in vibration white finger. 1992

Goldsmith PC, Bunker CB, Leslie TA, Terenghi G, Abadia Molina F, Polak J & Dowd PM.

Skin Pharmacology Society, Cleveland, Ohio

32. Capsaicin modulates the cutaneous response to endothelin-1 1992

Leslie TA, Hayes N, Bunker CB, Levell NJ, Foreman JC & Dowd PM.

Skin Pharmacology Society, Cleveland, Ohio

33 Infective panniculitis as a manifestation of pseudomonas infection in a patient with 1993

acquired immune deficiency syndrome.

Smith R, Asboe D, Ross J, Fisher M, Bunker C & Gazzard B.

The Medical Society for the Study of Venereal Diseases, Zurich

34. Cutaneous manifestations of Kikuchi’s disease 1993

Ross JS, Aqel NM & Bunker CB.

British Association of Dermatologists, Oxford

36. Cold challenge modulates cutaneous responses to endothelin-1 after capsaicin treatment. 1993

Leslie TA, Bunker CB, Hayes N, Levell NJ, Foreman JC & Dowd PM.

Skin Pharmacology Society, Hong Kong

37. Dermatology and Audit-The Telestation Project. 1994

Roberts N & Bunker CB.

Forum on Computers in Medicine/British Medical Informatics Society, RSM, London

38. In situ localisation of interleukin-4 mRNA and proteins in atopic dermatitis. 1994

Rowe A, Sadri R, Farrell A, Roberts N, Ross J, & Bunker CB.

Skin Pharmacology Society, London

39. Localisation of inducible nitric oxide synthase in psoriatic dermal microvasculature 1995

Rowe A, Farrell AM, Kazmi SH & Bunker CB.

British Society for Investigative Dermatology, Oxford

40. Zoon’s Balanitis: an Immunohistochemical Study. 1996

Farrell AM, Francis N & Bunker CB.

British Association of Dermatologists

41. Are “Idiopathic Scrotal Cysts” Idiopathic? An Immunohistochemical Approach 1996

Farrell AM, Trendell-Smith NJ, Francis N & Bunker CB.

61


42. Changes in the Peripheral T Cell VB Repertoire in Psoriasis. 1996

Miles R, Farrell AM, Staughton RCD, Bunker CB & Aspinall R.

British Society of Investigative Dermatology, Glasgow

43. HIV related skin diseases in man 1997

Bunker CB.

British Veterinary Dermatology Study Group, Stratford upon Avon

44. Zoon’s plasma cell balanitis-conservative treatment is warranted. 1998

Kooner, Sweeney O, Mallon E, Francis N, Bunker CB, Dinneen M.

British Urological Society

45. HLA-Cw*0602 and psoriasis 1998

Mallon E, Bunce M, Savoie H, Wojnarowska F, Welsh K, Easterbrook PJ, Gotch F & Bunker CB.

5th European Congress on Psoriasis/7th International Psoriasis Symposium, Milan

46. Human retrovirus-5 and psoriasis 1998

Mallon E, Griffiths DJ, Bunker CB, Weiss RA & Venables PJW.

5th European Congress on Psoriasis/7th International Psoriasis Symposium, Milan

47. Zoon’s (Plasma Cell) Balanitis - Conservative treatment is warranted. 1998

Kooner R, Sweeney O, Mallon E, Francis N, Bunker CB, Dinneen, M

British Association of Urological Surgeons, Harrogate

48. Clinicopathological features of very thin melanoma with unusual aggressive behaviour 2001

and the expression of CD95 and CD95 ligand.

Fearfield LA, Rowe A, Francis N, Fisher C, MacKie RM, Gore ME & Bunker CB

5th International Conference on Melanoma, Venice

49. Expression of Human Endogenous Retrovirus K in Melanoma 2008

Singh S, Kaye S, Francis ND, McClure M, Bunker CB.

Melanoma Study Group, Birmingham

50. Human Endogenous Retrovirus K Gene Expression in Cutaneous Malignant Melanoma. 2009

Singh S, Kaye S, Francis N, Gore M, McClure M & Bunker CB

Residents Forum, American Academy of Dermatology, San Francisco

(Withdrawn: Dr Singh unable to attend due to illness)

51. Human endogenous retrovirus K expression in melanoma 2009

Singh S, Kaye S, Francis ND, Peston D, Gore ME, McClure M & Bunker CB

12th world Congress on Cancers of the Skin, Tel Aviv, Israel.

52. A novel broad-spectrum PCR-luminex assay for identification of ward HPV 2009

De Koning M, ter Schegget J, Kamp M, Kleter B, Feltkamp M, Eekhof J, Bavinck JNB, Purdie K,

Harwood C, Meys R, Bunker CB, Quint W.

25th INTERNATIONAL PAPILLOMAVIRUS CONFERENCE MAY 8-14 2009, MALMÖ, SWEDEN

53. Immune reconstitution-associated disease in the dermatological care of the human immunodeficiency 2012

virus-infected patient: an under-recognised phenomenon

Meys R, Purdie K, de Koning M, Quint W, Harwood CA & Bunker CB.



54. Male Genital Dermatoses in the Immunocompromised 2012

Shim T & Bunker CB.

62

British Society for Male Genital Dermatology, British Association of Dermatologists, Birmingham

55. Male genital dermatoses in immunocompromised patients.

Shim TN, Hawkins D, Muneer A, Minhas S, Freeman A, Jameson C, Francis N, Dinneen M & Bunker CB. 2013


56. Human leucocyte antigen and human papilloma virus in male genital lichen sclerosus, penile precancer 2014

and penile cancer.

Shim TN, Meys R, Goolamali SI, Tavarozzi, F, Francis N, Dinneen M, Freeman A, Jameson C,

Muneer A, Minhas S, De Koning MN, Purdie KJ, Gotch FM, Marsh SGE, Harwood CA & Bunker CB..

World Congress on Cancer of the Skin, Edinburgh

57. Aetiopathogenesis of Male Genital Lichen Sclerosus (MGLSc), Penile Pre-cancer (PCIS) & 2015

Penile Cancer (PSCC)

Shim TN, Meys R, Goolamali SI, Francis N, Dinneen M, Freeman A, Jameson C,

Muneer A, Minhas S, Marsh S, de Koning MN, Gotch FM, Harwood CA.& Bunker CB.

RSM AbbVie Dermatology Trainee Research Prize finalist.

Royal Society of Medicine, London

58. Male genital oedema and Crohn’s disease. 2015

Bunker CB & Shim TN


59. Aetiological factors in the pathogenesis of male genital lichen sclerosus, penile precancer and 2015

penile cancer

Shim TN & Bunker CB


60. Cutaneous tuberculosis and HIV coinfection: a case series. 2016

Fitzgerald M, Bunker CB, Pozniak A & Morar N.

European Academey of Dermatovenereology, Athens

61. Use of biological therapy in HIV: a review of the evidence. 2016

Doiron P, Morar N & Bunker CB.



POSTERS PRESENTED AT MEETINGS:

1. Topical minoxidil does not increase scalp blood flow in androgenic alopecia. 1986

Bunker CB & Dowd PM.

British Society for Investigative Dermatology, York

2. Topically applied hexyl nicotinate lotion increases the cutaneous blood supply

in patients with Raynaud’s phenomenon. 1988

Dowd PM, Lanigan S, Rustin MHA & Bunker CB.

British Society of Investigative Dermatology, Manchester

3. Isotretinoin given in the treatment of systemic sclerosis may hasten the decline in pulmonary function. 1988

Bunker CB, Maurice PDL, Little S et al.

British Thoracic Society, London

4. Digital cutaneous vascular responses to histamine compound 48/80 and neuropeptides in normal subjects 1989

and Raynaud’s phenomenon.

Bunker CB, Foreman J & Dowd PM.

63

Society for Investigative Dermatology,Washington D. C.

5. Mechanisms of action of vasoactive neuropeptides on human cutaneous endothelial cells. 1989

Bull HA, Bunker CB &Dowd PM.

Society for Investigative Dermatology,Washington D. C.

6. A double-blind placebo controlled trial of topical hexyl nicotinate in primary Raynaud’s phenomenon. 1989

Bunker CB, Cooper F & Dowd PM.


7. Calcitonin gene-related peptide in Raynaud’s phenomenon. 1989

Bunker CB, Foreman JC, O’Shaughnessy D et al.

Skin Pharmacology Society, New York

8. Calcitonin gene-related peptide in Raynaud’s phenomenon. 1989

Bunker CB, Foreman JC, O’Shaughnessy D et al.

Bayliss and Starling Society, Nottingham

9. Cutaneous endothelial cell responses to substance P and histamine 1989

are attenuated by calcitonin gene-related peptide.


Bayliss and Starling Society, Nottingham

10. Dermatology in Bloomsbury-The first 200 years. 1989

Bunker CB, Rustin MHA, Heagerty A & Dowd PM.


11. Cold-related disorders. 1989

Rustin MHA, Bunker CB & Dowd PM.


12. Colchicine-a good therapy for morphoea. 1989

Heagerty AHM, Bunker CB, Rustin MHA & Dowd PM.


13. The novel vasodilator calcitonin gene-related peptide in the treatment of severe Raynaud’s phenomenon. 1989

Bunker CB, Foreman JC, Reavley C & Dowd PM.


14. Digital vascular responses to neuropeptides and histamine at low temperatures in Raynaud’s phenomenon. 1990


Society for Investigative Dermatology, Washington D. C.

15. The effects of capsaicin on mast cells in normal human skin. 1990

Bunker CB, Cerio R, Bull HA et al.

European Society for Histamine Research, Kuopio, Finland

16. Digital vascular responses to histamine and neuropeptides at low temperatures in Raynaud’s phenomenon. 1990


European Society for Histamine Research, Kuopio, Finland

17. Dermatology in Bloomsbury-The first 200 years. 1990

Bunker CB, Rustin MHA, Heagerty A & Dowd PM.

A glance through history. University College Hospital

18. Calcitonin gene-related peptide-immunoreactive nerves in Raynaud’s phenomenon and systemic sclerosis. 1990

Terenghi G, Bunker CB, Springall DR, Foreman JC, Dowd PM & Polak J. M.

64

Pathological Society of Great Britain and Ireland, Nottingham

19. Intravenous calcitonin gene-related peptide in severe Raynaud’s phenomenon. 1990

Bunker CB, Reavley C, O’Shaughnessy D & Dowd PM.

British Society for Rheumatology, London

20. Henry Radcliffe Crocker (1845-1909) Physician to the skin department, UCH, London (1879-1909). 1990

(Silver Medal winner).


American Academy of Dermatology, Atlanta

21. The cutaneous endothelial cell in health and disease. 1990



22. Endothelin in human skin-immunohistochemical, receptor binding and functional studies. 1990

Terenghi G, Bull HA, Bunker CB, Springall DR, Zhao Y, Wharton J, Dowd PM & Polak JM.

2nd International Conference on Endothelin, Tokyo

23. Basophil histamine receptors (H3) in atopic dermatitis. 1991

Bull HA, Courtney PE, Bunker CB, Rustin MHA, Pearce F & Dowd PM.

Society for Investigative Dermatology, Seattle

24. Henry Radcliffe Crocker (1845-1909) Physician to the skin department, UCH, London (1879-1909). 1991



25. Sir Thomas Lewis FRS and the Neurovasculature of the skin 1991

(Gold Medal winner)


American Academy of Dermatology, Dallas

26. CGRP(8-37) is an antagonist of CGRP in human skin. 1992

Bunker CB, Hayes N, Foreman JC & Dowd PM.

Society for Investigative Dermatology, Baltimore

27. Sir Thomas Lewis FRS and the Neurovasculature of the skin 1992


British Association of Dermatologists, Bournemouth

28 Sir Thomas Lewis FRS and the Neurovasculature of the skin 1992


17th European Conference on the Microcirculation, London

29. Raynaud’s phenomenon 1862-1992 (Bronze Medal winner) 1992

Goldsmith P, Bunker CB & Dowd PM.


30. Raynaud’s phenomenon 1862-1992 1993

Goldsmith P, Bunker CB & Dowd PM


31. Panniculitis with pseudomonas septicaemia in AIDS. 1993

Smith RA, Ross JS, Branfoot AC, Asboe ID, Gazzard BG & Bunker CB.


32. Interleukin-4 in atopic dermatitis. 1994

65

Rowe A, Sadri R, Farrell A, Roberts N, Ross J & Bunker CB.

British Society for Investigative Dermatology, Bath

33. Penile Dermatoses in Dermatological Hands. 1995

Ross JS, Ramsay B, Farrell AM & Bunker CB.

American Academy of Dermatology, New Orleans

34. Expresssion of inducible nitric oxide synthase in atopic dermatitis. 1995


Society for Investigative Dermatology, Chicago

35. The effects of L-NAME on the erythema and extravasation due to histamine and bradykinin in human skin. 1995

Paul W, Roberts N, Farrell A, Fearfield L, Page CP & Bunker CB.

Skin Pharmacology Society, Vienna

36. Expression of Inducible Nitric Oxide Synthase in Atopic Dermatitis. 1995



37. An outbreak of MRSA in a Dermatological Unit 1995

Farrell AM, Shanson D, Roberts NM, Ross JS, Fry C, Cream JJ, Staughton RCD & Bunker CB.

British Association of Dermatology, Glasgow

38. Localisation of IL-4 Receptors in Inflammatory Skin Disease 1996

Rowe A, Choudhury AI, Farrell AM & Bunker CB.

British Society of Investigative Dermatology, Glasgow

39. Expression of Interleukin-4 Receptors in T-Lymphocytes and Mast Cells in Inflammatory Skin Disorders. 1996

Rowe A, Roberts NM, Farrell A & Bunker CB.

Society of Investigative Dermatology, Washington D. C.

40. Oral Gold Therapy in Cutaneous Lupus Erythematosus (Revisited) 1996

Farrell AM & Bunker CB

British Association of Dermatologists, Bournemouth

41. Do Lauramacrogols Alter Cutaneous Neuronal Function when used Clinically in a Bath Oil? 1996

Fearfield LA, Farrell AM, Roberts NM, Ross JS, Hayes N, Foreman J & Bunker CB.

British Association of Dermatology, Bournemouth

42. Circumcision and Genital Disease 1997

Mallon E & Bunker CB.


43. HLA-C locus genotyping of psoriasis in HIV disease using sequence specific amplification primers 1997

Mallon E, Young D, Gotch F & Bunker CB.

British Society for Investigative Dermatology, Bristol

44. The Ultrastructural Pharmacology of endothelin -1in human cutaneous vasculature. 1997

Simpson-Dent AL, Moss J, Woodrow DF & Bunker CB.

Society for Investigative Dermatology, Washington DC.

45. Itchy Folliculitis in HIV 1997

Fearfield LA, Francis N, Rowe A, Bunker CB & Staughton RCD.

British Association of Dermatologists, Harrogate

46. Bone Marrow involvement in cutaneous mastocytosis 1997

66

Fearfield LA, Henry K, Costello C & Bunker CB.

European Association of Dermatovenereology, Dublin

47. HLA-CW*0602 and guttate psoriasis 1998

Mallon E, Bunce M, Savoie H, Gotch F, Easterbrook PJ & Bunker CB.

International Investigative Dermatology, Cologne

48. Decreases in cutaneous peptidergic innervation in HIV-associated xerosis 1998

Rowe A, Mallon E, Rosenberger P, Barrett M, Walsh J & Bunker CB.


49. Eosinophil chemokines in HIV-associated eosinophilic folliculitis. 1998

Fearfield LA, Francis N, Rowe A, Bunker CB & Staughton RCD


50. The Ultrastructural Pharmacology of vascuklar permeability in human skin. 1998

Simpson-Dent AL, Moss J, Woodrow DF & Bunker CB.


51. A randomised, double-blind, crossover study of the antipruritic actions of topical lauramacrogols 1998

Fearfield LA, Agnew K & Bunker CB.

British Society for Investigative Dermatology, Liverpool

52. Cutaneous mast cell distribution is unchanged in HIV-associated xerosis 1998

Rowe A, Mallon E, Aladeshi A, Walsh J & Bunker CB.

British Society for Investigative Dermatology, Liverpool

53. Circumcision and Genital Dermatological Morbidity (Bristol Cup Winner) 1998

Mallon E, Hawkins DA, Dinneen M, Fearfield L, Francis N & Bunker CB.

British Association of Dermatologists, Brighton

54. Expression of the mitotic suppressor p15INK4b is altered in psoriatic epidermis. 1999

Rowe A, Mallon E & Bunker CB.

British Society for Investigative Dermatology, Cardiff

55. Human retrovirus-5 is not involved in the pathogenesis of psoriasis 1999

Mallon E, Griffiths DJ, Venables PJW, Bunker CB, Weiss RA.


56. Epidermal HLA class I variable chain expression is down-regulated in chronic plaque and guttate psoriasis 1999

Rowe A, Schilling JP, Mallon E & Bunker CB


57. Female Pattern Androgenic Alopecia - a histopathological study 1999

Trendell-Smith NJ, Simpson-Dent S, Mallon E, Fearfield LA, Staughton RCD, Francis N & Bunker CB.

British Association of Dermatologists, Edinburgh

58. Thin melanomas with unusual aggressive behaviour 1999

Fearfield LA, Rowe A, Fisher C, Gore M & Bunker CB.


59. Decreased peptidergic innervation adjacent to venous ulcers. 2000

Rowe A, Guest M, Allerston A, Davies AH & Bunker CB.

British Society of Investigative Dermatology, Edinburgh

60. The Fox Brothers: Founders of dermatology at Westminster & Charing Cross Hospitals 2001

Agnew KL, Hunt SJ, Cream JJ, Staughton RCD, Bunker CB.

67

British Association of Dermatologists,

61. Attenuation of GAP-43 and NF-200 innervation in chronic venous ulceration. 2001

Rowe A, Guest M, Davies A & Bunker CB. J Invest Dermatol 2001;117:441.

Society for Investigative Dermatology, Washington DC

62. Expression of p16 in relapsing and non-relapsing very thin melanoma 2001

Fearfield LA, Rowe A, Francis N, Fisher C, McCann B, MacKie RM, Gore ME & Bunker CB.

Society for Investigative Dermatology, Washington DC

63. HLA-Cw*0602 in the Pathogenesis of Psoriasis 2002

Mallon E, Bunce M, Rowe A, Newson R, Gotch F, Bunker C.

World Congress of Dermatology, Paris

64. Prognostic factors in very thin melanoma 2002

Fearfield L, Rowe A, Francis N, Fisher C, McCann B, MacKie R, Gore M, Bunker C.


65. Cutaneous findings in thirty-seven patients with chronic lymphocytic leukaemia 2002

Agnew K, Catovsky D, Costello, C, Ruchlemer R, Bunker CB.


66. Chronic erosive vegetative genital herpes simplex as a immune reconstitution disease 2002

after initiation of HAART in two patients with HIV infection.

O’Donoghue NB, Bunker CB, Francis N and Fuller LC.


66. Anorexia, Alcohol, Eczema and Poliosis. 2003

Simpson-Dent SL, Sidwell R & Bunker CB.


67. A Retrospective Study of 174 men with Lichen Sclerosus of the Penis 2003

Hunt SJ, Francis N, Dinneen M, Hawkins D, Bunker CB

British Association of Dermatologists, Brighton.

68. Skin Disorders and their radiological manifestations 2003

Sykes K, Brenner C, Jones J, Bunker C, Chinn R.

Radiological Society of North America, Chicago

70. Kissing Naevus of the Penis: A Historical and Embryological Review 2004

Phan PT, Francis N, Madden N, Bunker CB

American Academy of Dermatology, Washington DC

71. Epidermodysplasia verruciformis human papillomavirus types are frequently detected 2004

in skin lesions associated with HIV infection.

Dyche J, Harwood C, Bunker C


72. Cutaneous lupus erythematosus (LE) in HIV Infection: 2005

minocycline induced or immune restoration disease (IRD)? (P14.44)

Goolamali, SI, Edmonds EVJ, Francis N, Nelson M & Bunker CB.

European Association of Dermatovenereology, London

73. Radiotherapy induced vitiligo – an example of the Koebner phenomenon. (P08.63) 2005

Topham EJ, Bunker CB, Morar N.


68

74. A case of angiokeratoma circumscripta of the penis. (P04.28) 2005

Saha M, Barlow R & Bunker CB.


75. Urine metabolic profiling using high resolution nuclear magnetic resonance (NMR) spectroscopy 2007

in male genital lichen sclerosus (MGLSc).

Bunker CB, Cox J, Williams H & Edmonds EV.

Society for Investigative Dermatology, Los Angeles

76. Gene expression profiling in male genital lichen sclerosus (MGLSc). 2007

Edmonds EV, Buisson S, Barton G, Francis N & Bunker CB.

Society for Investigative Dermatology, Los Angeles

77. Borrelia Burgdorferi is not associated with male genital lichen sclerosus in the UK. 2007

Edmonds EV, Francis N, Ho-Yen D, Bunker C.

European Society for Dermatological Research, Zurichdmonds

78. Wound management in toxic epidermal necrolysis (TEN). 2007

Abela C, De Leo A, Shah H, Fu B, Jawad M, De Sica Chapman A, Bunker CB, Williams G.

European Burns Association, Budapest

79. Localised bullous tinea corporis due to trichophyton rubrum. 2008

Singh S, Schmulewitz L, Bunker CB.

European Association of Dermatovenereology, Paris

80. Expression of human endogenous retrovirus K in melanoma. 2008

Singh S, Kaye S, Francis ND, McClure MO, Bunker CB.

International Investigative Dermatology Meeting, Kyoto

81. Detection and quantification of gene expression in archival formalin-fixed, paraffin-embeded skin tissue. 2008

Bunker CB, Singh S, Kaye S, Francis ND, McClure MO.


82. HPV associated mucocutaneous disease post HAART/IRD – patient immunophenotype. 2008

Meys R, Asboe D, Gotch FM, Bunker CB.


83. Beta human papillomavirus (beta-HPV) types are common in persistent warts in HAART 2009

treated HIV positive individuals.

Meys R, Purdie KJ, de Koning MN, Quint WG, Cox A, Atkins M, Asboe D, Hawkins DA,

Gotch FM, Harwood CA, Bunker CB.

Society for Investigative Dermatology, Montreal

84. Immunogenetics of HIV-associated HPV Disease after HAART. 2009

Meys R, Fowles F, Little A-M, Marsh SGE, Asboe D, Hawkins DA, Gotch FM, Bunker CB.


85. Quantification of Human Endogenous Retrovirus K (HERV-K) Expression in Primary Melanoma,

Normal Skin and Benign Naevi.

Singh S, Kaye S, Francis ND, Peston, D, Gore ME, McClure MO, Bunker CB. 2009


86. Expression of Human Endogenous Retrovirus K (HERV-K) mRNA and Production of 2009

Putative Viral Particles by Melanoma Cell Lines.

Singh S, Bunker CB, Kaye S, Tristem M, Gore ME, McClure MO.


87. The neurocutaneous environment of warts in HIV infection 2009

69

Meys R, Mantovani C, Asboe D, Hawkinns D, Gotch FM, Terenghi G and Bunker CB.

European Society for Dermatological Research, Budapest

88. Clinical features of Toxic Epidermal Necrolysis (TEN): with CWH TEN management protocol 2010

De Sica-Chapman A & Bunker CB.

4th International Drug Hypersensitivity Meeting, Rome

89. G-CSF enhances wound healing in severe TEN 2010

& should be considered in management of fulminant TEN irrespective of neutropaenia

De Sica-Chapman A & Bunker CB.

4th International Drug Hypersensitivity Meeting, Rome

135. The HPV profile of cutaneous warts in HIV infected patients 2010

Meys R, Purdie KJ, de Koning MN, Krishna SK, Kamp M, Nelson M, Asboe D, Hawkins DA,

Quint WG,

Gotch FM, Harwood C, Bunker CB.

Society for Investigative Dermatology, Atlanta

136. The HPV profile of genital warts in HIV infected patients. 2010

Meys R, Purdie KJ, de Koning MN, Krishna SK, Kamp M, Nelson M, Asboe D,

Hawkins DA, Quint WG,

Gotch FM, Harwood C, Bunker CB.


137. Penile Carcinoma in-situ and β-HPV types 2010

Krishna SK, Meys R, Purdie KJ, de Koning MN, Bardhan A, Gotch FM, Quint WG,

Harwood C, Bunker CB.


138. HPV genotype distribution in cutaneous and genital warts is different in HIV infected patients.

de Koning MNC, Meys R, Purdie KJ, Nelson M, Asboe D, Hawkins DA, Gotch FM, Harwood CA,

Bunker CB, Quint WGV.

26th International Papillomavirus Conference, Montreal 2010

139. High risk HPV but no Betapapillomavirus types detected in penis in-situ cancers

de Koning MNC, Meys R, Krishna SK, Purdie KJ, Francis ND, Ryder TA, Walker MM, Harwood,

CA, Bunker CB, Quint WG.

26th International Papillomavirus Conference, Montreal 2010

140. Cutaneous HPV-related immune reconstitution associated disease (IRAD) in HIV: 2011

an underrecognized phenomenon.

Meys R, Weir J, Gotch F, Bunker CB.

American Academy of Dermatology, New Orleans

141. Case report of an unusual skin tumour mimicking a basal cell carcinoma. 2011

Cutaneous lymphadenoma/ adamantinoid trichoblastoma.

Rickaby W, T Maruthappu T, Perret C, Bunker CB & Freeman A.

Pathological Society, Ghent

142. Central nervous system disorder of unknown aetiology as a cuse of neuropathic pruritus. 2011

Chandrakumar A & Bunker C.


143. HrHPV but no betaPV types detected in penis in-situ cancers. 2011

de Koning MNC, Meys R, Krishna SK, Purdie KJ, Francis ND, Ryder TA, Walker MM, Harwood CA,

Bunker CB & Quint WG.

27th International Papillomavirus Conference and Clinical Workshop, Berlin

144. HPV distribution in warts is different in HIV infected patients. 2011

70

de Koning MNC, Meys R, Purdie KJ, Nelson M, Asboe D, Hawkins DA, Gotch FM, Harwood CA,

Bunker CB & Quint WG..

27th International Papillomavirus Conference and Clinical Workshop, Berlin

145. Non-melanoma skin cancer and pre-cancer in HIV infection: the role of human papillomavirus (HPV). 2011

Goolamali SI, Mladkova N, Purdie KJ, de Koning MNC, Quint WGV, Francis N,

Meys R, Harwood CA& Bunker CB.

3rd HIV Symposium ,Blizard Institute, Barts and The London School of Medicine and Dentistry, London

146. Non-melanoma skin cancer and pre-cancer in HIV infection: the role of human papillomavirus (HPV). 2011

Goolamali SI, Mladkova N, Purdie KJ, de Koning MNC, Quint WGV, Francis N,

Meys R, Harwood CA& Bunker CB.

William Harvey Day, St Bartholomew’s Hospital,

Barts and The London School of Medicine and Dentistry, London

147. Adamantinoid Trichoblastoma: A Rare Clinicopathological Entity Mimicking Basal Cell Carcinoma. 2012

Maruthappu T, Rickaby W, Freeman A, Perrett CM and Bunker CB.

American Academy of Dermatology, San Diego

148. Male Genital Lichen Sclerosus (MGLSc) and Urine. 2012

Shim TN and Bunker CB

American Academy of Dermatology, San Diego

149. HPV is associated with non-melanoma skin cancer in HIV. 2012

Goolamali SI, Mladkova N, Purdie KJ, de Koning MN, Quint WG, Francis N, Morar N,

Meys R, Harwood CA and Bunker CB.

Society for Investigtaive Dermatology, Raleigh

150. Urinary voiding symptomatology (microicontinence) in male genital lichen sclerosus. 2012

Shim TN, Patel N & Bunker CB.


151. Human papillomavirus is associated with nonmelanoma skin cancer in human immunodeficiency virus. 2012

Goolamali S, Mladkova N, Purdie K, de Koning M, Quint W, Francis N, Morar N, Meys R,

Harwood CA & Bunker CB.


152. Human papillomavirus in non-melanoma skin cancer. 2012

Goolamali SI, Mladkova N, Purdie KJ, de Koning MNC, Quint MGV, Francis N, Morar N, Meys R,


European Society for Dermatological Research, Venice

153. HPV in male genital lichen sclerosus, penile carcinoma in situ and penile squamous carcinoma. 2013

Shim T, de Koning M, Muneer A, Minhas S, Francis N, Jameson CF, Dinneen M, Purdie KJ,

Goolamali SI, Harwood CA & Bunker CB.


154. HPV in non-melanoma skin cancer/precancer in HPV. 2013

Goolamali SI, Mladkova N, Purdie KJ, Shim TN, de Koning MN, Quint WQ, Francis N,

Morar, N, Meys R, Harwood CA & Bunker CB.


155. Skin cancer in ageing HIV positive patients. 2013

EE Merika, DTA Lim, D Asboe, A Pozniak, M Boffito, CB Bunker and N Morar

British HIV Association, Manchester

156. Skin cancer in ageing HIV positive patients. 2013

EE Merika, DTA Lim, D Asboe, A Pozniak, M Boffito, CB Bunker and N Morar

National HIV Nurses Association (NHIVNA), Birmingham

71

157. Male Genital Dermatoses in HIV. 2013

Shim TN, Hawkins D, Muneer A, Minhas S, Freeman A, Jameson CF, Francis N,,

Dinneen M & Bunker CB

STI & AIDS World Congress,

International Society for Sexually Transmitted Diseases Research (ISSTDR),

International Union against Sexually Transmitted Infections (IUSTI), Vienna

158. HPV in non-melanoma skin cancer/pre-cancer in HIV. 2013

Goolamali SI, Mladkova N, Purdie KJ, Shim, TN, de Koning MN, Quint WG, Francis N, Morar N,

Meys R, Harwood CA, & Bunker CB.

5th Blizard Institute HIV Symposium, Barts and The London, London

159. Male genital lichen sclerosus and filaggrin. 2014

Shim TN, Brown SJ, Campbell LE, Francis N, Dinneen M, Hawkins D, Muneer, A, Minhas S,

Freeman A, McLean WHI & Bunker CB.


160. Cables 1, male genital lichen sclerosus and penile cancer. 2014

Shim TN, Francis N, Peston D, Phan S, Minhas S, Nuneer A, Dinneen M, Freeman A & Bunker CB.


161. A case series of pyoderma gangrenosusm after deep inferior epigastric perforator-flap breast reconstruction. 2014

J Simpson, P Harris, G Stamp, S James, C Bunker & L Fearfield.


163. Human leucocyte antigen and human papilloma virus in male genital lichen sclerosus, penile precancer 2014

and penile cancer.

Shim TN, Meys R, Goolamali SI, Tavarozzi, F, Francis N, Dinneen M, Freeman A, Jameson C,

Muneer A, Minhas S, De Koning MN, Purdie KJ, Gotch FM, Marsh SGE, Harwood CA & Bunker CB..


Scholarship winner and plenary presentation

161. Prevalence of human papillomavirus in male genital lichen sclerosus, penile carcinoma in situ and 2014

penile carcinoma: correlation with p16INK4a status.

Shim TN, de Koning MN, Gollamali SI Meys R, Francis N, Jameson C, Freeman A, Dinneen M, Minhas S,

Muneer A, Purdie KJ, Harwood CA & Bunker CB.


162. Immunosuppression, human papilloma virus and Merkel cell polyomavirus in male genital lichen sclerosus, 2014

penile precancer and penile cancer.

Shim TN, Goolamali SI, Francis N, Dinneen M, Muneer A, Minhas S, Freeman A, Jameson C, Purdie KJ,



163. Human papillomavirus (HPV), Merkel cell polyomavirus (MCV), HIV and non-melanoma skin cancer. 2014

Goolamali SI, Shim T, Purdie K, Mladkova N, Francis N, Harwood CA & Bunker CB.


164. A rare case of colocalisation between lichen planus and vitiligo. 2015

Kravvas G, Veitch, D & Bunker CB.


165. Dermatological manifestations of syphilis. 2015

Noy M, Bunker CB, Fuller C, Shelley J, Weir J, & Fearfield L.

British Association of Dermatologists, Manchester

166. Immunogenetics of non-melanoma skin cancer/pre-cancer in HIV. 2015

Goolamali SI, Meys R, Shim TN, Mletzko S, Fowles F, Tavarozzi F, Gotch F, Harwood CA & Bunker CB

72

European Society for Dermatological Research, Rotterdam

167. Obesity related lichen sclerosus and bariatrics. 2015

Doiron P & Bunker CB.

European Academy of Dermatology and Venereology, Copenhagen

168. Cutaneous tuberculosis and HIV coinfection: a case series. 2016

Fitzgerald M, Bunker CB, Pozniak A & Morar N.



169. The immunogenetic profile of non-melanoma skin cancer (NMSC) and pre-cancer subtypes in HIV. 2016

Goolamali, Meys R, Shim TN, Mletzko S, Fowles F, Tavarozzi F,.Gotch FM, Marsh SGE,


European Academy of Dermatology and Venereology, Vienna

170. The diagnosis and management of male genital lichen sclerosus and penile intraepithelial neoplasia: 2016

Audit of 374 patients

Kravvas G, Shim T, Doiron PR, Freeman A, Muneer A, Dinneen M, Francis N & Bunker CB

European Academy of Dermatology and Venereology, Vienna

171. Human papilloma virus (HPV) in non-melanoma skin cancer/pre-cancer in HIV. 2016

Goolamali SI, Mladkova N, Purdie KJ, Shim TN, de Koning MNC, Quint WGV, Francis N, Morar N,

Meys R, Harwood CA & Bunker CB.

British Skin Foundation, Skin Deep: 20 Years of Research, London

172. Human papilloma virus (HPV), Merkel cell polyomavirus (MCV), HIV and non-melanoma skin cancer. 2016

Goolamali SI, Shim TN, Purdie KJ, Mladkova N, Francis N, Harwood CA & Bunker CB


173. Immunogenetics of non-melanoma skin cancer /pre-cancer in HIV. 2016

Goolamali SI, Meys R, Shim TN, Mletzko S, Fowles F, Tavarozzi F, Gotch FM, Marsh SGE,



174. The immunogenetic profile of non-melanoma skin cancer (NMSC) and pre-cancer subtypes in HIV. 2016

Goolamali SI, Meys R, Shim TN, Mletzko S, Fowles F, Tavarozzi F, Gotch FM, Marsh SGE,



175. The balanopreputial mycobiome in health and disease: male genital lichen sclerosus. 2018

Watchorn RE, van den Munckhof EHA, Quint KD, de Koning MNC, Quint WGV & CB Bunker.

British Society for Investigative Dermatology, London

176. The Balanopreputial Microbiome in Male Genital Lichen Sclerosus. 2018

Watchorn RE, van den Munckhof EHA, Quint KD, de Koning MNC, Quint WGV & CB Bunker.

International Investigative Dermatology, Orlando

177. Circumcision is not always curative in male genital lichen sclerosus 2018

M Shah, RE Watchorn & CB Bunker


73

CLINICAL CASES PRESENTED AT MEETINGS:

1. Digitate dermatosis, St. John’s Hospital Dermatological Society 1986

2. Erythrokeratoderma variabilis, Royal Society of Medicine 1986

3. True histiocytic lymphoma, Royal Society of Medicine 1986

4. Pseudoporphyria cutanea tarda, St. John’s Hospital Dermatological Society 1986

5. Cock’s peculiar tumour, Royal Society of Medicine 1987

6. Granulomatous cheilitis and Crohn’s disease, St. John’s Hospital Dermatological Society 1988

7. Giant cell arteritis and SLE, British Association of Dermatologists, The Royal Free Hospital, London 1988

8. HTLV-1 associated ATLL: indolent cutaneous prodrome, Royal Society of Medicine 1988

9. Familial localised scleroderma, telangiectasia, and cytogenetic abnormalities, Royal Society of Medicine 1989

10. HTLV-1 associé au lymphome/leucémie de l’adulte: prodrome cutané peu évolutif. 1989


11. Cock’s peculiar tumour, European Academy of Dermatology and Venereology, Florence 1989

12. HTLV-1/ATLL: indolent prodrome, European Academy of Dermatology and Venereology, Florence 1989

13. Cock’s peculiar tumour, American Academy of Dermatology, San Francisco 1989

14. Eyelid lesions and Histiocytosis X (Langerhans-cell histiocytosis), Royal Society of Medicine 1990

15. Eyelid lesions and Histiocytosis X (Langerhans-cell histiocytosis), 1990


16. Morphoea and mononeuritis multiplex (with Drs Dowd and Goldsmith) 1990


17. Wegener’s granulomatosis, Royal Society of Medicine 1990

18. Scleredema of Buschke, Royal Society of Medicine 1991

19. Neuro-Behçets disease, Royal Society of Medicine 1991

20. Erythrokeratoderma variabilis, British Association of Dermatologists, The Royal London Hospital 1991

21. Granulomatous cheilitis (Crohn’s), British Association of Dermatologists, The Royal London Hospital 1991

22. Scleredema of Buschke, British Association of Dermatologists, The Royal London Hospital 1991

23. Irritant contact dermatitis due to water (with Dr P Goldsmith) 1991

British Association of Dermatologists, The Royal London Hospital

24. Paget’s disease of the scrotum (by Dr A Bewley), St. John’s Hospital Dermatological Society 1992

25. Paget’s disease of the scrotum (by Dr A Bewley, with Dr R. Staughton), Royal Society of Medicine 1992

26. Trichorrhexis nodosa (by Dr J Ross), St. John’s Hospital Dermatological Society 1992

74

27. Cholesterol emboli (by Dr J Ross), Royal Society of Medicine 1993

28. Epidermolysis bullosa acquisita (by Dr R Yu), St. John’s Hospital Dermatological Society 1993

29. Synthetic fibre hair transplant (by Dr J Ross), St. John’s Hospital Dermatological Society 1994

30. Venous vascular malformation (by Dr A Farrell), St. John’s Hospital Dermatological Society 1994

31. Cronkite Canada syndrome (by Dr C Gooptu), Royal Society of Medicine 1994

32. Scleredema diabeticorum (by Dr A Farrell), Royal Society of Medicine 1994

33. Merkel cell carcinoma (by Dr C Gooptu), Royal Society of Medicine 1994

34. Acquired Ichthyosis and Leiomyosarcoma (by Dr A Farrell), Royal Society of Medicine 1994

35. Multiple pilomatrixomas, dystrophia myotonica and AIDS (by Dr A Farrell), Royal Society of Medicine 1994

36. Staphylococcal scalded skin syndrome in HIV (by Dr A Farrell), Royal Society of Medicine 1994

37. Pyoderma gangrenosum of the penis (by Dr A Farrell), Royal Society of Medicine 1995

38. Eosinophilic fasciitis (by Dr A Farrell), Royal Society of Medicine 1995

39. Meningococcal septicaemia with extensive skin necrosis, Royal Society of Medicine 1995

40. Pyoderma gangrenosum /Takayashu’s arteritis 1995

(by Dr J Ross, with Dr R Staughton), Royal Society of Medicine

41. Degos Disease (by Dr A Farrell), Royal Society of Medicine 1995

42. A military bite (by Dr A Farrell, with Dr J Cream), Royal Society of Medicine 1995

43. Aquagenic urticaria and HIV (by Dr L Fearfield), Royal Society of Medicine 1996

44. Hansen’s disease presenting as erysipelas, Royal Society of Medicine 1997

(by Dr G Osborne, with Dr P Easterbrook),

45. Familial cutaneous leiomyoma and uterine leiomyoma, Royal Society of Medicine 1997

(by Dr L Fearfield with Dr R Staughton)

46. Angioimmunoblastic lymphadenopathy/dysproteinaemia (by Dr L Fearfield), Royal Society of Medicine 1997

47. Cutaneous CMV in AIDS mimicking nodular prurigo (by Dr E.Mallon), Royal Society of Medicine 1997

48. Ig A pemphigus (by Dr E Mallon, with Dr P Mortimer), Royal Society of Medicine 1998

49. Chronic erosive herpes simplex of the penis in HIV following immune reconstitution in AIDS 1988

(by Dr L Fearfield) Royal Society of Medicine

50. Dermatomyositis associated with carcinoma of the bladder (by Dr E Mallon), Royal Society of Medicine 1997

51. Reticular erythematous mucinosis in HIV, Royal Society of Medicine 1998

(by Dr R Morris-Jones, with Dr R Staughton)

75

52. Phimosis and stridor due to Kaposi’s sarcoma (by Dr R Morris-Jones), Royal Society of Medicine 1998

53. Sinus histiocytosis with massive lymphadenopathy/Rosai-Dorfman Disease, Royal Society of Medicine 1998

(by Dr S.Grabcyznska)

54. Zosteriform metastasis of SCC in HIV (by Dr L Fearfield), Royal Society of Medicine 1999

55. Verrucous lupus erythematosus (by Dr O O’Gorman-Laylor), St. John’s Hospital Dermatological Society 1999

56. Buschke-Lowenstein tumour of the penis (by Dr O O’Gorman-Lalor), Royal Society of Medicine 1999

57. Granulomatous CTCL (by Dr L Fearfield), Royal Society of Medicine 2000

58. Leukaemia cutis- response to UVB (by Dr W Porter). Royal Society of Medicine 2000

59. Reticular erythematous mucinosis (by Dr R Sidwell). St. John’s Dermatological Society 2000

60. Granuloma faciale (by Dr S Dawe, with Dr R Staughton). St. John’s Dermatological Society 2000

61. Anorexia, alcohol, eczema and poliosis (by Dr S Simpson-Dent). Royal Society of Medicine 2000

62. Common variable immunodeficiency (by Dr R. Sidwell ) Royal Society of Medicine 2000

63. Metastatic squamous carcinoma following excessive sunbed exposure (by Dr K Agnew) 2000 Royal Society of Medicine

64. Follicular mucinosis/conglobate acne - A case for diagnosis (by Dr S Dawe) Royal Society of Medicine 2000

65. ?IFAP (ichthyosis follicularis with alopecia and photophobia - A case for diagnosis (by Dr K Agnew) 2001


66. Non-venereal sclerosing lymphangitis of the penis (by Dr J Jones). Royal Society of Medicine 2001

67. Case for diagnosis: ? acne in HIV. (by Dr S Hunt with Dr R Staughton). Royal Society of Medicine 2001

68. The cutaneous side effects of cetuximab (by Dr S Hunt). Royal Society of Medicine 2002

69. Epidermodysplasia verruciformis-like eruption with HIV (by Dr S Davison). Royal Society of Medicine 2002

70. Severe acneiform folliculitis and HIV (by Dr S Hunt). Royal Society of Medicine 2002

71. Anogenital in situ /frank carcinoma in monozyotic twins with SLE (by Dr K Agnew) 2002


72. Toxic Epidermal Necrolysis treated with Human Iv Ig (by Dr N Lomax with Drs F Vega-Lopez & R Yu) 2002


73. Delayed persistent and recurrent cutaneous reactions to jellyfish sting (by Dr P-A Phan). 2002

St. John’s Hospital Dermatological Society

74. Severe multifocal anogenital epithelial neoplasia in HIV (by Dr K Agnew). Royal Society of Medicine 2003

75. Cutaneous CMV immune restoration disease in HIV (by Dr S Riaz). Royal Society of Medicine 2003

76. Divided naevus of the penis (by Dr P-A Phan). Royal Society of Medicine 2003

76

77. Spontaneous regression of extramammary Paget’s disease after excision or underlying inguinal apocrine 2004

carcinoma (by Dr. J. Bowling). Royal Society of Medicine

78. A new cutaneous polyposis syndrome: response to acitretin (by Dr. N. Heaton). Royal Society of Medicine 2004

79. Solitary anogenital xanthogranulomas (by Dr. J. Bowling). Royal Society of Medicine 2004

80. Subcutaneous granuloma annulare of the penis in two adolescents (by Dr. R. Sidwell). 2004


81. Dorsal perforation of the prepuce (with Dr H. Malhomme). Royal Society of Medicine 2004

82. Pyoderma gangrenosum of the penis treated with topical tacrolimus (by Dr. A. Lally, with Dr N Turner). 2005


83. Necrolytic migratory erythema due to glucagonoma. (by Dr. N. Attard). Royal Society of Medicine 2005

84. Metastatic medulloblastoma. (by Dr. E. Topham). Royal Society of Medicine 2005

85. Cutaneous lupus erythematosus in HIV infection: 2005

minocycline-induced or immune restoration disease (IRD)? (by Dr S Goolamali)


86. Herpes simplex scrotal immune reconstitution disease treated with imiquimod (by Dr E. Edmonds) 2005

Royal Society of Medicine.

87. Angiokeratoma circumscriptum of the penis (by Dr. M. Saha). 2005

Royal Society of Medicine.

88. Mycobacterium chelonae after facelift surgery. (by Dr. M. Saha, with Mr. L Ion). 2006

Royal Society of Medicine .

89. Progesterone Dermatitis due to Mirena coil (by Dr. A. Roberts). 2006


90. Eccrine poroma (by Dr. S. Henna). St. John ‘s Hospital Dermatological Society. 2006

91. Saxaphone penis (by Dr. M. Saha). St. John’s Hospital Dermatological Society. 2006

92. Cutaneous side effects of herceptin (by Dr. Ophelia Veraitch). 2006


93. Acute erosive dermatosis: ? factitious (by Dr. Rubetta Matin, with Dr. J. Cream). 2006


94. 3H Syndrome and TEN. (by Dr. A Chapman, with Dr. S. Mayou). Royal Society of Medicine 2006

95. Cock’s Peculiar Tumour. (by Dr. J Jones). Royal Society of Medicine 2006

96. Aneurysmal fibrous histiocytoma of the earlobe. (by Dr. WC Chan) Royal Society of Medicine 2007

97. HTLV-1 associated Adult T cell leukaemia-lymphoma. (by Dr. R Patalay, with Dr. S. Whittaker) 2007


98. Penile lymphoedema in association with occult Crohn’s disease (by Dr. M Saha) 2007


77

99. Juvenile Hyaline Fibromatosis. (by Dr. R Sidwell, with Prof M Pope) 2007


100. Sarcoidosis in HIV Infection. (by Dr A Roberts, with Dr N Morar and Dr. R Staughton) 2007


101. Chronic lymphoedema complicated by septic arthritis (by Dr W. C Chan). 2007


102. Penile acne, pili incarnarti and dermatitis artefacta (by Dr. Ien Chan). 2007


103. Mycobacteria chelonie following surgery for polyostotic fibrous dysplasia (by Dr. Priya Dewan). 2007

St. John’s Dermatological Society

104. Pityriasis rubra pilaris with Murray Williams warts (with Dr. Ien Chan). 2007

St. John’s Hospital Dermatological Society.

105. Extensive Squamous Cell Carcinoma of the Scalp Complicating Radiodermatitis 2007

(by Dr. C. Macedo and with Mr. N. Kirkpatrick)


106. Bloom Syndrome. (by Dr. T. Basu with Dr. R. Eeles) 2007


107. Angiolymphoid hyperplasia with eosinophilia of the penis. (by Dr. P.Dewan) 2007


108. Trichophyton erinacei kerion barbae. (by Dr. Ien Chan) 2007


109. Foreign body reaction following silicon implant rhinoplasty. (Dr. P. Dewan with Mr. Niall Kirkpatrick) 2007


110. Focal acral mucinosis. (by Dr. S. Zokaie) 2008

St. Johns Hospital Dermatological Society

111. Case for diagnosis-lupus erythematosus. (by Dr. C. Macedo). 2008


112. Giant idiopathic leg ulcer (dermatitis artefacta) . (by Dr S. Zokaie) 2008


113. Drug associated granuloma annulare. (by Dr. M. Liew) 2008


114. Erythrokeratoderma variabilis with onset in an adult. (by Dr. C, Macedo with Dr. R. Staughton) 2008


115 Cryptic blistering dermatosis and lipodystrophy (by Dr S. Zokaie) 2008


116. Cutaneous and systemic lupus erythematosus. (by Dr. E. Wedgeworth with Dr. Carullia and Dr. I. White) 2008


117. Folliculitis decalvans. (by Dr. O. Dadzie) 2008


78

118. Lentigo maligna melanoma of the face. (by Dr. C. Macedo) 2008

Masterclass in Advanced Cancer Medicine, Regent’s College, London

119. Spindle cell carcinoma of the scalp post radio exposure. (by Dr. C. Macedo) 2008

Masterclass in Advanced Cancer Medicine, Regent’s College, London

120. Carcinoma en curaisse and erysipeloides. (by Dr. C. Macedo) 2009


121. Myotonic dystrophy and basal cell carcinomas. (By Dr. S Goolamali) 2009

Coincidence or true association? British Association of D.ermatologists

122. Cutaneous HPV (IRAD) in HIV. (by Dr. R. Meys) 2009


123. Lues maligna and HIV. (by Dr. C. Borysiewicz) 2009


124. ?Ethambutol induced epidermolysis bullosa aqisita. (by Dr. A.Tewari) 2010


125. Severe acute fulminant bullous ‘exfoliative’ dermatitis due to flucloxacillin. (by Dr. N. Patel) 2010


126. Melanoma of the eyelid. (by Dr. C. Macedo) 2010

Masterclass in Malignant Melanoma , London Metropolitan University, London

127. Melanoma in HIV. (by Dr. C. Macedo) 2010

Masterclass in Malignant Melanoma , London Metropolitan University, London

128. Granuloma faciale (by Dr C. Borysiewicz) 2010


129. Reticulate hyperpigmentation in HIV: ? emtricitabine. (by Dr. A. Rao) 2010


130. Pityriasis lichenoides acuta. (by Dr. T. Basu) 2010


131. Sweet’s syndrome, carcinoid and myeloma: a long prodrome 2010


132. Pityriasis lichenoides acuta treated with mycophenolate. (by Dr. T. Basu) 2010


133. Multiple primary melanomas. (with Dr. L. Fearfield, by Dr A. Rao) 2010


134. Unilateral nevoid telangectasia in pregnancy. (by Dr. T. Maruthappa) 2010


135. Unilateral neuropathic pruritus. (by Dr. A. Chandrakumar) 2010


136. Nekam’s disease. (by Dr. N. Patel) 2011


79

137. Case for Diagnosis: ?syringotropic CTCL. (by Dr A. Chandrakumar) 2011


138. Punctate palmoplantar keratoderma. (by Dr. C. Borysiewicz) 2011


139. Acrodermatitis chronica atrophicans. 2011


140. Vertically acquired HIV and epidermodysplasia verruciformis. (with Prof R. Miller, by Dr. R. Meys) 2011


141. Adamantinoid trichoblastoma. (by Dr. T. Maruthappu) 2011


142. Chronic erosive verrucous HSV in CLL. (by Dr. T. Shim) 2011


143. Primary cutaneous amyloidosis of the penis. (with Dr. W. Porter by Dr. E. Merika) 2012


144. Penile melanoma in a patient with lichen sclerosus. (by Dr. N. Turnbull) 2012


145. Eccrine carcinoma of the scrotum and metastatic extramammary Paget’s disease. 2012

(with Drs. C. Macedo and L. Fearfield by Dr. R. Sinha)


146. Case for diagnosis/facial psoriasis. (by Dr. A. Chandrakumar) 2012


147. ?Granulomatous rosacea-in HIV and post-blepharoplasty. (with Dr N. Morar by Dr A. Scott) 2012


148. X-linked gammaglobulinaemia and a chronic unilateral leg ulcer. (with Dr N. Morar by Dr R. Sinha) 2012


149. Chronic erosive and verrucous herpes simplex of the penis in in chronic lymphocytic leukaemia. 2012

(by Dr T.Shim and wit.h Mr A. Muneer)



150. Giant condyloma of the penis. (by Dr T. Shim, with Mr. S. Minhas) 2012


151. Penile amyloid. (by Dr E. Merica and with Drs P. Craig and W. Porter) 2012


152. Insterstitial granulomatous drug eruption in HIV. ? raltegravir. (by Dr. A. Scott with Dr. N. Morar) 2012


153. Lichen sclerosus associated with perineal urethrostomy. 2013

(by Dr T. Shim, with Prof A Mundy and Ms D. Andrich)


154. HTLV1 presenting with dyshidrotic eczema. (by Dr. R. Meys: SpR prize winner) 2013


155. Nevoid urticaria pigmentosa. (by Dr. E. Merika with Dr. S. Singh) 2013

80

156. Acantholytic dermatosis localized of the penis. (by Dr. M-C, Wilmot with Drs. C. Perrett and E. Calonje) 2013


157. Intense Pulsed Light (IPL) and premature ageing. (by Dr. L. Thomas) 2013


158. Generalised essential telangectatsia. (by Dr. L. Thomas) 2013


159. Connective tissue disease. (by Dr. N. Rouhani) 2013


160. Pyoderma gangrenosum post deep inferior epigastric perforator-flap 2013

breast reconstruction. (by Dr J Simpson with Mr P Harris, Mr S James and Dr L Fearfield)


161. Acral blistering ? due to tetrazepam. (by Dr. D. Laheru) 2014


162. Acrodermatitis chronica atrophicans. (by Dr. D. Sandhu) 2014


163. Folliculotropic mycosis fungoides. (by Dr. D. Sandhu) 2014


164. Anetoderma. (by Dr. D. Sandhu) 2014


165. Recalcitrant facial actinic dermatitis and severe Bowenoid Papulosis (by Dr. M. Noy with Dr. C. Fuller) 2014


166. Nodular prurigo in HIV treated by thalidomide. (by Dr. M. Noy with Dr. N. Morar) 2014


167. Penile squamous carcinoma in an elderly cirrcumcised Moslem (by Dr G. Kravvas, with others) 2015

Clinical Cases from around Europe, D3T01.2

European Academy of Dermatology and Venereology, Copenhagen

168. Facial Demodicosis (by Dr. M. Noy) 2015


169. Obesity-related male genital lichen sclerosus (by Dr P. Doiron, with Messrs. M. Dinneen and A. Muneer) 2016


170. ‘Idiopathic’ cellulitis and oedema of the penis (by Dr T. Shim) 2016


171. Primary cutaneous amyloidosis of the penis (by Dr E. Merika) 2016


172. An atypical case of penile carcinoma in situ (by Dr M. Noy, with Dr N. Morar and others) 2016


173. Two salutary and instructive cases of penile cancer (by Dr G. Kravvas, with others) 2016


174. Sebopsoriasis associated with HIV infection (by Dr T. Tull with Dr N. Morar) 2016


81

175. Cutaneous tuberculosis and HIV (by Dr M. Fitzgerald, with Dr A. Pozniak) 2016


176. Use of anti-TNF therapy for severe psoriasis in HIV (by Dr P. Doiron with Drs N. Morar and A. Pozniak) 2016


177. Salutary cases of penis cancer: i) HIV & ii) urethral primary (by Dr P. Doiron, with Dr. H. Menagé) 2016


178. Eosinophilic fasciitis (by Dr K. Heelan): Prizewinner 2016


179. A white plaque on the glans penis: epidermal nevus (by Dr P. Doiron) 2016


180. Lichen nitidus of the breast (with Dr S-M. Ang) 2016


181. Destructive acneiform folliculitis in HIV 2016


182. Pretibial myxoedema (by Dr R. Ramessur) 2016


183. Psoriatic arthritis and vitiligo: adalimumab (by Dr S. Mounsey) 2016


184. Sneddon-Wilkinson disease (by Dr S-L Chan) 2017


185. Porokeratosis ptychotropica (by Dr E. Ong) 2018


186. Multiple eruptive dermatofibromas in HIV (by Dr E. Panou, with Dr W. Bakkour) 2018

187. Haemorrhagic necrosis of the skin (by Dr E. Panagou, with Prof H. Cohen) 2018

188. Male genital lichen sclerosus and sensory neuropathy (by Dr N. Papalexopoulou with Dr M-C. Wilmot) 2018


82

INVITED LECTURES:

1. Responding to Patients with Skin Problems 1986

North West Thames RHA Pharmaceutical Course, London

2. Dermatology for Chiropodists 1988

Guy’s Hospital, London

3. Psoriasis and Eczema 1991

Homerton and St Bartholomew’s Hospitals Vocational Training Scheme, London

4. The Mouth, Anus and Male Genitalia 1992

Dermatology for Genitourinary Physicians, Westminster Hospital, London

5. Tropical and Imported Dermatology 1992

Westminster Hospital Dermatology Course for GPs, London

6. Skin at the Deep End 1992

Inaugural Consultant Appointment Lecture, Westminster Medical School Old Student’s Day, London

7. Dermatology

GP Refresher Course, Westminster Hospital 1992

8. Calcitonin Gene-Related Peptide 1992

Dermatopharmacology Symposium, American Academy of Dermatology, San Francisco

9. Psoriasis - Treatment in General Practice 1993

Chelsea & Westminster Hospital Dermatology Course for GPs, London

10. Calcitonin gene-related peptide and Raynaud’s phenomenon 1993

The Skin Investigation Society (THESIS), Bristol


Dermatopharmacology Symposium, American Academy of Dermatology, Washington DC

12. What to cut out and what to refer. 1993


13. Psoriasis 1994


14. Lumps and Bumps. What to cut out. 1994

Chelsea & Westminster Hospital Minor Surgery course, London


Dermatopharmacology Symposium, American Academy of Dermatology, New Orleans

16. HIV and the Skin 1995

Inauguration of GUM Department, St Albans Hospital, St Albans

17. Indications for Surgery 1994

Chelsea & Westminster Hospital Minor Surgery course, London

18. HIV and the Skin: an Experiment of Nature: Research implications 1995

HIV and the Skin Course, Chelsea and Westminster Hospital, London

19. Penile Dermatoses 1995

83

BPMF Advanced Course in Sexually Transmitted Diseases, Chelsea and Westminster Hospital, London

20. Dermatology and Cancer 1995

Club for the Advancement of Palliative Care, St Bartholomew’s Hospital, London


Advanced Course in Sexually Transmitted Diseases, British Postgraduate Medical Federation, London

22. Dermatomyositis 1995

Dermatomyositis and Polymyositis Support Group, Institute of Education, London

23. Nasty Spots and Rashes 1995

Charing Cross Hospital GP Course, Postgraduate Centre, Charing Cross Hospital, London

24. Male Anogenital Skin Disease 1995

St. John’s Dermatology Centre, St Thomas’s Hospital, London

25. Nasty Spots and Rashes 1996

Charing Cross Hospital GP Course, Postgraduate Centre, Charing Cross Hospital, London

26. HIV as an experiment of nature - avenues for Skin research. 1996

HIV and The Skin Study Day, Gleeson Lecture Theatre, Chelsea & Westminster Hospital, London

27. Indications for Surgery - What should be cut out. 1996

Refresher Course for GPs, Postgraduate Medical Centre, Chelsea & Westminster Hospital, London

28. Dermatology 1997

GP Refresher Course, Postgraduate Medical Centre, Charing Cross Hospital, London

29. HIV as an experiment of nature - avenues for Skin research 1997

HIV and The Skin Study Day, HIV/GUM Education Unit, Chelsea & Westminster Hospital, London

30. Raynaud’s Phenomenon. 1997

19th International Charing Cross Symposium, London


Dept. of GU Medicine, Charing Cross Hospital, London


Dept. of GU Medicine, Royal South Hants Hospital, Beaulieu, Hants.

33. MRCP Part II clinical examinations for SHOs - Dermatology 1997

Chelsea & Westminster Hospital, London

34. “Sorting the Skin Lumps – Which are safe, which should be removed and which referred” 1997

The Skin in Your Practice ( for General Practitioners), Chelsea & Westminster Hospital, London

35. HIV as an experiment of nature - Avenues for skin research. 1988

HIV and the Skin Course, Chelsea & Westminster Hospital, London

36. Skin Disease in the Elderly 1998

Medicine in Old Age Course, Postgraduate Education Centre, Charing Cross Hospital, London

37. Serious Rashes: Important Lumps 1998

Refresher Course for General Practitioners, Chelsea & Westminster Hospital, London

38. Dermatological Self Assessment 1998

84

GP Refresher Course, Postgraduate Education Centre, Charing Cross Hospital, London


Trent Region Specialist Registrar Training Day, Leicester

40. The Diagnosis of Common Skin Complaints in General Practice 1998

Postgraduate Education Centre, Charing Cross Hospital, London

41. Penile Dermatology 1999

MSc in Sexually Transmitted Disease, UCL, London

42. Epidemiology and Prognostic factors in Melanoma - Symposium on Skin Cancers for GPs 1999

Postgraduate Medical Centre, West Middlesex Hospital, London

43. HIV/Penile Dermatology 1999

Department of Dermatology, Amersham Hospital, Amersham

44. Below the Belt. Genital Dermatology (with Dr Sallie Neill) 1999

The Skin and Your Practice - GP Course, Chelsea & Westminster Hospital, London


Department of Dermatology, Churchill Hospital, Oxford

46. Expanding Role of the Dermatology Nurse - Consultant View. 1999

British Dermatological Nursing Group, British Association of Dermatologists, Edinburgh

47. Skin Health and Disease 1999

Medical Society, St Paul’s Girls’ School, London


Department of Dermatology, Kings College Hospital, London

49. Dermatology for the Urologist, 2000

Section of Urology, Royal Society of Medicine, London


Department of Dermatology, Addenbrooke’s Hospital, Cambridge

51. Dermatology of the Penis 2000

Department of Dermatology, NYU, New York

52. Scientific evidence and expert clinical opinion for the investigation and management 2000

of Stage II malignant melanoma. Royal College of Physicians, London

53. Penile Rashes 2000

The Skin in Your Practice - GP Course, Chelsea & Westminster Hospital, London

54. How to sort the lumps and bumps and which to refer 2000

The Skin in Your Practice - GP course, Chelsea & Westminster Hospital, London

55. Clinic visit and hands on diagnosis/Workshop 2000

The Skin in Your Practice - GP course, Chelsea & Westminster Hospital, London

56. Dermatology for the General Physician 2000

Revision Course in General Internal Medicine for SpRs, Charing Cross Hospital, London

57. Penile Skin Lesions 2000

South West Thames Regional Dermatology Meeting, St. George’s Hospital, London

85

58. Male Genital Dermatology 2000

Fifth Annual Aberdeen Dermatology Symposium, Aberdeen Royal Infirmary, Aberdeen

59. Inflammatory Skin Conditions- male 2000

Genital Skin Conditions & The Dermatology of HIV Course, Chelsea & Westminster Hospital, London

60. Prize Rarities - male. 2000

Genital Skin Conditions & The Dermatology of HIV Course, Chelsea & Westminster Hospital, London

61. Genital Dermatoses in Men 2000

Dermatology Day, Royal Pharmaceutical Society, London

62. Seminar in Oncology: Skin Cancer 2000

Royal Marsden Hospital, London

63. Drug eruptions 2001

Royal College of Physicians Teach In -Update in Dermatology, London

64. Penile Pearls 2001

Surgical Sixty Club Meeting, Charing Cross Hospital, London

65. Problems in diagnosis and management of the commoner penile dermatoses. 2001

Joint Meeting of the Section of Dermatology and the MSSVD, RSM, London

66. Dermatology for the General Physician 2001

SpR Revision Course, Charing Cross Hospital, London

67. The Diagnosis of Melanoma 2001

John Thornton Ingram Lecture,

General Internal Medicine for the Physician Course, Royal College of Physicians, London

68. Inflammatory Diseases of the Penis. 2001

European Association of Dermatovenereology – Workshop IV: perigenital dermatoses, Munich

69. Inflammatory dermatoses in the male 2001

HIV, GUM & The Skin Course, Chelsea & Westminster Hospital, London

70. Genital intraepithelial neoplasia in the male 2001


71. Prize rarities-male 2001


72. Dermatology of the Penis 2002

Pan-Thames Teaching Programme, St. John’s Institute of Dermatology, London

73. Management of Skin problems 2002

GP Refresher course, Charing Cross Hospital, London


HIV/GUM Dept., Royal Sussex County Hospital, Brighton

75. Dermatology Emergencies 2002

SpR Revision Course in General Medicine, Charing Cross Hospital, London

76. The normal penis and congenital abnormalities 2002

Genital Skin Conditions and the Dermatology of HIV disease. Chelsea & Westminster Hospital, London

77. Inflammatory skin conditions – male 2002

86


78. Penile intraepithelial neoplasia: diagnosis and medical management 2002


79. Prize rarities: male 2002


80. Update on Penile Cancer: suspicious dermatoses– diagnosis and treatment 2003

British Association of Urological Surgeons, Manchester

81. Male genital dermatology 2003

Department of Dermatology, Hope Hospital, Manchester


Medical Society for the Study of Venereal Diseases, Non-consultant career grade conference

Loughborough University

83. Pitfalls in the diagnosis of cancer of the penis 2004

Indian Association of Dermatology, Venereology and Leprosy, Mumbai, India

84. Pitfalls in the diagnosis of cancer of the penis 2004

Chandigarh, India

85. The diagnosis of melanoma 2004

Chandigarh, India

86. Penis pre-cancer 2004

St John’s Hospital Dermatological Society, London


Current Issues in Sexual & Reproductive Health, Margaret Pyke Memorial Trust, London

88. The dysfunctional foreskin 2004

Dermatovenereology Focus Session, British Association of Dermatologists, Belfast

89. Penile rashes 2004

Primary Care Dermatology Society Lecture, Birmingham

90. Male genital dermatoses 2004

West Scotland Regional meeting, Glasgow

91. The dysfunctional foreskin 2004

Workshop 21. Male Genital Dermatology, European Association of Dermatovenereology, Florence

92. Lumps and Bumps 2005

GP Vocational Training Scheme, Chelsea & Westminster Hospital

93. Lesions of the penis.

British Association of Urological Surgeons, Section of Oncology Educational Meeting, London, 2005

94. The SAC Perspective, BAD Training Day (Feb) 2005


95. The SAC Perspective, BAD Training Day (Mar) 2005


96. Perianal Dermatology 2005

Primary Care Dermatology Society Meeting, Cambridge

87


Registrars Training Day, BAD.

98. ‘Bottoms up’ – male ano-genital dermatology – diagnosis and management 2005

The skin in your practice GP course, Chelsea & Westminster Hospital

97. The Dysfunctional Foreskin 2005

Symposium S16 – Penile Dermatoses, European Association of Dermatovenereology, London


West Yorkshire Regional Dermatology Meeting, Leeds

99. The Normal penis and Dysfunctional Foreskin 2005

Genital Skin Conditions and the Dermatology of HIV Disease, Chelsea & Westminster Hospital

100. Penile intraepithelial neoplasia 2005

Genital Skin Conditions and the Dermatology of HIV Disease, Chelsea & Westminster Hospital

101. Hidden Secrets, Genital Dermatoses – Penile lesions 2006

Urology Section, Royal Society of Medicine, London

102. Penile Dermatology – an overview 2006

South East Thames GUM/Dermatology Alliance, Maidstone

103. Male Genital Dermatology and Precancerous Dermatoses 2006

British Association of Urological Surgeons, Penis Cancer Teaching Course, Manchester

104. MMC and Training-the Future 2006

Education on Education, British Association of Dermatologists, Manchester

105. Competency Assessments Feedback 2006


106. Bottoms up – male anogenital dermatology – diagnosis and management 2006

Skin in your Practice, Chelsea & Westminster Hospital

107. Getting Your Hands on a Penis 2006

St John’s Hospital Dermatological Society, Presidential Vignette, London

108. Penile Carcinoma in Situ 2007

Indian Association of Dermatology, Venereology and Leprosy, Dermacom, Chennai, India

109. Non-venereal infections of the the penis 2007

American Academy of Dermatology, Washington, D.C.


Department of Dermatology, Boston University School of Medicine, Boston

111. Penile carcinoma in situ 2007

Causation and management of penile cancer. Joint Urology/Dermatology Sections, RSM, London


Special Presidential Lecture, Noah Worcester Dermatological Society, London


Scottish Dermatology Association, Dunfermline

114. ‘His and Hers’: Genital Dermatology (with Dr S Neill) 2007

88



Primary Care Dermatology Society, Bristol

116. Male Genital Dermatology Masterclass 2007

Primary Care Dermatology Society, Bristol

117. Deerstalking in Scotland 2007

Presidential Address, West London Medicochirurgical Society, London

118. The Normal Penis and the Dysfunctional Foreskin 2007

Dermatology in Genitourinay & HIV Medicine Course, Chelsea & Westminster Hospital

119. Penile Intraepithelial Neoplasia: diagnosis and management. 2007


120. CGRP in Raynaud’s Phenomenon and other Projects. ‘Festschrift’: Professor Pauline M Dowd 2007


121 ‘Festschrift’. Dr Richard Staughton 2007

Chelsea & Westminster Hospital

12. The pathogenesis of male genital lichen sclerosus. 2008

Indian Association of Dermatology, Venereology and Leprosy, Dermacon, Chandigarh

123. Preancerous Dermatoses of the Penis and penile carcinoma in situ. 2008

BAUS Section of Oncology, Spring Training Meeting, Leicester

124. Penile Dermatoses. 2008

BAD SpR Training Event, Windsor

125. Dermatoses affecting the male genitalia. 2008

Clinical Dermatology Update Programme, Manchester

126 Pathomechanisms: Male Genital Lichen Sclerosus, Malignant Melanoma, and HPV IRAD in HIV. 2008

Dermatology Lunchtime Seminar Series, St. John’s Institute of Dermatology, KCL, London

(with Drs Singh and Meys)

127. Common clinical errors in the management of malignant melanoma. 2008

UK KEY ADVANCES IN CLINICAL PRACTICE SERIES (2008):

Key Advances in the Effective Management of Malignant Melanoma. 2nd National Update, London

128. Masterclass in Advanced Cancer Medicine-Skin Cancers 2008

Panellist and Case presentations (with Dr. C. Macedo)

129. The Normal Penis and the Dysfunctional Foreskin 2008


130. Penile Intraepithelial Neoplasia: diagnosis and management. 2008


131. Male Genital Dermatoses. 2008

Kuwaiti Dermatology Association, Kuwait

132. Topics in the Diagnosis & Management of Malignant Melanoma 2009

Primary Care Dermatology Society of Ireland, Dublin


89

Primary Care Dermatology Society of Ireland, Dublin

134. Male Genital Dermatology/The Dysfunctional Foreskin 2009

Sexuality and Sexual Health Section, Royal Society of Medicine, London


Advanced Medical Dermatology Symposium S011, American Academy of Dermatology

San Francisco

136. A Practical Approach to Penile Skin. 2009

Colposcopy and Genital Dermatosis Special Interest Group. British Association for Sexual Health and HIV

London


Solent Skin Society, Winchester

138. HIV Dermatology: Current Issues 2009

International Society of Dermatology, Prague


Section of Dermatology, Royal Academy of Medicine in Ireland, Dublin

140. Male Genital Dermatology, 2009

Primary Care Dermatology Society, Scottish Meeting, St. Andrews

141. HIV and Dermatology: Current issues. 2009

HIV and Dermatology Virtual Clinic Meeting (Gilead), St. Stephen’s Club, London


St John’s Institute of Dermatology, MSc Course, London




Maadi Military Hospital, Cairo


Maadi Military Hospital, Cairo


Pan-Thames, GUM/HIV Spr Training Day, Medical Society of London

147. Masterclass in Advanced Cancer Medicine-Skin Cancers 2010

Panellist and Case presentations (with Dr. C. Macedo)


St John’s Institute of Dermatology, SpR Training, London

149. HIV Dermatology: Current Issues from London 2010

HIV Symposium SO 17, American Academy of Dermatology, Miami Beach

150. Ethical Issues in Private Practice in Dermatology 2010



Dowling Oration, Lincoln


90

American Dermatological Association, New York

153. Impact of ARVT on HIV Dermatology 2010

EADV, Gothenburg

154. Lichen Sclerosus and Carcinoma in Situ of the Genitalia: His and Hers (with Dr Sallie Neill) 2010

EADV, Gothenburg


Sharm Derma, Sharm El Sheikh, Egypt

156. HIV Dermatology: Current Issues, 2010

Sharm Derma, Sharm El Sheikh, Egypt

157. Male Genital Dermatology and the Impact on Sexual and Urinary Function 2010

European Society for Sexual Medicine, Malaga

158. Melanoma in the 21st Century: Why This Disease is Important for All Physicians 2010

Royal College of Physicians Regional Lecture

South West Regional Update, Taunton


British Association of Dermatologists & St John’s Hospital Dermatology Society

Annual UK Consultants Course, London

160. HIV Dermatology in the 21st Century: Neil Smith memorial lecture 2011

St John’s Hospital Dermatological Society


6th Annual GPSI Meeting, Leeds

162. The Immunocompromised Patient in Dermatology 2011

Primary Care Dermatology Society of Ireland, Galway

163. Dermatological Signs in Internal Malignancy 2011

Primary Care Dermatology Society of Ireland, Galway

164. HIV and the Skin: 2011 2011

Current Issues in Sexual Health 2011: 3rd National Conference, London

165. The Dysfunctional Foreskin and Penis Pre-cancer 2011

UCLH Penile Cancer Day

166. Male Genital Dermatology: from Dyspareunia to Penis Cancer 2011

VII All-Russian Congress “Men’s Health”, Rostov-on-Don

167. Melanoma 2011

GP Seminar, UCLH, London

168. Male Genital Dermatology: The Dysfunctional Foreskin and Penis pre cancer and Cancer 2011

British Association of Urological Surgeons, Liverpool

169. Skin and HIV 2011

BASHH HIV Focus Meeting, RSM, London

170. Genital and Oral Lesions-Whats your Diagnosis? (with Drs Setterfield, Neil and Pelisse 2011

EADV, Lisbon


91

1st BASHH Genital Dermatology Course, London

172. Penile Dermatoses and their Management 2011

British Association of Dermatologists & St John’s Hospital Dermatology Society


173. Melanoma: Why This Disease is Important for All Physicians 2011

Eastern Mediterranean Seminar on General Medicine,

Medical Royal Colleges Association, Limassol, Cyprus

174. HIV Dermatology post HAART 2011



175. Emergency Dermatology 2011



176. HIV Dermatology in the Era of HAART 2011

ASICON, Lucknow

177. Lichen Sclerosus and Penis Cancer 2011

AIIMS, New Delhi


Eropean Society for Sexual Medicine, Milan

179. Pathogenesis of Male Genital Lichen Sclerosus 2012

Dermacon 2012, Jaipur


Ulster Dermatological Society, Craigavon


European Association of Urology, Paris

182. Male Genital Lichen Sclerosus 2012

Male Gential Dermatology and Oral Dermatology: the fundamentals

University of Hertfordshire, Hatfield

183. What does the Dermatologist expect from the Pathologist in Penile Pathology? 2012

Selected Aspects of Genital Dermatopathology,: 19th Update in Dermatopathology

St Johns’s Institute of Dermatology, London.

184. Male Genital Dermatology: from Dyspareunia to Penis Cancer 2012

Astellas ‘Seven Wonders of the Skin’, London

185. From Dyspareunia to Penis Cancer: Male Genital Dermatology 2012

Hampstead Medical Society, London



186. New Healthcare Providers stepping into Dermatology: Reorganisation of the NHS 2012

International League of Dermatological Societies, 1st Dermatology Summit. Berlin

188. Penis Cancer: An Unnecessary Disease 2012

EADV, Verona

92

189. Lichen Sclerosus and Lichen Planus (Male) 2012

Ano-Genital and Mucosal Dermatology Course, St Thomas’ Hospital

190. The Aetiopathogenesis and Medical Management of Male Genital Lichen Sclerosus 2012

British Association of Urological Surgeons, Glasgow


British Association of Dermatologists, Trainee session, Birmingham

192. The Pathogenesis of Male Genital Lichen Sclerosus 2012

British Association of Dermatologists, Professors & Registrars Forum, Birmingham

193. Presidents Address 2012


194. HIV Dermatology Post HAART 2012

International Medical Meeting, Riga

195. The Dysfunctional Foreskin: from Dyspareunia to Penis Cancer 2012

BASHH SAS Conference, Loughborough

196. HIV Dermatology in the 21st Century 2012

SAS Clinical Update Meeting, Manchester


BAD SpR Training Event, London

198. Male Genital Lichen Sclerosus (Lichen Planus & Zoon’s balanitis) 2012

2nd BASHH Genital Dermatology Course, London


Eropean Society for Sexual Medicine, Amsterdam (in absentia: snow)

200. HIV Dermatology in the Era of HAART 2013

Astellas ‘Seven Wonders of the Skin’, London


St John’s Registrar Teaching, London

202. Penis Pre-Cancer and Carcinoma in Situ 2013

British Association of Dermatologists Non-Melanoma Skin Cancer Update


203. HIV Dermatology post HAART; Current Issues 2013

World Congress of Dermatology Vancouver 2015 Preview

American Academy of Dermatology, Miami Beach


Male Gential Dermatology and Oral Dermatology, University of Hertfordshire, Hatfield

205. Dr Robin Graham-Brown and the BAD/BSF 2013

Festschrift, Midlands Dermatological Society, Leicester

206. HIV Dermatology in the Era of ARVT 2013

Guest Lecture, British Society for Skin Care in Immunocompromised Individuals, Liverpool

207. London EADV Spring Symposium 2015: British Bid 2013

EADV Board, European Academy of Dermatology & Venereology, Istanbul

93

208. Aetiopathogenesis and Management of Male Genital Lichen Sclerosus 2013

European Academy of Dermatology & Venereology, Istanbul

209. Malignant Melanoma Pitfalls 2013

Clinical Dermatology Update Meeting, SAS Doctors, Manchester

210. The Dysfunctional Foreskin-from dyspareunia to penis cancer 2013

Baltic Association of Dermatovenereologists, Kaunas


3rd BASHH Genital Dermatology Course, London

212. HIV Dermatology 2013

Primary Care Dermatology Society, Edinburgh

213. Perianal and Penile Dermatology 2013

Primary Care Dermatology Society, Edinburgh

214. The Aetipathogenesis and Management of Male Genital Lichen Sclerosus 2013


215. HIV Dermatology post cART 2014

European Dermatology Forum, Bern

216. Lichen Sclerosus in Men

Male Gential Dermatology and Oral Dermatology, University of Hertfordshire, Hatfield 2014

217. Crisis in Dermatology: Happy Birthday PCDS 2014

Primary Care Dermatology Society, Kenilworth

218. A Different Perspective: Male Genital Lichen Sclerosus 2014

British Society for the Study of Vulval Disease, Glasgow

219. Selected Topics in Male Genital Dermatology 2014

Registrar Training Day, Australasian College of Dermatologists, Melbourne


Australasian College of Dermatologists, Melbourne

221. The Aetiopathogenesis of Male Genital Lichen Sclerosus 2014

Genital Dermatology Symposium, Australasian College of Dermatologists, Melbourne

222. Toxic Epidermal Necrolysis 2014

Australasian College of Dermatologists, Melbourne


Baltic Association of Dermatovenereologists, Riga

224. Clinical and Research Agenda, British Association of Dermatologists 2014

UK TREND Launch, London

225. The Aetiopathogenesis of Male Genital Lichen Sclerosus 2014

Dowling Club, Moscow

226. Melanoma and Non-melanoma Skin Cancer in HIV 2014


227. HIV and Skin Manifestations 2014


94




BASHH Genital Dermatology Course, London

230. HIV Dermatology in the Era of cARV Therapy 2014

College of Podiatry Annual Conference, Bournemouth


North London Academic Dermatology Meeting, London

232. HIV Dermatology in the Era of cART 2014

Retired Fellows’ Society, Royal Society of Medicne, London

233. Male Genital Lichen Sclerosus-from dyspareunia to penis cancer 2014

Urology Arena, Berne


John Thornton Ingram Lecture, Royal College of Physicians

Medical Dermatology Meeting, (RCP, BAD, BSMD, BSSCII), London

235. HIV Dermatology in the Era of cART


236 When to think of HIV (and how to proceed)


237. Male Genital Lichen Sclerosus-From Dyspareunia to Penis Cancer 2015

Grand Rounds, Dpartment of Dermatology, UCSF, San Francisco

238. Toxic Epidermal Necrolysis. 2015

Residents Seminar, Department of Dermatology, UCSF, San Francisco

238. Male Genital Skin Disease 2015

FO35, AIDS and STIs, American Academy of Dermatology, San Francisco

239. Penile Dermatology for the Urologist 2015

Inaugural European School of Urology Course: Penile Diseases

European Association of Urology, Madrid

240. HIV in Dermatology 2015

Dubai Derma, 15th Dubai World Dermatology and Laser Conference and Exhibition

Dubai


Dubai Derma, 15th Dubai World Dermatology and Laser Conference and Exhibition

Dubai


Teach In. Dermatology for the General Physician, Royal College of Physicians



5th Annual Anogenital and Oral Genital Dermatology Course, St John's Institute of Dermatology



95

‘Best of British’, ILDS Member Society Meeting


245. The Many Faces of Skin Manifestations in HIV 2015

SY05, Sexually Transmitted Infections


246. HIV Skin Disease in the Era of cART 2015

CO06, Microbiology & Infectious Diseases


247. Lichen Sclerosus in Males 2015

SY21, Genito-Anal Disorders


248. HPV Infection in HIV Infected Patients 2015

SY25, HPV–New Horizons


249. Male Genital Lichen Sclerosus: Aetiopathogenesis & Management 2015

SY70, Men’s Issues


250. The Many Faces of Skin Manifestations in HIV 2015

The World Congress Experience (Vancouver), Telelecture, Diegem (Belgium)

251. Male Genital Lichen Sclerosus: Aetiopathogenesis & Management 2015

The World Congress Experience (Vancouver), Telelecture, Diegem (Belgium)

252. HIV & Co-infections: HPV & HSV 2015

D1T5.4 Review and Updates: HIV

European Academy of Dermatology & Venereology, Copenhagen



254. Male Genital Lichen Sclerosus - from Dyspareunia to Penis Cancer 2015

Dept. of Dermatology, Edinburgh

255. Topics in Male Genital Dermatology - MGLSc, CIS and IPL 2015

Joint RSM Urology/ BAUS Andrology Teaching Day, Andrology Today, London


UK National DermSoc Day, British Association of Dermatologists, London






North Thames Dermatology/Rheumatology Training Day, UCLH

260. Toxic Epidermal Necrolysis-Guidelines v Lifelines 2015

West Midland Regional Dermatology Meeting, Birmingham


British Association of Dermatologists Training Event, London

96

262. Male Genital Dermatoses 2015


263. Selected Topics in Male Genital Dermatology 2016

Dansk Dermatologisk Selskab, Munkebjerg, Veijle

264. Melanoma 2016

Dermatology Workshop for Nuffield Health GPs, King Edward VII Hospital, London


Advanced Medicine Conference, Royal College of Physicians, London


European School of Urology Course: Penile Diseases, European Association of Urology, Munich


Primary Care Dermatology Society of Ireland, Killarney

268 The Diagnosis of Melanoma 2016

Primary Care Dermatology Society of Ireland, Killarney





270. HIV Dermatology in the Era of cART (Plenary Lecture) 2016

European Academy of Dermatology & Venereology, Athens


Pierre Deville Memorial lecture, Royal Society of Medicine


BASHH Genital Dermatology PLUS Course, London




2nd International Conference of Dermatology & XIIIth SODVELON, Kathmandu







278. This House believes that UK Dermatology is not ready for Evidence Based Medicine 2016

Opposer to the motion

British Association of Dermatologists & St John’s Hospital Dermatology Society,




97







282. Bowenoid Papulosis 2017

European Academy of Dermatology & Venereology, Geneva

283. Male Genital Lichen Sclerosus - from Dyspareunia to Penis Cancer 2017

Society for the Study of Sexually Transmitted Diseases in Ireland, Dublin


European School of Urology Course: Penile Diseases, European Association of Urology, Copenhagen


Pan-Thames, Dermatology SpR Training, Guy’s Hospital, London


Dowling Club Meeting, Valletta, Malta






Primary Care Dermatology Society, London

289. How to Prevent Penis Cancer 2018

British Society for Geriatric Dermatology, British Association of Dermatologists, Edinburgh

Numerous lectures annually to medical students at the several institutions at which I have worked:

e.g. 12 per annum at Imperial College 2005-2010

ma (cantab.), md (cantab.), frcp (lond.) - newa1 curriculum vitae july, 2018 professor c. b. bunker...

Documents